List of Devices Companies in United States - 772

3Daughters is a clinical development company focused on enhancing women’s healthcare through innovative contraceptive solutions. The company aims to fill critical gaps in women's health by developing research-driven products that prioritize patient safety, efficacy, and accessibility. Their flagship products include 3D-001, a frameless, nonhormonal intrauterine device (IUD) designed to reduce insertion pain, and the Slider™ System, which features the i-Slider™ for insertion and the r-Slider™, a magnetic retriever for easy placement and removal. This technology leverages physics and geometry to improve comfort and minimize complications associated with traditional IUDs. 3Daughters targets women seeking reliable, long-acting contraception, particularly those who may be deterred by pain or hormonal side effects. The company has secured over $2 million in seed funding to advance its products through clinical trials, with a commitment to regulatory compliance and quality management. Their mission is to transform women’s healthcare by improving contraceptive accessibility and comfort.

410 Medical is a medical device company dedicated to developing innovative products that enable clinicians to improve care for critically ill patients. LifeFlow® PLUS, 410's recently approved product, is designed to enhance the speed and efficiency of volume resuscitation, improving care for patients with life-threatening conditions such as sepsis, hemorrhage and cardiac arrest.

4C Medical Technologies, Inc. is a medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR). We are the first transcatheter MR therapy that directly addresses mitral regurgitation without replacing the native mitral valve, thus preserving the native mitral annulus and left ventricle. The device is positioned supra annular to the leaking native mitral valve to stop the leak from entering the left atrium. Its atrial only fixation ensures minimal disruption to critical cardiac structures within the left ventricle including the chordae tendineae and the left ventricular outflow tract. Our initial focus is to develop a novel therapy for mitral regurgitation (MR), and subsequently for tricuspid regurgitation (TR).

Abaxis develops and commercializes medical device and innovative technology and services that support best medical practices, enabling practitioners to respond to the health needs of their patients, while operating point of care, onsite diagnostics for human and animal health.Abaxis is now part of Zoetis.

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.htm

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Based in Danvers, Massachusetts, USA, Abiomed, Inc., part of Johnson & Johnson MedTech, is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit www.abiomed.com. Important Safety Info: https://bit.ly/39kvb47

Access Vascular is offering our suite of vascular access solutions designed to help clinicians address common catheter complications that afflict patients while helping save hospitals time and money.

Ace Vision Group, Inc. (AVG) is a privately held U.S. ophthalmic medical device company developing Laser Microporation Therapeutic technologies to address age-related eye dysfunction and address the eye's natural biomechanical performance. AVG's Laser Scleral Microporation (LSM) is a therapeutic eye laser treatment that aims to restore visual function naturally without sacrificing distance vision. AVG's brand promise is to provide the field of ophthalmology with innovative devices, Microporation Therapeutic procedures, and education for the treatment of age-related ocular dysfunction, disability, and disease.

ACON Laboratories is an international diagnostic and medical device company with our corporate headquarters in San Diego, California USA. For more than 15 years, ACON has led the way in making high quality diagnostic and medical devices more affordable to people all around the world. The ACON name is well known in over 130 countries. Headquartered in San Diego, California, the US office is the center of strategic management, administration, business development, innovative research and development. Our state of the art manufacturing facility is ISO 13485:2003 certified, FDA registered and has been inspected by US FDA. Our current product lines include Diabetes Care, Clinical Chemistry (including Urinalysis and Point of Care Tests) and Immunoassay EIA/ELISA. We also have a number of new products in the pipeline for introduction in the future.

3D ultrasound therapy

Actipulse Neuroscience® is a neurotechnology company focused on non-invasive brain stimulation therapies for neurological and psychiatric disorders. Founded in 2017, the company has offices in Cambridge, MA, and Paris, with a presence in Mexico. Actipulse aims to make neuromodulation treatments accessible by transitioning them from hospitals to home-based solutions, targeting conditions such as depression, Alzheimer’s, and Parkinson’s diseases. The company has developed a proprietary portable transcranial magnetic stimulation (TMS) device designed for home use. This device delivers high-frequency magnetic pulses to address issues like neuroinflammation and neuroplasticity loss. Actipulse is conducting clinical trials for major depressive disorder and exploring applications for neurodegenerative disorders. Their home-based treatment model allows for remote administration of TMS under clinical guidance, integrating with telemedicine platforms. Actipulse envisions establishing neuromodulation as a standard therapy alongside traditional pharmacological treatments.

Actuated Medical has quickly emerged as a leader in the design and development of medical devices and components. Using proprietary actuation technologies, our innovations address a wide variety of medical challenges ranging from clearing occlusions to easing tissue penetration to enabling MRI assisted procedures. From start to finish, our team designs, develops and manufactures under an ISO-certified quality control system. In addition, we continually seek feedback from domain experts to ensure our products not only solve real problems but also are readily accepted by clinicians. With a proven track record of receiving federal grants to support research and development, the company has built a successful business model that takes medical devices from conception to regulatory approval to market.

Adient Medical is a medical devices company that specializes in absorbable devices that automatically vanish, eliminating the need for removal procedures.

Since 1983, surgeons and neurologists have turned to Ad-Tech for Gold Standard products that help them deliver life-changing care to patients around the world. Our innovative electrodes are used to treat intractable epilepsy, in neurodiagnostics and neurosurgery. With devices ranging from intracranial electrodes for Long Term Monitoring (LTM) and Intraoperative Monitoring, (IONM) and a wide variety of device specifications, we manufacture the devices medical professionals count on for optimal care outcomes. We're humbled by the important role our products can play in the work of caregivers and the lives of their patients. That's why Ad-Tech products are registered and approved for use in more than 60 countries. All are manufactured in the United States. As an ISO 13485 certified company, we observe the highest standards of quality and an unwavering commitment to regulatory compliance. At Ad-Tech, surgeons and their patients always come first.

Advanced Bifurcation Systems Inc. has developed a novel technology to enable effective stenting of coronary arteries at their branch points (bifurcations). This comprehensive platform is a paradigm shift in interventional cardiology that will reduce the need for open-heart surgery, hospitalizations, and repeat coronary angioplasties. The technology will simplify procedures and improve outcomes while reducing angioplasty times which results in significant improvement to the overall patient care at a reduced cost.

Over the past decade, Advanced Brain Monitoring has developed and implemented mobile, user-friendly platforms for acquiring, integrating, analyzing and reporting multi-sensor data in real-world applications. Our strong and growing technical team includes PhD- and masters-level hardware engineers, biostatisticians, software engineers and experts in signal processing, experimental design and clinical trials. ABM seeks to build on existing collaborations within the academic community and develop strategic partnerships across industry with like-minded professionals.

Advanced Radiation Therapy is the provider of AccuBoost. AccuBoost is the latest innovation in breast radiation therapy. The primary beneficiaries of the AccuBoost Technique are the breast cancer patients: who receive conformal radiation with better targeting, less toxicity, much less skin reaction, minimum exposure to the heart and lungs and a superior cosmetic result.

Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a person's genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method. Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects. Our vision is to be earth's most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.

Nasal breathing is a very important function of human life and any obstruction in the nasal airway also known as a congested or blocked nose, can dramatically impact the quality of life.The VIVAER treatment, performed in a doctor’s office, is a non-invasive procedure without any incisions. The patient'snasal valve area is gently reshaped using low-temperature radiofrequency energy with lasting results.

Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Affinity Life Sciences for over 10 years providing the highest quality services for Lyophilization, Reagent Manufacturing, Immunoassay test and more.

Ainos Inc. is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, women's health, pneumonia, Ainos Pen, AI Nose, and other medical technologies. The company was founded in 1984 and is engaged in developing innovative medical technologies for point-of-care testing and safe and effective treatments for various health conditions.

AirLife is the global leader in consumable breathing products, specializing in respiratory care, anesthesia, and patient monitoring solutions. AirLife has brought together the most trusted brands in anesthesia and respiratory care, such as SunMed, Salter Labs, Ventlab, Ethox Medical, Westmed, Vital Signs and Ballard. Our family of brands offers a product portfolio that spans the continuum of care from first responder to home care, with safety, patient comfort, and clinical performance in mind.

AIROS™ Medical, Inc. is a medical technology manufacturer, designer, and specification developer specializing in compression therapy. Our team of engineers, quality and regulatory experts, and clinical partners create medical devices that improve quality of life for patients battling lymphatic and venous disorders, including the AIROS 6 and AIROS 8 Sequential Compression Device systems.

Akrivita (formerly SeeTrue), a woman-owned company, specializing in microcapillary needles for precision microinjection. At AkriVita, we've developed the MultiPort Microcapillary Needle using advanced 3D printing and unique resin, ensuring precise and consistent needles. This innovative design eliminates recalibrations, reduces downtime and costs, and minimizes clogging. Our high-contrast needles offer consistent flow, improving the success rates of microinjection procedures. AkriVita provides biomedical scientists and healthcare practitioners with reliable tools that enhance outcomes, save time, and cut costs, enabling them to focus on advancing human health through discovery and innovation.

Alafair Biosciences is a privately-held, commercial-stage medical device company focused on the development of novel clinical products using its proprietary hydrogel technology. With a patent portfolio covering a broad range of clinical applications, Alafair is focused on building a robust product pipeline. Its products are distributed through a dispersed network of independent distributors across the United States.

Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases. The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula. The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by top-tier venture investors Athyrium Capital Management, Bessemer Venture Partners, Frazier Healthcare, and Third Rock Ventures.

We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com

Alleviant Medical is a medical device company developing next-generation therapies for heart failure.

Allied Healthcare Products, Inc. is a leading manufacturer of medical gas construction equipment, respiratory therapy equipment, home healthcare products, and emergency medical supplies. Our products appear worldwide in a range of medical applications, including hospital care, sub-acute treatment, long-term care, home healthcare, and medical emergencies. Allied Healthcare Products, Inc. is a U.S. manufacturer of FDA approved respiratory medical devices and immobilization products with over 60 years of experience in the industry. Our products are produced in an ISO13485:2016 facility and we carry the capability to apply the CE mark to the products we produce. Allied manufactures transport ventilators, airway products, and immobilization devices under the Life Support Products (LSP) brand. For more information, please visit www.alliedhpi.com or www.ahp300.com.

Allotrope Medical is committed to helping surgeons safely and easily identify the ureter during pelvic operations. The Houston-based company's first product –StimSite™–is designed to assist surgeons in the critical step of ureter identification in millions of operations performed every year. It received funding from Y-Combinator the Mountain View, CA based group that also invested in Door Dash, Dropbox, and Airbnb, and has been voted Top Innovation by a panel of expert surgeons at SAGES (Society of American Gastrointestinal and Endoscopic Surgeons). It also was the past runner-up in the MedTech Innovator contest out of over 600 companies from around the world, and took home top prize at the 2020 Texas A&M New Ventures Competition. Our vision is to advance smooth muscle stimulation technology as the standard of care to help improve minimally invasive surgical outcomes and drive healthcare efficiency. We are building a dynamic team of high performing, accountable, attentive individuals looking to serve patients, partners and institutions in focused surgical specialty markets.

Allvivo Vascular is a medical device company that develops biomimetic coatings for devices, offering dual function coatings with nonthrombogenic and antibacterial properties.

Alpha Medical Instruments,developer, manufacturer, Balloon flotation catheters, venous catherization, right heart, measurements, venous, pulmonary artery pressures, cardiac output

ATEC is a medical device company dedicated to revolutionizing the approach to spine surgery through innovation. ATEC’s Organic Innovation Machine™ is the greatest concentration of spine knowhow in the industry and committed to the creation of clinical distinction. Leveraging 100% spine focus and expertise, we seek to improve spine surgery by rethinking, redesigning and seamlessly integrating the technologies required from the ground up. The innovation that results from that process is being rapidly adopted because, like us, spine surgeons covet informatic and procedural sophistication that enables more predictable, more reproducible care. Our flagship technology, the Prone TransPsoas (PTPTM) Procedure, leveraged decades of experience to advance first-generation lateral surgery with a more familiar patient position and elevated neuromonitoring.   EOS imaging, the backbone of ATEC’s informatic ecosystem, provides radiographic imaging, enabling standing, full-body, global alignment assessments. We are further developing EOS technology to elevate spine care with unprecedented capabilities. Our vision is to be the standard bearer in spine. Visit our website for more information: www.atecspine.com

Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers. The company's lead product utilizes a novel, non-invasive drug device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). Alpheus Medical's work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American Cancer Society and National Brain Tumor Society.

Aluna is designed to help you understand your chronic respiratory condition (such as asthma) and allow you to take control of your lung health. Using a combination of machine learning, our spirometer device and mobile app, you can now use the daily measurements to help you understand and manage your asthma.

Amicrobe is a biotechnology company that develops locally applied products using the Amicidins™ technology platform for preventing and treating life-threatening infections with reduced commercial risk.

Amphix Bio spun out from Northwestern University in Chicago, IL in 2021. The company is developing a new class of supramolecular therapies that instruct cells to initiate regenerative processes and restore function lost from injury, disease, or aging. These therapies contain tens of thousands of biological signals that trigger targeted signaling pathways while forming scaffolds to support tissue growth. Amphix Bio's goal is to use regenerative medicine to increase human healthspans — the length of time that people can live productive, fulfilling lives.

Amplexd is a patient-scientist led company, comprising pharmaceutical industry veterans and senior product developers blending the best of cutting-edge technology and patient-centric design to develop accessible, non-invasive treatments for HPV-induced cervical dysplasia.

Amplifi Vascular is developing the Amplifi™ Vein Dilation System, a wearable, external blood pump designed to enlarge veins using proprietary technology. This system aims to increase eligibility for arteriovenous fistula (AVF) surgery, accelerate AVF maturation, reduce AVF failures, and prolong primary patency. By rapidly dilating and preparing veins prior to AVF creation, the device seeks to provide sustained and reliable vascular access for hemodialysis patients. As of now, the Amplifi Vein Dilation System is under development and not available for sale.

AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. To learn more about pulsatile intravascular lithotripsy, visit www.avspulse.com.

Amron International is a manufacturing company that specializes in high-quality diving, tactical, hyperbaric, and outdoor equipment with over 30 years of industry experience.

Established in 1993 in California, USA, Amsino is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. The Amsino product portfolio includes Sterile Water and Saline, IV Therapy, Waste Fluid Management, Respiratory, Urology, and Enteral Feeding products. Amsino products are distributed in the United States and more than 80 countries worldwide. Visit www.amsino.com for our complete product offering.

Novel Angioplasty Balloon with Guidewire Anchoring Technology that Enables Device Advancement Interventional Cardiology Neurointervention Interventional Radiology Endovascular Interventions

ANEUVO® is a Platform and Therapy Development company focused on treating chronic injuries and conditions that have not been curable through traditional pharmaceutical approaches. ExaStim™ is a non-invasive neuromodulation system developed by Aneuvo that has received FDA Breakthrough Device Designation for treating spinal cord injury.

Animal Biotech Industries, Inc. is a private corporation that was established in 1990 to support the biomedical research community by supplying them with high quality post mortem tissues, organs and glands. To this end, ABI was conceived and is currently operated by scientific professionals who have dedicated themselves to producing superior animals and tissues as well as superior service.

Anresco offers a full range of microbiological services including routine QA testing, FDA Detention Without Physical Examination (DWPE) testing, shelf life studies, inoculation challenge studies, validations of food safety programs (e.g. for compliance with HACCP), and FSMA mandated environmental testing. With decades of experience working with manufacturers, importers, product developers, and more, their microbiologists have the professional expertise to help ensure the safe consumption of all perishable food products.

Anuncia Medical is a neurotherapeutic device company currently solving the large unmet need in cerebrospinal fluid (CSF) management and neurocritical care.

Are you ready for a transformative leap in small bowel capsule endoscopy? Meet ProScan, our cutting-edge AI Assisted Reading Tool meticulously designed to revolutionize the diagnostic process for patients suspected of small bowel bleeding. ProScan leverages advanced artificial intelligence algorithms to significantly reduce the time required for reviewing capsule endoscopy studies, enabling quicker and more precise diagnoses. It is meticulously engineered to expedite the evaluation of capsule endoscopy images, enhancing the timeliness of a diagnosis and initiation of therapy. Headquartered in Plano, Texas, AnX Robotica brings versatility in development and integration of multi-discipline technologies such as precise magnetic, robotic control, in house ASIC design, artificial intelligence, micro-optical imaging, image processing, and wireless transmission. With more than 200 patents granted or applications pending, and dozens of clinical papers published in major international journals, AnX Robotica, together with its sister companies, have become the leading companies in robotic capsule technology.

Apex Medical Technologies is a healthcare company that specializes in non-latex elastomeric thin film dip molding, offering synthetic alternatives to replace latex-based products.

Aphena Pharma Solutions is a large pharma solutions provider focused on contract packaging, repackaging and manufacturing for the pharmaceutical, OTC, dietary supplement, animal health and medical device marketplaces. With over 25 years of experience in pharmaceutical packaging, Aphena was formed in 2011 by a family of well established companies (PrePak Systems, TestPak, Celeste and Integrated Pharmaceutical Packaging). The strategic alliance is now called Aphena Pharma Solutions. Aphena has five FDA registered facilities in the US and offers several capabilities to our customers. Aphena provides clients with a full range of solutions to address their pharmaceutical packaging and manufacturing requirements. With our continued investment in technology, advanced packaging systems and rigorous cost control, we can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the development of a product – including concept, manufacturing, packaging and distribution – we provide clients with services and solutions to help ensure a successful product launch. Our team of seasoned experts collaborates with clients and addresses every aspect of their product. We partner with clients to develop the solutions they need to succeed in a highly competitive marketplace, and we're committed to delivering an end result that is on schedule and cost effective.

ApiJect Systems, Corp. a medical technology company whose device development platform will make the safety and performance advantages of single-use prefilled syringes affordable. The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners.

Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.

Revolutionizing Diabetes Care: No More Needles! At Apollon Inc., we're changing the game for diabetes management. Imagine checking your blood sugar without a single prick - that's what our new continuous glucose monitoring (CGM) system does. Using cutting-edge Raman spectroscopy, we're making glucose monitoring easy, painless, and affordable for everyone. Our device is as small as a smartwatch, needle-free, and designed with your safety in mind. We're currently working with MIT to perfect it, bringing together the best talent from Boston to Seoul. Diabetes affects millions worldwide, and we're here to make their lives better. Our goal? To help more people manage their health easily and comfortably. Join us in this exciting journey. Together, we can improve lives, one simple glucose check at a time. Let's make diabetes management stress-free for everyone!

Get the professional care you deserve when you visit our ARC walk-in medical clinic. We specialize in treating acute illnesses and injuries without you having to make an appointment. You will receive the highest quality diagnosis with safe and effective treatments in a timely manner. We provide accurate and prompt lab work on site to ensure that you get the most appropriate treatment. You can also act as an important part of our research by volunteering as a study participant. ARC of Arkansas conducts Phase II-IV Clinical Trials, Registries and Health Outcome Studies which are aimed at finding new and better treatments for various medical conditions and diseases.

Arconic Corporation, headquartered in Pittsburgh, Pennsylvania, is a leading provider of aluminum sheet, plate and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, building and construction, industrial, and packaging end markets. Keep up with us here to find out how we're helping to advance the automotive, aerospace, commercial transportation, industrial, packaging and building and construction markets. Social Media Disclaimer We welcome conversation on our LinkedIn page about anything relevant to Arconic and its products. We do ask that everyone follow a few simple guidelines: Please keep it professional and refrain from profanity, direct personal criticism aimed at Arconic employees or speculation about the company. Please do not post copyrighted or confidential material. Anything that violates these guidelines, Arconic policies, or that we find to be otherwise inappropriate for any reason may be hidden or removed.

Aretech is a world leader in developing advanced rehabilitation technologies for improving function and independence. We offer robotic body-weight support systems for a variety of therapy needs. Our technology includes ZeroG 3D, ZeroG, Ovation, and Luminaire. ZeroG 3D is a 3-Dimensional BWS System for multi-directional, unrestricted movement within a 3D workspace. The ZeroG Gait and Balance System is for gait and balance training along a custom designed ceiling track. Ovation is an interactive treadmill for patients up to 700 pounds to walk on a treadmill with motivating goals and metrics. Luminaire offers dynamic body-weight support over a slat-belt treadmill. All our products are hand-crafted in the United States and designed for durability with an emphasis on quality.

Our mission is to decrease the quantity and severity of infections that cause human suffering through the creation and development of novel, targeted, antimicrobial therapies. Our lead technology, Veriox®, is a first-of-it's-kind, proprietary peracid/hydrogen peroxide based non-systemic antimicrobial agent. Our vision is to improve societal health by protecting humans, animals and the environment from harmful viruses and chemical agents. ArmiClenz™ (EPA registered disinfectant spray, cleaner/odor control) and ArmiVet™ (Topical wound, rash and hot spot care for animals) are two exciting new consumer brands that support our vision.

Arsenal Medical is a clinical-stage company that develops biomaterials to solve challenging and underserved medical problems. It was founded by serial entrepreneur-investor Carmichael Roberts and academic luminaries Robert Langer and George Whitesides, who shared a vision for how materials can transform medicine. The company’s foundational product, ResQFoam, is a life-saving intervention that addresses non-compressible intra-abdominal hemorrhage in trauma patients. It has been designated a breakthrough device by the FDA.

Was SilverBack Therapeutics, merged with ARS Pharma in 2023 ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including food, medications, and insect bites. The company was founded in 2015 and is based in San Diego, California.

Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The first target market for this technology is the $5B knee treatment market. Here, our device (KneeStim) will enable mobile quadriceps strengthening and re-education for the 14M+ seeking conservative, cost- and time-efficient knee treatment. Company status: * Working prototype * Feasibility study conducted * Four patents issued; two pending * Independent market validation with likely prescribers * Regulatory pathway established * Reimbursement codes identified This device has not yet been cleared by the FDA for marketing, and all above statements are prospective.

Revolutionary speech therapy tools for parents and speech therapists. Simple to use & works twice as fast as traditional methods.

Arxspan provides cloud-based solutions to meet the scientific data management needs of leading life sciences, chemicals, and scientific companies globally. Arxspan offers ArxLab®, a suite of web-based scientific informatics applications, allowing scientists to record, manage, and share their research data​: * Notebook - Intuitive electronic laboratory notebook (ELN) optimized for collaborative models in current research environments * BioReg/ChemReg Registration - Configurable repository for registering unique chemical/biological entities and subsequent batches * Assay - Flexible system for registering assay protocol and result data * Inventory - Comprehensive tool for defining and managing chemical and biological compounds, reagents, equipment, and other items * Search - Robust decision support platform for querying, visualizing, and reporting data * Workflow - ArxLab Workflow allows users to create new work requests and to assign them to users and/or groups. The workflow management tool enables scientists to manage and prioritize all scientific projects, as well as to make procedure requests to internal colleagues and external partners. For more information, please visit our website at www.arxspan.com

Asana Medical focuses on the development and commercialization of medical devices for gastrointestinal applications.

Aseptica is a medical device development company focused on EDTA related products.

Aspire Biotech is a biomaterials Research and Development company focused on improving medical devices through the development of superior biomaterials.

Founded in 1987, ATL, A Bureau Veritas Company, is a Scientific Sourcing Solutions Company. For more than 30 years, we’ve exceeded the highest expectations of the world’s most demanding customers in the Consumer Products, Pharmaceutical and Medical Device industries. ATL, A Bureau Veritas Company, has become a recognized leader in creating innovative sourcing solutions across the entire product life cycle, from discovery through commercialization. Our services range from standard rules-based testing to operating and managing entire scientific functions. We’re experts in the field of scientific sourcing. Across all levels of complexity, oversight and location, we transform cost-saving measures into strategic solutions. We can elevate your existing proficiencies and resources — all while protecting the critical continuity of business, knowledge and talent. Our capabilities include: Analytical Chemistry, Engineering, Life Science, Product Performance Testing, Product Safety and Regulatory, and Quality Assurance. At ATL, A Bureau Veritas Company, our unique solutions help maximize readiness, efficiency and productivity for our clients. We are committed to continue making “exceptional our ordinary” while delivering the science that makes life better. Careers At ATL, A Bureau Veritas Company, we don’t just do the science, we have the opportunity to transform organizations. We need people who want to grow with us and contribute directly to our clients’ success. As scientific sourcing experts, the largest and most respected companies in the world ask us to create innovative solutions to big problems. We have more input and influence, so we can have a significant impact on brand-name products and visible projects. And you can play a bigger role.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company’s lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; AT-H201, a drug candidate to improve lung function in COVID-19 patients; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. Atossa Therapeutics, Inc. has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the potential treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Atreon Orthopedics is a tissue regeneration company powered by breakthrough regenerative technology and renowned scientific expertise. Tendon and ligament injuries affect ten million people yearly, spanning all lifestyles and demographics. Atreon is committed to dramatically improving healing and long-term outcomes for patients encountering these soft-tissue injuries. ROTIUM®, our initial product for rotator cuff repair, is a bioresorbable wick designed as a scaffold to harness and hold biologically active substances at the repair site providing a pro-healing environment that promotes healthy tissue and native tissue regeneration. Recently published human and animal studies and over 10,000 cases have shown a safe and effective solution to improving biology, restoring function, and improving rotator cuff success rates.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure's Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure's Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure's cryoICE cryoSPHERE®+ and cryoSPHERE MAX™ probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals

Auctus is developing a dynamic vertebral body tethering system to treat pediatric scoliosis with an adjustable non-fusion system

Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company's revolutionary xvision Spine System® allows surgeons to see patients' anatomy as if they have "x-ray vision" and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 US states. Augmedics has received numerous honors, including being named a 2021 Index Awards Finalist, a Fast Company World Changing Ideas Awards 2021 Finalist, and one of Time Magazine's Best Inventions of 2020. It was recently featured in The Economist documentary How will businesses use the metaverse? To learn more or schedule an xvision demo, visit augmedics.com.

Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

AuST is a medical device design, development, and manufacturing firm specializing in minimally invasive medical devices. We excel at collaborative development and have taken numerous products from concept to market using a process that focuses on rapid design iteration and ample clinical feedback. Our design expertise is supported by in-depth experience with quality management and US and European regulatory systems. We maintain a fully resourced product development lab and pilot production facility in Mountain View, California. We also maintain volume manufacturing capability in Salt Lake City, Utah. In addition to our development capabilities, we offer a number of novel technologies that can enhance device performance and manufacturability.

Autocam Medical is a precision-machining contract manufacturer of highly engineered implants and instruments for surgical applications. Our product specialties include custom bone screws, bone plates and fixation devices; and perfect-fit complementary, surgical drivers, drill bits, taps and other rotary cutting instruments. We have decades of experience in every aspect of medical machining manufacturing, with specialties in CNC milling, turning, mill/turn and cutter-grinding of all surgical-grade materials, including titanium and other high-performance specialty alloys and plastics. Autocam Medical partners with customers to provide Design for Manufacturability consultation for precision-machined components, involving our engineering team early in the planning stage adds value to the entire process. Our in-depth knowledge of how medical devices work and interact gives customers an added competitive advantage.

Autonomic Technologies is a medical device company that focuses on the development and commercialization of innovative therapies for autonomic disorders, particularly severe headaches.

Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

Autonomous Medical Devices Incorporated (AMDI), with its principal place of business in California, employs a world class team of engineers, scientists, clinicians, and manufacturing experts dedicated to the development and manufacture of point-of-care diagnostic devices using breakthrough microfluidics, protein engineering, and data/cloud connectivity. AMDI will launch its first products from its ISO:13485 certified 110,000 square foot facility in Santa Ana, CA.

AVACEN Medical is a healthcare technology company that specializes in noninvasive medical devices for pain management, offering drug-free alternatives for various chronic and acute conditions.

Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.

NeoMed develops innovative enteral collection and delivery products supporting the specialized feeding and medication dosing needs of the low birth weight, neonatal and pediatric patient. We are committed to improve patient outcomes through product designs that meet safety, clinical, and regulatory guidelines while supporting cost containment objectives.

Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, we’re dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertix’s Guardian™ is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

Axcess Surgical is a medical devices company that specializes in creating advanced surgical innovations for optimum results.

Developing seamless neural interfaces.

Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on miniaturized rechargeable technology. The Axonics Sacral Neuromodulation System™ is the first CE-marked rechargeable SNM system designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction (not available in the US).

Axon Therapies is addressing a root cause of heart failure with their frontline therapy by selectively ablating the neural pathway carrying information from the chronically hyperactive sympathetic nervous system (SNS) in order to restore volume balance, stop disease progression and improve symptoms

We believe good oral care is critical to everyone’s health and wellness. Dental professionals and consumers alike should have access to technologies that improve oral health. We are committed to the belief that these technologies should be proven effective through empirical evidence, have elegant & intuitive design, and be as minimally invasive as possible. At Azena, every insight is given a chance to develop, to be validated by science and clinical research, and to inspire the creative minds of our designers and engineers. We continually challenge ourselves to explore innovation for the betterment of oral healthcare. We base our innovation on the foundations of science and aesthetic design to create effectiveness, simplicity, ease-of-use, and overall appeal. With a focus on improving oral healthcare, we design, develop, validate, manufacture, and market world-class devices for both dental clinicians and consumers. We are continually searching for new solutions to enhance oral care. Our offerings are created at the intersection of where art, science, and technology meet.

BAMF Health is the world's first vertically integrated platform for molecular imaging and radiopharmaceutical therapy. Using the most advanced imaging and therapy technologies, BAMF Health is dedicated to providing comprehensive and intelligent treatment options for patients with serious health issues such as cancer, heart disease, and stroke.

Barrow Neurological Institute is a healthcare institution specializing in neurology and neurosurgery services.

BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory located in Salem, NH. BA provides testing services to Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide including: Analytical Testing and Method Development, Microbiological Testing and Environmental Monitoring Services, Biologics, Stability Testing & ICH-compliant Storage, Impurities Testing, Advanced Therapeutics and Extractables & Leachables Studies.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

Beeken Biomedical is an medical device company focused on the development, licensing and commercialization of wound care products. Beeken Biomedical introduces innovative and cost-effective technologies that rapidly stop bleeding and help protect wounds from infection. Beeken Biomedical is committed to improve solutions in wound care for healthcare professionals and consumers.

Novoste is the global leader in the field of vascular brachytherapy.

Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared autonomous insulin delivery device in the market and offers the potential to substantially improve overall outcomes across broad populations of PWDs. To learn more, visit www.betabionics.com. For safety information, visit: www.betabionics.com/safety.

Beyond Air Inc. is a commercial stage medical device and biopharmaceutical company focused on harnessing nitric oxide therapy. The company is built on a legacy of innovation and is revolutionizing nitric oxide therapy. Beyond Air Inc. has experience and leadership that go beyond, with a team of industry professionals dedicated to advancing medical treatment. For more information, visit https://www.beyondair.net/

An innovation driven start up company catering to the unmet needs of the biomaterial community and medical device industry. With our state of the art research and development facilities in theUS and India, combined with our platform technologies derived from a family of novel and proprietary biodegradable polymeric biomaterials, we work with and for our customers to translate their demands into high quality products for a wide range of medical device and therapeutic applications in a cost effective manner. Our expertise lies in the area of absorbable polyurethanes, absorbable polymers derived from functionalized natural products, drug molecules and amino acids, adhesion prevention barriers, absorbable drug eluting stent coatings, tissue adhesive and sealant, medical device coatings, drug delivery, drug device combination, absorbable implantable devices and tissue engineering.

Onychomycosis is a pervasive, disfiguring, and often painful infection of the nail, surface of the nail bed, and/or nail matrix caused by fungi that are ubiquitous in the environment Over 35 million patients in the US suffer from this type of infection, including approximately 1 in 3 diabetic patients. Research demonstrates an increased risk of other foot disorders and amputations in diabetic patients with onychomycosis. There are no current treatments that effectively treat this type of infection. Our patented TherawaveTM 100 technology delivers a safe and effective High Frequency Energy (HFE) precisely to the infected nail plate and surface nail bed to eliminate the fungal infection while sparing surrounding tissue.

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. With an intense focus on ease of use, Bigfoot will optimize the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. The company's pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. Bigfoot will be the first company to deliver a monthly subscription-based service leveraging a smart, connected insulin dosing platform to meet the needs of a diverse population with insulin-requiring diabetes. Bigfoot's investigational system is comprised of best-in-class proprietary and licensed components holistically and securely integrated, leveraging intuitive design, machine learning, and a mobile app running on an off-the-shelf smartphone, all designed to keep glucose levels in an optimal range. "The net result is a company that brings something unique to the table: a remarkable depth of knowledge and technical know-how combined with the personal motivation and direct patient experience necessary to really make a difference in this space." ---The MedTech Strategist, October 24, 2016

We provide you with the best experts in the biopharma industry. Through our flexible, consultative approach, we'll align you with professionals with the expertise you need when you need them the most. From early clinical and device development to the post-market phase, we help you bridge your expertise gaps.

BioCircuit Technologies is a medical device company developing tools for the repair of nerve and other tissues.

Biocoat Incorporated develops and licenses biomaterial coatings for medical devices that are custom engineered to meet client design parameters. Its specialty is supplying lubricious hydrophilic coatings for medical devices. Our full-service coating solution includes industry-leading coating performance, high-touch customer service, and dip coating equipment that is specifically designed to maximize the coating process. HYDAK® Hydrophilic Coating Advantages * Exceptionally hydrophilic * Lubricious when wet, preventing trauma and tissue abrasion * Abrasion resistant * Very thin, flexible coatings can be applied * Biocompatible * Non-thrombogenic * Prevents adhesion of platelets, proteins, microorganisms * Carrier for bioactive substances to make o anti-bacterial surfaces o anti-thrombogenic surfaces

Biocrede is a biomedical technology company that develops innovative biomed-tech solutions to restore health, extend life, and reduce hospitalization length for patients worldwide.

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical-grade remote care from in-hospital to home. Learn how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services or visit our website at BioIntelliSense.com. 

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. Our award-winning dental lasers enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 36,200 laser systems to date in over 90 countries around the world.

Biolinq has created a new Biowearable experience by using an array of electrochemical sensors so small you can barely feel them. Our metabolic health sensors work together to provide maximum reliability for continuous sensing applications. With the potential of multiple analytes such as glucose, ketones, and lactate, we provide an entirely new user experience with actionable metabolic health insights. Over the next 10 years we intend to bring Biosensing and Biowearables mainstream. We are dedicated to the personal and professional growth of all our team members and strive to create a positive and creative work environment.

ABOUT Biologics Consulting is a complete FDA regulatory and product development consulting firm for cell & gene therapy, biologics, pharmaceuticals, and medical devices. In the three decades since its founding, Biologics Consulting has become the go-to consulting partner for companies large and small seeking to bring innovative, safe, and effective products to market in the US. Our team of regulatory scientists, FDA consultants, and professional services staff has decades of industry and FDA experience that allows us to provide an unparalleled insider perspective for our clients. OUR DIFFERENCE The Biologics Consulting difference is all about the unique combination of regulatory expertise we have under one roof. Our team has depth of knowledge and breadth of experience across all product types and development pathways. This value proposition allows us to address the full scope of a client's regulatory and product development challenges from preapproval to commercialization. OUR EXPERIENCE AREAS - Biologics - Medical Devices - Pharmaceuticals - Biosimilars OUR SERVICES - CONSULTING – Regulatory, Product Development, Clinical Planning and Quality support. - SUPPORT SERVICES – Medical Writing, e-Publishing & Submissions, US Agent Services, Due Diligence OUR CLIENTS Our clients span the industry, from established multi-national pharmaceutical, biotechnology, and medical device companies to academic and research institutions. We also support small biotech and medical device start-ups. Since our founding, we have professionally services over 4,500 clients from 58 different countries.

At BIOMOTUM, we envision a world where all people have access to optimal mobility. Our mission is to optimize human mobility by providing intelligent and intuitive wearable systems, to a wide range of users in the medical and consumer markets. We empower individuals to live healthy and productive lives through the use of our clinically validated products. The Problem A person's ability to engage in physical activity, including activities of daily living, is essential to their health, independence, and general wellbeing. According to the CDC, approximately 50 million U.S. adults and children have a physical disability and are unable to engage in some activities of daily living or achieve a sufficient amount of physical activity. Mobility training is critical to improving mobility but there is currently no viable way to deliver a sufficient dose of active gait training. Our Solution The BIOMOTUM System addresses the need for individuals to be mobile while being able to engage in sufficient mobility therapy. It allows them to walk independently in the clinic, at home and in the community. Clinical trials have repeatedly demonstrated improvement in mobility outcomes in children with CP. As a smart device, it provides rehabilitation professionals and users activity data to facilitate progression and continued improvement in mobility. Our History BIOMOTUM was founded in 2019, by Dr. Zach Lerner, Dr. Ray Browning and Joe Lerner. The founders have been associates for many years. Drs. Lerner and Browning met in 2011 through a shared interest pediatric physical activity as a way to improve chronic diseases and have maintained collaborations since that time.

By creating a new medical modality of remote-controlled micro-robots called Bionauts™ we can transform the way the biopharmaceutical industry develops treatments, allowing us to engineer the therapeutic index for efficacy and maintain safety.

BioQ Pharma is a specialty pharmaceutical company that focuses on setting a new standard of care for infusible drugs.

BioQ Pharma is a late stage specialty pharmaceutical company focused on developing.

AT BIOREP, WE MAKE PRODUCTS THAT ENHANCE - AND SAVE - LIVES. Beginning with our shared passion for health, we believe in making life better by innovating and developing new biomedical tools, and improving and understanding surgical techniques.

Biosapien is a late-stage pre clinical company focused on novel drug delivery platforms.

BioSurfaces, based in Ashland, Massachusetts, is a life science company with deep leadership and a diverse team of specialists. The company's proprietary electrospinning technology known as Bio-Spun™ creates product solutions by engineering biology with synthetic cellular matrices for applications ranging from IVRT and delivery of bio-active therapeutics to medical devices and consumer health products. These materials can be made to form a variety of unusual and difficult-to-manufacture shapes while also demonstrating improved biocompatibility over other textile-based materials. The BioSurfaces manufacturing process also allows the incorporation of drugs or other bioactive agents directly into the nanofibers for localized release. BioSurfaces' technology is validated by leading organizations in pharmaceuticals, medical devices, life sciences, and consumer products.

BioTissue is the leader in innovative applications of human birth tissues for regenerative wound healing, aiming to improve patient outcomes. The company is committed to promoting regenerative healing through its birth tissue products.

Biotricity is a global frontrunner in the realm of digital health. Our mission is to bridge the gap between patients and healthcare providers, ushering in a new era of care delivery that is both efficient and patient-centric. At Biotricity, we're not just transforming remote patient monitoring; we're redefining the very essence of healthcare itself. We are proud to offer award-winning health technology seamlessly integrated with state-of-the-art software. With over 100,000 patients placing their trust in us to improve their long-term cardiac health, we have solidified our position as a trusted healthcare partner. Biotricity's remote patient monitoring devices are designed to optimize patient and healthcare provider workflows. Our goal is to provide critical insights into a patient's health swiftly, resulting in faster treatment and improved outcomes. Our advanced hardware and software solutions enable accurate identification of cardiac problems as they occur, transforming the landscape of care for clinics and patients alike. Physicians can now access real-time data with reports in days, not weeks, while patients wear user-friendly, discreet monitoring devices, offering peace of mind throughout the process. At Biotricity, we firmly believe that the future of healthcare lies in connected medical devices that generate data leveraged by both physicians and individuals. We envision a healthcare ecosystem where these devices seamlessly integrate with big data, predictive AI, and machine intelligence, ushering in an era of better and faster analytics for superior care delivery. Join us as we continue to lead the way in digital health innovation, pioneering advancements that are not just transforming healthcare but also enhancing lives. Together, we are creating a healthier and more connected future. Biotricity's stock is trading under the ticker, “BTCY”.

Birchwood is a healthcare company that offers incontinence and wound care products to healthcare professionals and patients.

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient product for triage and monitoring of disease progression.

Medical device design and development. First patented product under development is BondTrue, which standardizes surgical closure for better wound healing. Unlike other closure techniques, BondTrue knows where the incision was made so it can precisely realign the wound back together, reducing wound complications, saving time and costs.

Since its founding in 1987, BA Sciences has been a trusted provider of high-quality analytical testing services to life science companies worldwide. With a commitment to excellence, compliance, and innovation, the company has established itself as a premier analytical testing services provider in the industry. Originally located in North Reading, Massachusetts, BA Sciences moved its operations and headquarters to its current home located in Salem, New Hampshire. The footprint of the HQ laboratories facility started at 30,000 square feet but has since expanded to over 60,000 square feet, and there are additional laboratory and office facilities located in Framingham, MA and Morrisville, NC.

We are part of bess group (www.bessgroup.com), a group of dynamic and developing companies, headed by our holding company bess AG (Berlin, Germany). It is our vision to provide life sciences products of high value yet cost-effective, enabling us to become market leaders in as many of our medical fields as possible. Though much has changed at Boston Medical Products over the past 39 years, one thing remains constant: our commitment to deliver the world's finest specialty surgical products - products that clinicians rely on and patients can trust. Founded in 1980 by three physicians - including world-renowned ENT surgeon William W. Montgomery, M.D. - as a way to make Dr. Montgomery's original innovations widely available, Boston Medical Products continues to be driven by his life-long commitment to superior patient care. Over the years since our beginning, we have expanded our line of products with innovations from some of the world's leading physicians, health care innovators, and opinion leaders. Boston Medical Products today develops, manufactures and sells many different types of specialty products that meet the exacting needs of clinicians specializing in Otolaryngology, Pulmonary Medicine, Respiratory Therapy and Speech Pathology. In the established patient oriented tradition, Boston Medical Products has developed an educational website www.trachs.com as a service to provide patients with the very best products and resources for their laryngectomy and tracheostomy needs. It is a website where you can not only find the products you need for your care and comfort, but information and support that will help you make decisions and improve your quality of life.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.

BrainCool Inc is an innovative medical device company that develops, markets, and sellsleading medical cooling systems for indications and areas with significant medical benefitswithin the healthcare sector. The company focuses on two business segments, Brain Coolingand Pain Management.

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA and Jerusalem, Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS.

Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women's Health. Our Vision is to build the leading Gastroenterology company in the U.S., with a complementary focus on innovation in Women's Health, premised on our expertise in pharmaceutical development and commercialization. We value dedication, energy, and enthusiasm, and we focus on innovation and results while striving to achieve our corporate mission and vision. Sebela Pharmaceuticals is committed to cultivating an inclusive environment where all employees are treated with respect. We accomplish this by fostering a culture of diversity, equity and inclusion, which is essential to innovation and continuous improvement. Sebela operates from three locations with offices in Roswell, Georgia, Braintree, MA and headquarters in Dublin, Ireland.

Bridge to Life was founded with the mission of improving organ transplants through licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, we continue to explore emerging science and preservation technologies.

We are an investment banking and venture capital advisory firm that focuses on the healthcare industry. We have relationships with corporate partners, venture capitalists, hedge funds, family offices, and HNWI internationally. We represent companies and venture capitalists in biotech, pharma, diagnostics, devices, and imaging. BUSINESS DEVELOPMENT We listen to clients' goals for financing and do deep research for the right financial partner that includes family offices, angels, venture capitalists, hedge funds, and small funds. We provide personalized venture capital and investment banking advisory services. We keep the number of companies from one to three. We put together co-lead investors to help make the transition go smoothly. We represent multiple companies and venture capitalists in foreign countries looking for a foothold in California and the U.S. We work with U.S. companies looking for relationships internationally. We understand cultural differences and can help bridge the gap of communication on deals. FINANCE Expertise at targeting financial partners internationally. We create extensive relationships with private funding sources—from family offices to strategic angels. We build solid associations with healthcare and technology venture capitalists throughout the world. We comprehend the complexity of creating tranches in an investment. We work with lead investors and help put international syndicates together. We represent venture capitalists and individual companies and we understand the key points of closing deals STRATEGY We understand how to create materials that synthesize the company's strengths and message. We work with multiple CEOs and help design winning and concise pitches while providing personalized assistance on each call with investors and find areas that can be improved. We research influencers and non-profits in the scientific community that can help sway financiers' opinions. We analyze the current venture market for your company and find out which other companies in your space are getting financed and why. We design multi-tiered strategies of creating associations with the best financial partners.

Bright Uro is an early-stage medical technology company headquartered in Irvine, CA. They are building the next generation of diagnostic devices for Urology.

Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain. Their Neural Ice™ has the potential for long-lasting pain control from one injection, intended to eradicate the pain of pain.

Bryn Pharma is a privately held pharmaceutical company based in North Carolina. Primary focus is on the development and commercialization of innovative allergy products for the management of anaphylaxis. The mission of Bryn Pharma is to empower patients with a life-saving device that is small enough to comfortably fit in your pocket and easy to use in the event of an anaphylactic attack. Our intranasal delivery system will be an exciting alternative to epinephrine auto-injectors providing patients a needle-free option that is easy to use, portable, and affordable.

Gust is the global SaaS platform for founding, operating, and investing in scalable, high-growth companies. Gust’s online tools help entrepreneurs start, run, and fundraise for companies and provide deal flow and relationship management for investors. As the world’s largest community of entrepreneurs and early-stage investors from 191 countries, Gust pioneered the equity funding collaboration industry and is the official platform of the world’s leading angel investor federations and venture accelerators. More than 500,000 startups have already used Gust to connect with over 70,000 investment professionals. Gust powers the official online hubs of the world’s largest innovation ecosystems including New York City (Digital.NYC), Boston (StartHub.org) and London (Tech.London).

BTS Research is a Contract Research Laboratory that delivers cGMP/GLP biological services to clients in the pharmaceutical, biopharmaceutical, biotech, academic research, medical devices and related industries.

Butterfly’s mission is to create access to valuable clinical insights using innovative ultrasound technology, made simple with artificial intelligence, to benefit all patients worldwide. Through the delivery of high-quality, affordable, easy-to-use, intelligently connected ultrasound, Butterfly Network enables better clinical decisions through better information and insight at the point of care. With Butterfly, seeing is knowing – in the hospital, community, or home.

Cadence Biomedical, a commercial-stage medical device company headquartered in Seattle, Washington, is committed to working with healthcare professionals, patients and caregivers to advance neurorehabilitation. The company's primary commercial product, Kickstart®, is a neurorehabilitation device designed to accelerate a recovery to walking in stroke, multiple sclerosis, spinal cord injury patients and in individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. For more detail, please see www.cadencebiomedical.com.

Cala kIQ is a healthcare technology company that specializes in digital therapeutics and medical devices.

Caldera Medical is a medical device company solely focused on women's health with a commitment to our mission of "Improving the Quality of Life for Women!" We develop, build and market best in class surgical products for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Working closely with surgeons to help those here at home, as well as women around the world, through our humanitarian programs to give them the access to the education and treatment they deserve. Mission - To Improve the Quality of Life for Women Vision - To be the Global Leader in Women's Pelvic Health Values "C4"​ - Care / Collaborate / Challenge / Create

Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today. Founded in 2016, Calyxo is led by executives and investors with a strong track record of commercializing paradigm-shifting solutions in the field of urology. Our team features some of the most talented, high-achieving and brightest minds in the medical device industry who are compelled by a desire to make a difference in kidney stone care. We are proud of our collaborative, diverse, fun and dynamic culture. We drive our actions based on our core values which we call ‘F.I.T to WIN.’ Find Joy: We celebrate wins and enjoy the journey! Integrity: We are truthful, honorable, and reliable. Transparency: We share what’s going on in our business. We are open, honest and have a clear communication across our organization. Win as a Team: We are earnest collaborators. We hold ourselves and each other accountable.

Cannuflow is a healthcare technology company that offers innovative fluid management solutions for knee, shoulder, and hip arthroscopy procedures.

CapsoVision is a medical device manufacturer based in Silicon Valley, USA. We are engaged in the development of innovative capsule endoscopy (CE) solutions that empower physicians, streamline clinical operations and enhance patient experience. Our novel small bowel capsule endoscope CapsoCam Plus® is the only CE system with a 360° field of view, no capital equipment, and a state-of-the-art CapsoCloud® cloud-based software for efficient image review and analysis.

At Capstan Medical, we’re driven by an unwavering commitment to transforming the treatment of structural heart disease. By merging surgical robotics with catheter-based technology and next generation implants, we’ve pioneered a patient-optimized approach to repair and replace heart valves.

Caption Health has been acquired by GE HealthCare. Follow us at @GEHealthCare and @CaptionCare for the latest updates and healthcare news.

Cardiac Insight, Inc. is a privately held medical device company based in Seattle, Washington, renowned for its Cardea SOLO ECG system. With FDA clearance since 2017, this tool provides comprehensive cardiac evaluations, comfortably worn over seven days. Dr. Dave Hadley and Dr. Vic Frolicher, creators of the Cardea 20/20 ECG, introduced a proprietary handheld 12-lead ECG device that enhances electrocardiogram reliability for detecting cardiovascular issues in young athletes, transforming athletic heart care. The Cardea 20/20 ECG incorporates breakthrough interpretive algorithms and international criteria, enabling swift identification of complex cardiac abnormalities leading to Sudden Cardiac Arrest (SCA). In 2021, Cardiac Insight joined forces with global electronic components leader Dreamtech, solidifying its position as a leading innovator in cardiac healthcare diagnostics, poised for exponential growth.

Contact: contact@cardiosense.com Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.

Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSA-XT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading analysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms. The LSA-XT and Ultra instruments introduce enhancements to Carterra’s flagship product, the LSA, increasing sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity. For additional information, please visit www.carterra-bio.com.

Casana is innovating healthcare delivery with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The FDA-cleared Heart Seat® captures heart rate and blood oxygenation. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along. The Heart Seat will become commercially available upon future clearance of non-invasive blood pressure.

At Castor, we believe in the power of clinical research and the power of technology. And we know that together, these forces can help extend human healthspan. To achieve this reality, we must make patient-centered clinical trials a possibility for everyone, anywhere in the world. That's why we are using technology to capture the world's research data and optimize each activity of a clinical trial. From recruitment to monitoring, our modular clinical trial platform makes it easier to design and deploy trials, enroll and engage patients, collect data and analyze results. Each module can be used individually or in unison with others, providing the ability to customize each solution to fit your needs, and grow at your own pace. That's delightful for patients, effortless for study teams, risk-free for sponsors.

Medical device company innovating a patent-pending device to provide safety with indwelling urinary catheters.

Alta Biomaterials is a biomedical company that specializes in design and development of proprietary coating and surface modification technologies for medical device OEMs.

CeloNova BioSciences is now ALTA Biomaterials! In Jan 2023, CeloNova BioSciences has become Alta Biomaterials! Alta Biomaterials is an expert design and development partner to medical device OEMs looking for proprietary coating and surface modification technologies that enhance biocompatibility and drug delivery while providing anti-inflammatory, thromboresistance and pro-healing properties.

Centric Medical is dedicated to improving the quality of life for patients with distal extremity symptomatology, increasing procedural efficiency and efficacy through design, uncompromising quality standards, and the most technologically advanced manufacturing platforms.

CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered in Horw, Switzerland. Please visit myceqursimplicity.com for more information.

CereVasc, Inc. is a clinical-stage, medical device company developing novel treatments for neurological diseases. The company is focused on developing the eShunt™ System for the treatment of patients with hydrocephalus. CereVasc aims to improve patient outcomes and redefine the treatment of communicating hydrocephalus through its innovative medical devices.

Founded in 2015, Cerevast Medical, Inc. is a clinical-stage medical device company based in Bothell, Washington, USA. Leveraging our core expertise in the fields of ultrasound and microsphere technologies, we are committed to developing novel, first-in-class therapeutic solutions to restore health and improve the quality of life for patients that suffer from major diseases.

Cerora (www.cerora.com) is devoted to alleviating suffering and empowering people by transforming antiquated opinion-based methods into enlightened biosensor-based neurodiagnostics. The company intends to make a major positive impact in brain health assessment globally with an initial focus on concussion. The Company is leading the way in the development and testing of mobile software and hardware technologies required to provide critical, objective, biomarker-based brain function diagnostic information. Located in the high-tech nexus at Ben Franklin Technology Partners of Northeastern Pennsylvania's Tech Ventures on Lehigh University's Mountaintop Campus in Bethlehem, Pennsylvania, Cerora has assembled a team of experienced medical scientists and management professionals.

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

Ceutical Laboratories provides services to the pharmaceutical, medical device, dietary supplement, veterinary, cosmetic, and food industries. Ceutical Labs provides formulation development, design development, project management, process development, analytical testing (chemistry, microbiology, and physical testing), consulting, training, regulatory submissions (IND, NDA , ANDA, 510K, PMA, etc.), regulatory compliance, ESG submissions, quality system implementation, validation support, FDA management, auditing, IT solutions, and marketing expertise. YOUR SUCCESS is our goal. Analytical testing equipment includes GC, GC/MS, HPLC, HPLC/MS, HPLC/MS/MS, ICP, AAS, XRF, Polarimeter, and much more. Our formation expertise includes Rx, solid dose, topicals, and parenterals. Our laboratory has over 50,000 square feet. Our training facility has over 10,000 square feet. We will meet and exceed your expectations. We seek to help our customers achieve regulatory compliance. Our customers who have fully implemented our quality systems have received very few to no observations. We are routinely inspected by US FDA and Health Canada. Our goal is to remain compliant. We are a third party sampling and testing laboratory for US FDA.

CFD Research Corporation (CFDRC) specializes in engineering simulations and innovative designs for Aerospace, Biomedical, Defense, Materials, Energy, and other industries. Using our software and experimental facilities, we develop new hardware concepts, innovative designs, and prototypes. We have over 50 patents awarded or pending in the areas of biotechnology, combustion, propulsion, and materials. CFDRC’s software and expertise allow coupled multiscale, multiphysics simulations of fluid, thermal, chemical, biological, electrical, and mechanical phenomena for real-world applications. Such simulations provide dearer insights into complex systems and thus enable better decisions and facility better products with lower risk, reduced cost, and less time.

cGMP Validation was established in 1997 as a full service validation/compliance firm offering services for the pharmaceutical, bulk pharmaceutical, animal health, biotechnology, biologics, medical device and medical diagnostic industries. Our team is comprised of a group of professionals with considerable experience within the pharmaceutical industry. Educational disciplines consist of chemistry, microbiology, engineering, pharmacy and computer science. Team expertise was not only developed through working with operating companies giving them a unique ability to coordinate with client personnel to assure that all facets of the project start-up and validation are considered. Many of our project leaders have been middle to senior level Quality Assurance Managers, Production Managers or Facility Managers thus having an excellent understanding of industry standards and FDA expectations. Successful projects have been performed throughout North America as well as Internationally. Clients range in size from small to large for pharmaceutical (finished and bulk), biological, medical device and diagnostic manufacturers. cGMP prides itself on all projects regardless of size, being given the same professional attention and management.

Chemo Mouthpiece, LLC is an oncology supportive care company. We are proud to introduce our new device, the Chemo Mouthpiece™. The Chemo Mouthpiece™, is a new 510(k) cleared device for marketing in the US. This device is intended to be used to cool the oral mucosa to reduce the incidence and severity of chemotherapy induced oral mucositis, a painful and debilitating side effect. Historically, oral cryotherapy was used for short half-life drugs only, the Chemo Mouthpiece™ shifts that paradigm by studying its efficacy in multiple long half-life drugs, giving you and your patients a better choice!! The Chemo Mouthpiece™ device was developed based on the personal experience of inventor, founder and CEO David Yoskowitz, who when diagnosed with Hodgkin’s Lymphoma experienced oral mucositis firsthand. His treatment options included ice chips to mitigate and minimize the pain. Yet this caused nausea, was difficult to maintain in his mouth, and did not effectively cool the entire oral cavity which led him to search for a better option. An engineer by trade, he made it his mission to find a better way for cancer patients to cope with oral mucositis during treatment. He created a simple, effective, easy-to-use device to be used during chemotherapy treatments at home or in a hospital. The Chemo Mouthpiece™ efficiently cools the entire oral cavity. Patients can freeze the device at home and take it with them to be used during treatment, creating a simple solution for an unmet patient need.

CivaTech Oncology® designs innovative products that bring meaningful improvements to low dose rate brachytherapy. The CivaString® and CivaSheet™ can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products ensure that radiation oncologists can deliver individualized, targeted therapy to treat cancer. http://www.civatechoncology.com/

Clarapath is a medical robotics company automating the laboratory. Our first product is focused on automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.

Clear Guide Medical is a leader in next-gen medical imaging fusion and navigation technology. Our vision-based approach has been introduced in a family of clinical guidance products, including the CLEAR GUIDE SCENERGY for instrument guidance and SCENERGY FUSION for ultrasound and CT/MRI image fusion. Our products make minimally-invasive interventions like biopsies, ablations, pain injections, and peripheral nerve blocks efficient and cost-effective. The company is a privately-held spinout of the Johns Hopkins Medical Institutions and The Johns Hopkins University based in Baltimore, Maryland.

Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit, multispecialty academic medical center that integrates clinical and hospital care with research and education. Founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation, Cleveland Clinic has become one of the largest and most respected hospitals in the country. Cleveland Clinic facilities can be found throughout Northeast Ohio, as well as around the country and world including: Cleveland Clinic Florida Cleveland Clinic Canada Cleveland Clinic Abu Dhabi Cleveland Clinic Lou Ruvo Center for Brain Health - Las Vegas Cleveland Clinic health system includes eight regional hospitals, 16 family health centers, a children's hospital for rehabilitation and one affiliate hospital. Cleveland Clinic is accredited by The Joint Commission, the nation’s largest accreditor of healthcare organizations. Our family health centers offer: Outpatient care Primary care Numerous subspecialties Numerous locations All of our hospitals, family health centers, outpatient clinics and home healthcare programs are also accredited by The Joint Commission under its hospital accreditation program.

Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, we deliver accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Our treatments are defined by our commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. We are continuously expanding and refining our shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. Digital therapeutics under development on our platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, cardiology and immunology. Consistently named a best place to work, we foster an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in our mission to provide patients everywhere access to safe and effective prescription digital therapeutics. NOTE: Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the Federal Trade Commission and to recruitment@clicktherapeutics.com. Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application.

Introducing CLR, a simple solution for suction and irrigation through indwelling catheters such as chest tubes. The patented CLR Irrigator is an ergonomic suction/irrigator that empowers easy, one-handed lavage and evacuation of fluid collections such as hemothorax. Our unique CLR Port can stay attached to the indwelling catheter, allowing standard drainage as well as clean access for repeated/delayed lavage without breaking the drainage circuit. When it comes to thoracic irrigation, the solution is cl__r!

Coagulation monitor

CoapTech is bringing a series of breakthrough medical devices to worldwide markets, leveraging a patented, disruptive platform technology called the Point-of-care Ultrasound Magnet Aligned (PUMA) System. The PUMA Platform will disrupt multiple medical procedures, reducing health care costs, and improving efficiency, safety, quality, patient experience, and access to services around the globe. Invented by Dr. Steven Tropello, a Johns Hopkins-trained critical care physician, the PUMA System enables diagnostic, interventional and therapeutic procedures in hollow organs. The system combines magnetic attraction for device placement guidance, and ubiquitous, low-cost, point-of-care ultrasound for visualization in hollow cavities. Our lead device, the PUMA-G, selected because of its low risk, clear FDA pathway, and strong commercial viability, is for the insertion of Gastrostomy (feeding) tubes. PUMA-G enables a point-of-care (i.e. bedside, as opposed to operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers. By eliminating specialty suites and specialist consultants, PUMA-G will save hospitals money and improve efficiency and safety for this common procedure. PUMA-G has been validated in human anatomy, and has a streamlined regulatory pathway based on FDA presubmission feedback.

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. Cogent Biosciences, Inc. has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of CGT9486 and CGT0206 inhibitors. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.

Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer’s and Parkinson’s disease), cerebral trauma occurrences (such as epilepsy and stroke) as well as other Central Nervous System afflictions.

Collagen Matrix is a biotechnology company that specializes in developing medical devices and products for regenerative medicine using collagen as a key component.

CollaMedix develops medical devices that are based on collagen. These devices are made using electrocompaction technology. Electrocompacted collagen devices can enhance soft tissue repair and augmentation. One example is CollaFabric®, a load-bearing fabric made from collagen.

Comparative Biosciences Inc., a Genesis Drug Discovery and Development (GD3) Company, a premier preclinical contract research organization (CRO) committed, for the last 20 years, to providing expert high-quality contract research services to all sectors of the biomedical community. Extensive experience in the biotechnology and pharmaceutical industries provides our staff with an exceptional track record in preclinical research and drug development capabilities. Our on-site histology laboratory offers routine histopathology, special stains, immunohistochemistry (IHC), plastics, GLP antibody tissue cross reactivity (TCR), and histomorphometry services with quick turn around times. We also have the benefit of having an on site board-certified pathologist for evaluation and reporting of all the histology work done here.

CoNextions Medical is focused on developing novel solutions for tendon repair. For almost 2,000 years, suture has been the standard of care for the repair of injured tendons. We believe it is time for something new.

Confidence Pharmaceutical Research (CPR) is a dynamic force in the pharmaceutical industry, driven by a vision to revolutionize drug development. With a dedicated team of over 100 passionate professionals, Confidence combines the global reach and full-service capabilities of a large Contract Research Organization (CRO) with the agility and client-centric focus of a boutique firm. Our lean management approach ensures cost-effectiveness without compromising on quality, making us an ideal partner for organizations seeking innovative solutions in drug discovery and clinical research.

Conformal Medical develops medical devices to prevent stroke in patients with non-valvular atrial fibrillation. The company's proprietary technology will help left atrial appendage closure meet its true potential.

ConKay Medical Systems is an early-stage medical device company advancing unique solutions to treat valvular regurgitation in patients with progressive heart failure. Valvular regurgitation is when your valves do not close properly allowing blood to flow backwards in your heart causing shortness of breath, chest pain, and sometimes death. There are over 100 million people currently affected globally with valvular disease and an additional 5M Americans are diagnosed each year. ConKay's annular repair technology is designed to treat the main cause of functional regurgitation leaving the healthy leaflets intact to perform the way it was intended. We are currently focused on the Tricuspid valve. Message us for more information!

At Cook, we are building our future on Invention, Connection, People, and Community. As a privately owned company, we can look at the world our own way and do what we feel passionate about. What are we passionate about? That’s simple: Making unique, quality products and connecting with people to improve lives on both sides of the device. Central to our focus on building deep connections is our belief in the importance of identifying innovative solutions to help customers, patients, employees, and communities thrive. We understand that our ongoing success will come from creating inclusive, supportive, and healthy environments where we can prosper together. Our people are our greatest asset and are at the heart of everything we do. Come build with us.

Patented, Drug-Free, Faster, and More Effective Treatment for Vaginal Infections. Powered by Project Medtech.

Cordis is a medical devices company that specializes in cardiology equipment and healthcare technology.

Johnson & Johnson Innovation JLABS @ TMC, Houston. With a lead investment from the UK-based Wellcome Trust, a premier international medical foundation, CorInnova is developing a non-blood contacting cardiac assist device. CorInnova's device is a transformative biventricular device to treat acute heart failure. The technology will create a new paradigm for treatment. The device is designed to eliminate adverse events associated with existing cardiac assist technologies, and to expand eligible patients. The device may reverse the progression of HF, a blockbuster application. The device deploys minimally invasively into the pericardial sac in under 30 seconds, and has shown the ability to increase cardiac output by up to 50%. Addressable markets are up to $10 billion.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases The Company is focused on developing its lead product Neutrolin®, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters, currently in a Phase 3 clinical trial enrolling patients undergoing chronic hemodialysis. Such infections cost the U.S. healthcare system approximately $6 billion annually and contribute significantly to increased morbidity and mortality. Neutrolin has FDA Fast Track status and is designated as a Qualified Infectious Disease Product, which provides the potential for priority review of a marketing application by FDA and allows for five additional years of QIDP market exclusivity in the event of U.S. approval. It is already marketed as a CE Marked product in Europe and other territories. In parallel, CorMedix is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with active programs in surgical sutures and meshes and topical hydrogels. The company is also working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers.

Cortechs.ai develops and markets cutting-edge imaging solutions that are used by radiologists, neurologists, and oncologists in hundreds of clinics and research centers around the world. The Cortechs.ai team includes scientists, engineers, business professionals, and clinical specialists working towards the common goal of improving the diagnosis and treatment of patients with neurodegenerative disorders and cancers. Cortechs.ai's​ flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer's disease, multiple sclerosis, epilepsy and traumatic brain injury.

Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient's disease pathophysiology. The OptiMap™ System is a 510k cleared, electrographic flow mapping solution designed with AI, enabling physicians to See What Matters.

Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia® Atrial Shunt is the world’s first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction. Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Ventures, Edward Lifesciences and an undisclosed strategic investor. In the United States, the Corvia Atrial Shunt System is an investigational device and not available for commercial distribution or sale.

Corza Medical's mission is to aid and champion the surgical community with outstanding products and remarkable service that save time, money and effort. We are a leading provider of medical devices and Biosurgery serving surgeons and their teams, distributors and OEM partners around the world. With our expanding platform of industry-leading brands, including Quill® barbed sutures, Sharpoint® and Look™ surgical sutures, Katena® reusable ophthalmic instruments, Sharpoint ophthalmic knives, the TachoSil® fibrin sealant matrix, as well as Pearsalls and FSSB OEM solutions, Corza Medical delivers an exceptional customer experience and outstanding value to the entire surgical community. Find out more at http://corza.com

Courante Oncology is a full-service clinical research provider specializing in oncology product development. We offer a wide range of clinical trial management and support services to the pharmaceutical and medical device industries, including project management, clinical site monitoring, quality assurance, and medical writing servies. We believe the challenges of oncology clinical trials require a research team that is uniquely experienced and trained. Our strength lies in our collective experience and our ability to adapt to and meet our clients' specific research needs.

Cranial Technologies has been the world's leading non-surgical treatment provider for plagiocephaly (flat head syndrome) for over 35 years. It's our mission to provide exceptional treatment, experience, and outcomes for every family we treat. To date, we've cared for over 300,000 babies using our proven safe and effective DOC Band® cranial helmet. The DOC band is the first cranial helmet cleared by the FDA, and was cleared for post-surgical correction. Today, the DOC Band is the only device supported by clinical studies and 35 years of proven results. Each of our bands is custom made using state-of-the-art technology to ensure safety and comfort. Our clinics are family friendly, pediatric-focused, providing care exclusively for plagiocephaly patients. They are staffed by highly trained PTs, OTs, RNs, and Orthotists that work closely with families to achieve the best possible outcome for the babies we treat.

Credence MedSystems is setting a new standard in drug delivery, helping drug manufacturers differentiate their products through innovative delivery systems while preserving trusted processes. Credence is an innovator in injectable drug delivery devices, offering our pharma partners a simplified path to commercialization of a best-in-class delivery system. The Companion Safety Syringe System was born from Credence's philosophy of Innovation Without Change, allowing our customers to impress and protect their end users while preserving their existing processes, sourcing strategies and preferred primary package components. The Companion is available in luer needle, staked needle and dual chamber reconstitution configurations. Across the platform, the user performs the injection, receives end-of-dose cues and then the needle automatically retracts into the syringe, preventing reuse.

Crown Aesthetics, the premier medical aesthetics company, is dedicated to helping leading plastic surgeons, dermatologists, and aesthetic physicians around the world grow their businesses. We do that by delivering dramatic results in rejuvenation and restoration. Our non-invasive innovations – SkinPen®, the first FDA-cleared microneedling device; the post-microneedling protocol Skinfuse® and the platelet-rich plasma system ProGen™ – act as "gateway" products that draw new consumers to practices. Based in Dallas, Texas, Crown Aesthetics sets industry standards for efficacy, safety, and innovation. As a result, our customers consistently deliver the best aesthetic care in the business. Learn more at CrownAesthetics.com.

Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become a leader in Dermatology and Aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for eight years and has expanded its distribution to over 38 countries. For more information, visit www.crownlaboratories.com.

Cryosa is a clinical stage company developing a treatment for moderate to severe Obstructive Sleep Apnea (OSA). We believe that mask-free, hose-free, implant-free treatment is possible. Everyone is free to sleep, free to rest and free to live brighter days.

CSSi LifeSciences™ Drug & Medical Device Commercialization & Medical Device CRO Our goal is to ensure a successful and expeditious pathway to commercialization for our clients’ drugs and medical devices by providing insight-driven analysis that saves time, development costs, and resources. We enable faster, more informed decision making to increase commercial success, while reducing the risk of late-stage failures and post-authorization action. Unparalleled Success from Discovery to Commercialization • Commercialized over 500 new drugs, biologics, medical devices, and in-vitro diagnostics • Over 250 medical device 510(k) Class 1-3 submissions with 100% success. • Extensive Orphan, “First in Class,” and “First In” Indication success. • Reduced time to approval by over 600 days. • Over 100 NDA, ANDA and BLA submissions, with 96% success. • Greater than 60 EMA CHMP Marketing Authorizations. • SmartStudyTM design and feasibility assessments enhanced study efficiency and success and reduced protocol amendments by over 50%. CSSi LifeSciences Medical Device CRO has experience navigating regulations in over 100 countries. Often companies struggle with the pathways for a medical device from design to commercialization because of the ambiguity and complexity of the process. Regulations and requirements change frequently and vary by notifying bodies, country, level of risk (i.e., Class 1-3), specific product claims, and intended use. Our diverse team has many years of medical device commercialization experience, with the knowledge that goes beyond published guidance, documents and initiatives. CSSi LifeSciences Medical Device CRO aims to impact the timeline of regulatory clearance and increase profitability.

Curiteva is a privately held technology and manufacturing company dedicated to advancing spine surgery and improving clinical outcomes by partnering with providers and suppliers to deliver innovative and intuitive implant systems to the market. Our business is founded on a commitment to building world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering novel technology to meet the evolving needs of our customers and the patients they serve.

CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.

CURx Pharmaceuticals is a pharmaceutical company specializing in clinical and commercial development of therapeutics addressing unmet medical needs in patients with chronic disease.

CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body's own natural blood flow regulation system - which signals the brain to regulate cardiovascular function. Patient Stories on CVRx: The accounts and quotes of patients are genuine and documented. These stories represent a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to CVRx technologies. Barostim is a prescriptive device. For a list of all potential benefits and risks go to www.cvrx.com/benefit-risk-analysis/

Validation Consulting

Cynosure is a leader in the medical devices industry specializing in aesthetic medicine and cosmetic procedures.

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the United States designed to support eventual FDA marketing approval for antithrombotic removal during cardiothoracic surgery using the DrugSorb™-ATR Antithrombotic Removal System.

Cytrellis Biosystems, Inc. is a medical technology company located in Woburn, Massachusetts, founded in 2012. The company focuses on developing and commercializing innovative aesthetic devices aimed at dermatology and scar reduction. Its mission is to provide non-surgical solutions for sagging skin associated with aging, enhancing skin appearance and restoring youthful beauty. The primary product offered by Cytrellis is the ellacor System, which employs Micro-Coring Technology. This system is designed to treat moderate to severe wrinkles in adults aged 22 and older, specifically targeting the mid to lower face. The ellacor System enables aesthetic practitioners to effectively address age-related skin changes. Cytrellis Biosystems collaborates with leading physicians and partners to implement its aesthetic solutions. With a strong leadership team experienced in medical device development, the company is well-positioned in the beauty and personal care industry, competing with other notable players in the aesthetic and medical device sectors.

Dandelion Science is a US-Swiss Generative Neuromodulation™ company, committed to advancing precision therapies for vision and brain disorders. Led by a world-class team, Dandelion's mission is to enhance the lives of people affected by these conditions through the integration of advanced generative technologies and deep scientific expertise. The company boasts extensive intellectual property and has received prestigious funding from the US National Institutes of Health and the Swiss Innovation Agency.

Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt the contraceptive landscape by providing protection for one month, without the use hormones, and our suite of ethylene-vinyl acetate (EVA) matrixed IVRs that can provide flexibility in terms of drug loading, drug delivery, and modulation of release rates across a wide array of molecules, hormones, peptides and proteins, facilitating new indications and applications of the technology. Daré’s EVA IVR technology includes DARE-HRT1 for dual hormone replacement as a potential treatment for the vasomotor symptoms of menopause and DARE-FRT1 for vaginal progesterone delivery in support of fertility and the prevention of pre-term birth. In addition to its novel IVR technologies, Daré is developing a topical formulation of sildenafil, the active ingredient in the blockbuster product Viagra®, for the treatment of female sexual arousal disorder (FSAD) as well as a novel vaginal formulation of the selective estrogen receptor modulator (SERM) tamoxifen to address and alleviate the symptoms of vulvar vaginal atrophy (VVA) for women diagnosed with and treated for hormone-receptor-positive (HR+) breast cancer.

Deaton Engineering, Inc. (DEI) is a nationally established, full-service mechanical, electrical, software control engineering and integration company located in Georgetown, Texas. Established in 1991, DEI offers a wide variety of solutions and services to a broad range of industries with a focus on turnkey engineering and product development services for the life-sciences industries. Composed of a diverse group of Texas licensed Professional Engineers, engineers, designers, and technical staff, Deaton Engineering develops ideas or products from concept through implementation.

.decimal® is a medical device manufacturer of patient-specific devices, including BolusECT® compensators for electron conformal therapy, FlexiBol custom silicone bolus for photon therapy, Virtual Moldroom services for electron cutout outsourcing, modulators for advanced Solid IMRT® delivery, as well as apertures and range compensators used in proton therapy. We have been providing radiation therapy products to hospitals and cancer centers across the United States for thirty-five years.

Duke University spin-out, Deep Blue Medical Advances has developed a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Our surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, several additional products are in development, including an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line® Hernia Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.

Delcath Systems, Inc. (NASDAQ- DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product---Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. Delcath is in late-stage clinical development in the United States with initial commercial activities in Europe, where the Melphalan/HDS is marketed as a CE Marked device under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). Our commercial strategy for CHEMOSAT is to steadily grow clinical adoption in major European markets and utilize physician experience to support appeals for reimbursement. Since launch over 250 CHEMOSAT treatments have been performed at over 20 leading European cancer centers. In 2016, we launched our FOCUS Pivotal Study in Hepatic Dominant Ocular Melanoma, and are investigating orphan indications in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. We believe Melphalan/HDS is uniquely positioned to treat the entire liver as a stand-alone or complementary therapy.

Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.

DesignPlex Biomedical is an ISO 13485:2016 registered company that designs, develops and manufactures Class 2 and Class 3 medical devices. While our focus is primarily in cardiovascular and neuromodulation, we welcome any challenging medical device design or manufacturing that requires mechanical, electro-mechanical, electronics, or systems integration, Our 11,000 sq. ft. design studio and dedicated manufacturing areas can accommodate small to medium production volumes.

Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started: Improving human health. We are driven by over 10,000 ambitious, passionate people worldwide who are willing to fight like warriors to earn the trust of our customers by listening, serving with integrity, thinking big, and being dependable. We've already changed millions of lives and we're ready to change millions more. Our future ambition is to become a leading consumer health technology company while continuing to develop solutions for serious health conditions. We'll get there by constantly reinventing unique biosensing-technology experiences. Though we've come a long way from our small company days, our dreams are bigger than ever. The opportunity to improve health on a global scale stands before us.

Diality, Inc. is a privately held medical device company based in Irvine, California, focused on improving the lives of individuals affected by kidney disease. The company is dedicated to transforming the dialysis landscape by promoting personalized and cost-effective care models, moving away from traditional centralized facilities. Diality is developing the Moda-flx, a versatile hemodialysis system designed to be simple, mobile, and intelligent. This system allows healthcare professionals to provide personalized dialysis treatments in various settings while maintaining high-quality care. The Moda-flx is user-friendly, reducing training time for clinicians, and features secure data storage and cloud accessibility to support data-driven decision-making. The company is a member of the Advanced Medical Technology Association (AdvaMed) and adheres to its Code of Ethics. Diality has also joined Kidney Care Partners and secured significant investments, including a $24 million Series B2 funding round, highlighting its commitment to innovation in kidney care.

DiFusion Technologies, Inc. is an industry leader in advanced biomaterials for surgical implants. DiFusion Technologies is revolutionizing the field of implant technology by developing innovative solutions that reduce the foreign body response from the patient's immune system, thereby promoting early healing, reducing complications, and improving patient outcomes. The company's proprietary manufacturing process produces implants that decrease chronic inflammation currently associated with traditional biomaterials. Redefining the landscape of healthcare technology, our surgical implants cater to the precise needs of orthopedic surgeons, neurosurgeons, spine surgeons, and medical device distributors. By setting unprecedented standards in the industry, we're not just creating products - we're shaping the future of surgical care. Discover more about our groundbreaking surgical devices at difusiontech.com.

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal cord injured individuals.

Dimension Inx is the architect of regenerative microenvironments. Our materials give the body a blueprint to heal itself. We take a materials-centric approach to solving patient needs. By creating structures that emulate the body's microenvironment, we elicit an immediate regenerative response. We design for biofunctionality and manufacturability. Our platform is highly adaptable and not limited to any single material. Our collaborative studio approach allows us to co-create a lasting advantage by partnering with leading product and R&D organizations. Contact us to accelerate the development of new regenerative solutions today.

We are a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows.  Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together' by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles. 

Downstream Therapeutics is a biotechnology company that focuses on developing a combination drug-device to reduce cell injury after restoration of blood flow.

DP Clinical, Inc. is a privately held Contract Research Organization (CRO) specializing in neurology/CNS (including spinal cord injury), oncology, ophthalmology, infectious disease/vaccines, and rare disease Phase I-IV clinical programs. DP Clinical provides a full complement of clinical trial services to pharmaceutical, biotech, and medical device companies including trial management, monitoring, data management, biostatistics, regulatory, safety monitoring and reporting, and medical writing. Since 1994, we have worked for clients of all sizes — small to large pharmaceutical and biotech companies, academic research institutions, and government sponsors. DP Clinical provides integrated trial solutions as well as specific service components based on sponsor need. Our comprehensive services include: • Project management • Clinical trial monitoring • Data management • Biostatistics • Pharmacovigilance and safety • Regulatory affairs • Quality assurance • Medical writing

At Drawbridge, we’ve created the OneDraw™ technology to transform the way blood is sampled and shipped. But that’s just the start. Our ultimate goal? To give everyone, everywhere access to the powerful health information within their own bodies.

We're building scalable low-cost, high-performance diagnostics for infectious disease in communities, starting with Tuberculosis. Our mission is to create large scale diagnostics that can be used to test large samples such as those from food, water, environments and air to prevent infectious disease outbreaks. For all 7 billion of us.

DSG, Inc. is a leading global eClinical provider with a fully unified suite of innovative technology solutions and data management services for the global clinical research community. DSG's eClinical software platform provides competitive advantage that is cost-effective with on-time project delivery. DSG solutions have been used in thousands of clinical trials around the globe with our award-winning eCaseLink™ platform and eCaseLink Designer for enterprise licensing. Founded in 1992, the company is proud to be recognized as the first provider of a fully integrated EDC and IRT Randomization and Trial Supply Management system with the SCDM Data Driven Innovation Award. For more information, please visit www.dsg-us.com

Medical device sales/distribution organizations needed for a non-narcotic chronic pain treatment solution develop by DyAnsys Inc. Be a part of a billion-dollar market. This innovative solution has tremendous growth potential with the current focus on reducing the use of narcotics for pain treatment. DyAnsys Inc. has been growing rapidly and needs to expand its coverage of the U.S. market. Distributors who are already working in the pain management field and have a base of pain management clients are preferred. Successful candidates should: • Have been in the medical device sales and distribution business for at least five years. • Have a sales force or access to 1099 reps to assure full territory coverage. • Be able to focus on DyAnsys products to grow the business rapidly. To learn more: Call 1-888-950-4321 or e-mail new.distributor@dyansys.com DyAnsys Inc. is a global company, headquartered in the Silicon Valley (California, USA), and is led by a worldwide team of professionals drawn from the medical, mathematical and IT fields who are working hard to make DyAnsys a worldwide leader in providing advanced medical diagnostic and monitoring systems to clinicians in individual practices and hospitals. By using sophisticated mathematical analysis of the ECG and other electrical signals, DyAnsys applications focus on chronic and acute pain, anesthesia, diabetes, and fetal heart monitoring.

Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrack™, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events.

DynoSense Corp. is a medical technology founded by successful high tech veteran, with a mission to “innovate best in class products and services for better, longer, and healthy life that are integrated, accurate, secure, elegant, and simple to use”. We call it “Innovation For Life”.

Engineering and Design of Implantable Medical Devices We are the industry leader in Engineering and Design of implantable medical devices and have helped many companies through the product development and regulatory approval process. ECHOBIO LLC has over 18 years of experience with medical devices including self-expanding and balloon expandable stents, stent grafts, heart valves and others, as well as a strong background in implantable materials (metals, polymers, ceramics and biomaterials). This experience provides a solid foundation for using FEA and improves our simulation of devices and surgical procedures. We participate on international standards committees and pioneer innovative materials research to develop better engineering methods for making safe and reliable implantable medical devices. Our goal is to put our engineering and medical product expertise to work for customers and partners, helping them to move quickly and confidently to market with safe and effective products. From concept through design, development and regulatory approval, ECHOBIO LLC can help you create better products.

The company works with doctors to develop medical devices related tostructural heart disease and critical care monitoring.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable. Ekso Bionics is headquartered in San Rafael, California International Offices: Ekso Bionics Europe GmbH Friesenweg 20 Hamburg, 22763 Germany Tel: +49 40 800 4049 20

In 2005, we were founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments they aren’t happy with. Because different modalities of neuromodulation had previously proven to be effective and safe, we recognized an opportunity to be the leader in this new frontier of medicine and took it head on. Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments. Bringing new treatments to market will help improve patients'​ treatment options and lives.

Eliaz Therapeutics (ETI) was founded in 2015 by Isaac Eliaz, MD to leverage his significant expertise in Galectin-3 and Apheresis to develop and commercialize a therapeutic Apheresis device that removes Galectin-3 from the blood. Galectin-3 has a causal role in many life-threatening inflammatory and fibrotic diseases, immune dysregulation (including the cytokine storm), kidney deterioration and cancer that do not have effective treatments today. The initial indication will be Sepsis and Sepsis induced Acute Kidney Injury (AKI). AKI is a sudden decrease in kidney function with or without kidney damage, occurring over a few hours or days. Annual US hospitalizations for AKI are in excess of 4,000,000 and deaths exceed 500,000. Diabetes, hypertension, and advanced age are primary risk factors for sepsis and acute kidney injury. It is increasingly recognized as an in-hospital complication of sepsis, heart conditions, surgery and Covid-19. Its most severe stage requires treatment with dialysis or renal transplant therapy. Acute kidney injury is also associated with higher likelihood of long-term care, incidence of chronic kidney disease and hospital mortality, and higher long-term health care costs. Currently, there are no approved treatments to prevent, interrupt, or hasten recovery from sepsis and sepsis-AKI. XGAL3 apheresis has the potential to do all three and thus exert a dramatic impact on sepsis patient management and outcomes, potentially saving hundreds of thousands of lives per year.

Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: - Drug-eluting coronary stent systems (DES) - Fully resorbable drug-eluting scaffold systems (BRS) - Drug-eluting coronary bioadaptor systems Its latest innovation — the DynamX™ Coronary Bioadaptor System — is designed to be a significant advancement beyond drug-eluting stents (DES). Elixir Medical’s innovations are designed to make a meaningful change in patients’ lives. The company does not simply want to engineer a better medical device. Saving lives and helping patients enjoy their daily life is what drives us every day.

eLum Technologies, Inc. is an early stage medical device company focused on disruptive technologies to address endovascular diseases.

At Elutia we’re pioneering the future of patient care. Our proprietary drug-eluting biomaterial platforms stand at the forefront of medical innovation.

At embecta (formerly part of BD), we are singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of developing and providing solutions to the diabetes community, today, we are a global medical technology company and leader in insulin delivery devices. More than 30 million people in over 100 countries rely on our pen needle and syringe products every day.  BD is the manufacturer of the advertised products.   Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement 

Empirical Spine, Inc., is focused on developing disruptive solutions for the surgical treatment of spinal disorders, in order to deliver superior clinical outcomes while lowering overall healthcare costs. We are building a new standard in spine surgery that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life by creating a new category called Dynamic Sagittal TetherTM (DST). For patients with mobile degenerative spondylolisthesis, LimiFlexTM is the first and only Dynamic Sagittal Tether that restores the natural motion and stability required after a decompression by augmenting the posterior tension band, creating elastic resistance to flexion and maintaining lordosis, and offers the potential for significant reduction in cost, invasiveness, and sequelae compared to spinal fusion. The U.S. pivotal trial on our breakthrough LimiFlex Dynamic Sagittal Tether is fully enrolled and nearing its two-year endpoint. In summer 2022, we expect to submit results from this trial to the FDA for PMA approval. Follow our LinkedIn page for company news and updates. For more information about LimiFlex Dynamic Sagittal Tether visit the following website: https://www.limiflex.com/. Caution: The LimiFlex DST is an investigational device in the U.S. and is limited by law to investigational use.

CSA Laboratory Solutions is a nationwide service provider of practical, science-based multi-vendor laboratory instrument services and FDA compliance consulting. Theirservices include qualification (IQ/OQ/PQ), calibration, maintenance and asset management on a wide range of laboratory instrumentation and equipment. CSA also specializes in risk-managed validation techniques for software, manufacturing systems and processes that ensure operational reliability and compliance while managing the overall high cost of quality.

Founded in 2002 and headquartered in Seattle, WA, EMulate Therapeutics is a clinical-stage therapeutic device company. EMulate Therapeutics has invented and patented a groundbreaking technology that utilizes precisely targeted, ultra-low radio frequency energy (ulRFE®) to specifically regulate signaling and metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use non-invasive device called EMulate Therapeutics Voyager. The company's goal is to transform disease treatment on a global scale with ulRFE®. The proprietary technology has the potential to be applied to a wide range of conditions as well as veterinary medicine and non-medical applications. EMulate Therapeutics' initial focus is on the treatment of patients with brain cancer who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Additional pre-clinical work is focused on exploring new applications in oncology and pain treatment.

At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease. The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for: › Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression. › Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.

Encora Therapeutics is a healthcare technology company based in Boston, Massachusetts, founded in 2018. The company focuses on developing innovative, non-invasive wearable solutions for individuals with neurological movement disorders. Their mission is to enhance the quality of life for those affected by these conditions through advanced wearable technology and personalized treatments. The company specializes in wrist-worn vibratory stimulation devices that utilize artificial intelligence-powered vibration therapy. These wearables are designed to provide tremor relief and monitor disease progression, particularly for conditions like essential tremor. Clinical trials have shown significant reductions in tremor severity with their devices, which are user-friendly and well-tolerated. Encora Therapeutics employs advanced technologies such as signal processing and reinforcement learning to create effective solutions tailored to individual patient needs. Their clinical research has received recognition, including an "Abstract of Distinction" at the 2025 American Academy of Neurology Annual Meeting, underscoring the safety and efficacy of their products.

We are a team of engineers and physicians based in Hayward, California. We're developing PillBot™, a moving pill-sized camera that will enable 220+ million people around the world to get quick, easy endoscopies at home. Our dream is to save millions of lives through the early detection of cancer, ulcers, and more.

Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex's innovations focus on resetting the body's metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. Through the development of the ReCET System and the novel application of precise, controlled, non-thermal pulsed electric fields, Endogenex is establishing a new era in treatment options for people living with T2D, helping patients regain control of their blood glucose levels and slow disease progression. Endogenex is a privately held, clinical-stage company based in Minneapolis, MN.

Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence. With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.

Endomedix is a development stage, Medical Device venture, a C corp. The Company has developed a tunable polysaccharide platform that can produce a family of new biomaterials. The first spinoff of this platform is PlexiClot™ Absorbable Hemostat to control bleeding in brain & spinal surgeries, a $1.9B market. PlexiClot introduces the first fundamental innovation in bleeding control in these procedures since the current standard of care was introduced in 1945. The innovation is based on new mechanisms of action that will likely obsolete the current methods of relying on the biochemical action of thrombin and manual pressure to produce coagulation. PlexiClot will eliminate one cause of reoperations caused by current devices as documented in dozens of clinical publications. In addition to reducing the incidence of complications, PlexiClot is poised to save hospitals hundreds of millions of dollars in unreimbursed costs due to reoperation, lengthy hospital stays and early readmission to hospitals. PlexiClot's performance has been confirmed in 3 large animal trials, and Endomedix is currently planning to scale up production. PlexiClot's composition of matter, method of manufacture and mechanisms of action are protected by 8 issued patents, the most important of which expire in 2038. The Endomedix team is led by Richard Russo, a medical device vet with experience in prior start-ups with exits, and he is the lead cash investor. He has a history of success with new products, clinical & regulatory, and international. R&D is led by Piyush Modak, who leverages a small internal team through a constellation of renown subject matter experts. 18 neurosurgeons & physicians are investors. PlexiClot will be the 1st device approved by FDA specifically for brain surgery. This sector is marked by a high level of M&A activity, much of which occurs prior to final FDA approval. The program has drawn interest & support from surgeons and physicians, 18 of whom are investors.

In many medical settings, devices are commonly used to help doctors treat patients. For example, stents are often used to open blocked arteries, repair torn vessels, and even to keep nasal passages from swelling shut after surgery. Unfortunately these devices fail often resulting in additional surgeries and often replacements of the original device. Endomimetics has developed a BioNanomatrix that can be used to coat these devices and mimic human tissue which minimizes the need for additional surgeries, improves the longevity of the device, reduces complications associated with having foreign items implanted in your body. Applications Our endothelium mimicking nitric oxide releasing BioNanomatrix, initially developed for coronary and peripheral stents, is being assessed for several novel applications including: Stents to help with heart disease Stents and blood flow diverters to help with brain aneurysms Fistula implantation for dialysis patients Intranasal implants for chronic sinusitis sufferers

EndoTheia was founded in 2018 to develop the next generation of flexible endoscopic devices, with the goal of increasing therapeutic yields through added flexibility and dexterity.

Endovascular Engineering, Inc. ("E2"), is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.

Founded in 1985, Engineered Medical Systems, Inc. is a Medical Device Manufacturer in Indianapolis, Indiana. We now have a second location based in Penang, Malaysia. Each facility is ISO 13485 certified and they house our administrative, sales, engineering, and manufacturing resources. EMS is a privately held company producing a variety of medical devices in the disposable air management field as well as electronic medical devices. Our manufacturing capabilities include: -Product design from Concept to Completion -Prototype and tool building -Injection molding and complete assembly -Bonding capabilities include sonic welding, solvents and adhesives -Product testing -Delivery of finished devices to the clients dock

Enovis is a data analytics company that provides technology solutions for business intelligence and information management.

Envoy Medical (Nasdaq: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.

Our mission is to improve the lives of stroke victims suffering from difficulty with movement and coordination. Standard rehabilitation can help a patient recover some muscle function. However, mild electrical brain stimulation, when administered in conjunction with muscle training, has been shown in published research studies to significantly improve a patient's ability to move, resulting in often dramatic improvements to quality of life, when compared to muscle training alone. The EPIC Stimulator is a tiny leadless device that provides short low-energy electric pulses directly to the cortex. The implant procedure is very simple (~15 min). The EPIC contains no battery and is externally powered through a comfortable cap. The cap is only worn by the patient during muscle training (about an hour a day for 3 months). After all rehab is complete, the EPIC devices can be easily removed if desired. In addition to mild brain stimulation, the EPIC allows the recording of a patient's EEG, which is streamed to a handheld device and then to the cloud. This allows neurological changes in the brain to be tracked and quantified. Note, the EPIC is not approved by the FDA for human use. It is only for investigational use as part of a clinical trial.

Epicore Biosystems is a digital health company developing advanced sweat-sensing wearables that provide real-time personalized health insights for hydration, stress, and wellness. Our clinically validated products are deployed globally and licensed by leading brands in the sports and fitness, occupational safety, and clinical trials industries.

Erisyon is transforming the field of proteomics with the world's first single molecule protein sequencer. With unprecedented sensitivity and scalability for proteomics, Erisyon enables new applications across the Life Sciences Erisyon has emerged from the University of Texas at Austin to commercialize the world's first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT's Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.

Escalon, operates in the healthcare market, develop, manufacture, marketing, and distribution of medical devices for use in ophthalmology.

In 2005, Esco Technologies was incorporated in Philadelphia to seek new technologies. In addition, Esco Biotech Inc was established in Houston to sell Esco Lab products, which then merged into a new facility in Hatboro, PA two years later. In 2012, the Pharma and Medical divisions were established, with Pharma having a factory in Feasterville, PA. With sales growth accelerating, the company relocated into a much larger premise in Horsham in 2015 — a move that enabled an extensive expansion of our sales network throughout the US and Canada, making Esco Technologies a one-stop shop and key player for Life Sciences, Medical and Pharma in North America.

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Exergen Corporation is the recognized world leader in industrial and medical non-invasive temperature technology. From providing temperature sensors for NASA and various industries to creating one of the world's most popular baby gifts, Exergen creates non-invasive temperature measurement devices providing lower cost, higher accuracy, less invasiveness, and greater reliability than ever previously possible. The creator of the first temporal artery thermometer—the Temporal Scanner™, the most efficacious, non-invasive thermometer ever created. Exergen holds over 100 U.S. and foreign patents, and is the only manufacturer of retail medical thermometers in the U.S. Presently, 30% of hospitals and pediatricians currently use the Exergen Temporal Scanner, and well over 1 million consumers use one at home. Founded by Harvard-research scientist Dr. Francesco Pompei over two decades ago, Exergen Corporation is based in Watertown, Massachusetts, USA.

Eyenovia, Inc. (NASDAQ: EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, presbyopia, mydriasis and other eye diseases.

FastWave Medical is developing novel, cost-effective intravascular lithotripsy systems for calcific artery disease. Learn more here.

Femasys is a biomedical company focused on transforming women's healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc®, a first and only non-surgical product for permanent birth control and FemaSeed™, a first and only directed sperm delivery product for infertility treatment. Femasys' FemVue® product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician's office setting.

Overactive bladder (OAB) affects over 15 million women in the US. The sudden, urgent desire to pass urine greatly limits quality of life. Current treatments are not optimal, requiring frequent, time-consuming office visits, awkward vaginal probes, medications with potential side effects or surgery. Those suffering with OAB often consider the therapies too cumbersome and forgo treatment, opting instead to place limits on their life to accommodate the symptoms. Neuromodulation for OAB involving electrical stimulation of the sacral nerve is a proven and established therapy. However, despite being commercially available for over a decade only a small fraction of indicated patients have been treated. The cost and invasiveness of the surgery are often cited as concerns by prospective recipients. FemPulse has developed a novel, wearable medical device designed to deliver neuromodulation therapy directly to the nerves that regulate bladder function, without the need for surgical implant. The small device is easily placed by the patient herself and controlled with a smartphone app. The company is currently conducting clinical evaluations in the United States.

For ordering information, please contact: 3M+KCI at +1-800-275-4524, KCI Express® https://mykci.com/kci-express, or Your local 3M+KCI Sales representative ________________________ Managing ostomy complications and intestinal fistulas is a challenge. A high output ostomy stoma or enteric fistula can produce two to seven liters of effluent per day which can cause edema, wound formation, complications and infections. To improve the management of patients with enteric fistulas and high output ostomy stomas we developed the Wound Crown®, Fistula Funnel® and Isolator Strip®. These barrier devices have been used effectively to compress the surface of the body around enterocutaneous fistulas, enteroatmospheric fistulas, ostomy stomas, and wound drains with moderate to high output levels to seal and protect the perimeter skin from effluent and reduce edema.

Fluke Biomedical manufactures biomedical test and simulation products, including electrical safety testers, patient simulators & performance analyzer.

The Food and Drug Administration is an agency within the Department of Health and Human Services. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect the public health and to reduce tobacco use by minors. FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. FDA also plays a significant role in the Nation's counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.

Fractyl Health is a leader in creating innovative therapies to address the root cause of type 2 diabetes. We were founded based on groundbreaking research and biological insights showing the key role of the intestine in metabolic control. Our therapies are uniquely designed to target and control this controller for the treatment of metabolic disease. Our lead program, Revita DMR, is a first-in-class procedural therapy that is now in late-stage clinical trials for the treatment of type 2 diabetes. Our team is made up of passionate innovators at the intersection of biology and technology, working to deliver better real-world outcomes for people with metabolic disease.

Francis Medical is developing minimally invasive treatment solutions for prostate, kidney, and bladder cancer through the use of convective thermal water vapor. Currently, the company is in clinical trials for ablating cancerous prostate tissue. Founded in 2018, Francis Medical is located in Maple Grove, Minnesota. Francis Medical, Inc., formerly named NxPhase Medical, Inc., is a company that was created after Boston Scientific (BSC) acquired NxThera, Inc. in April of 2018. As a part of the BSC/NxThera transaction, a separate and independent entity, NxPHASE Medical, Inc. (“NxPHASE”), was established, and shares of NxPHASE were distributed to the shareholders of BSC/NxThera. In addition, BSC/NxThera granted NxPHASE a license to utilize BSC/NxThera’s convective vapor ablation technology to develop, evaluate, and commercialize certain devices to treat prostate, kidney and bladder cancer (“NxPHASE Field of Use”), while BSC/NxThera remains focused on the treatment of benign prostatic hyperplasia. Late in 2018, NxPhase Medical, Inc. went through a rebranding process and selected Francis Medical, Inc. as its new brand and identity. The name and foundation of the company are a tribute to and legacy of Michael Hoey’s (founder/inventor) father, Francis Hoey, whose life was ended by prostate cancer with treatments that had harsh implications on his normal daily living.

Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world's largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.

Freudenberg Medical is a global partner for the design, development and manufacture of medical devices, components, and minimally invasive product solutions. Our comprehensive technical capabilities range from the design and manufacture of minimally invasive, catheter, and handheld technology to the development and production of medical components utilizing advanced materials and processes. We are an industry leader in the manufacture of high precision silicone and thermoplastic components and tubing as well as metal hypotubes and coating technology. Freudenberg Medical is part of the Freudenberg Group, a global technology group. As an organization, we ensure that every project is supported by our unmatched range of global resources, financial stability, and the flexibility to optimize for business performance. www.FreudenbergMedical.com Explore the possibilities with Freudenberg Medical, please call 877-308-0558 or email info@freudenbergmedical.com

Freyja’s mission is to raise the standard of women’s health in both surgical and in-office procedures, enabling physicians to deliver safe and effective care.

FUSE Medical is an emerging medical device company committed to the advancement of anatomical motion, preservation, and restoration by offering Surgeons a fully comprehensive implant product selection for use in areas of: Spine Total Joint Reconstruction Sports Medicine Upper Extremity Lower Extremity Biologics Regenerative Medicine HEADQUARTERS Richardson, Texas - 20-minute drive from DFW airport PRODUCT LINES Spine Fusion Total Joint Reconstruction Sports Medicine Line External Fixation Options Comprehensive Foot Plating Systems Compression Stapling Systems Hammertoe Full Biologics Portfolio Rotium Tendon to Bone Bioresorbable Wick Phoenix Wound Care Synthetic Matrix BMAC PRP STERILE PACKAGED SYSTEMS Hammertoe Distal Radius Distal Fibula Lapidus MTP Clavicle Plating Cannulated Screws DISTRIBUTOR BENEFITS Comprehensive portfolio Robust product pipeline National distributors for thousands of products Transparency Grow with us!

Heart Hugger is a medical devices company that specializes in post-operative care for cardiac and thoracic surgery patients, focusing on pain management through a unique device.

GENESEARCH, INC is a biotechnology company that specializes in embryonic manipulation techniques for biomedical research purposes.

Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease.

Gilero offers end-to-end device design, development and contract manufacturing in the medical and pharmaceutical industries. Specializing in the areas of consumable and reusable medical devices, drug delivery, combination products and complex electromechanical systems, Gilero offers a wide range of services to meet your medical or drug delivery device needs.

Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care platforms. Our proven technologies make lives better by revolutionizing the connection between patients and providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials. Glooko is globally deployed in over 30 countries and 8,000+ clinical locations.

At Glucotrack, we are pioneers in diabetes technology, dedicated to transforming the way diabetes is managed. Our mission is to develop innovative, long-term solutions that prioritize accuracy and ease of use. With a commitment to reducing the daily burden of diabetes management, we create cutting-edge technologies designed to enhance the lives of those we serve. Join us in our journey towards a future where managing diabetes is simpler, more effective, and empowering.

Developer of oral, gut-targeted polymer therapeutics for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety-advantages avoiding invasive complications of surgeries and procedures.

Glytec's industry leading SaaS platform, trusted by 350+ hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing readmissions, and streamlining workflows while delivering a 6-8x ROI. The first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by 106 patents and over 100 publications. The Glytec Glucommander® solution, with clinical decision support, workflow alerts, patient monitoring, at-risk patient identification, and AI-driven analytics, is supported by a mission-driven team dedicated to helping healthcare leaders, clinicians and patients promote health equity and improve diabetes outcomes from hospital to home. We are on a mission, join us. For more information, follow Glytec on X (@Glytec) or visit www.Glytec.com.

Gore Medical makes medical devices used by healthcare professionals to improve the lives of patients worldwide. Come and learn more about our work.

General Prognostics (GPx) is revolutionizing remote chronic disease management with the world's first bloodless blood tests. Headquartered in Boston, MA, GPx is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.

Leveraging our deep experience in stroke medicine and bio-engineering, we have developed the world's most powerful and cost-effective solutions to save millions of lives impacted by ischemic stroke

Green Sun Medical LLC. is a Colorado company dedicated to developing transformative bracing technology to prevent spinal deformity surgery. We have assembled a world class surgeon advisory board of scoliosis thought leaders and veteran industry executives. Our tech enabled dynamic brace will provide precise corrective pressure to patients. For the first time ever, physicians will be able to monitor the performance of a brace in real-time.

Ground Zero Pharmaceuticals, Inc. (GZP) focuses on bringing medical product programs through the FDA regulatory process, from late discovery through final approval and postmarketing. GZP's philosophy of doing "what is necessary and sufficient and no more" at each stage of development aids clients via clean, cost-effective, targeted and accelerated development plans. With emphasis on completing each portion of a product's lifecycle in a rapid and resource sparing manner, while maintaining acceptable quality for FDA review, GZP adds value to our client programs by enabling accomplishment of important milestones.

Guided is a Georgia-based medical technology company that develops and commercializes non-invasive medical devices for early detection of cancer.

Gynesonics is a medical technology company that specializes in providing minimally invasive solutions for women's health, particularly in the treatment of uterine fibroids.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs in subcutaneous urography; and to improve resorption of radiopaque agents. The company is also developing Perjeta for breast cancer; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; and National Institute of Allergy and Infectious Diseases. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

Since 1979, Hand Biomechanics Lab has benefited from the synergy between the surgeon and bioengineer. We have created an environment that not only understands but also solves critical wrist and hand issues. Dr. Agee has carefully assembled a team specializing in the medical, engineering and business fields who work to develop new technology, always with the patient's best interest in mind.

Hardy Diagnostics offers products and services related to microbiology. The company's products are used in pharmaceutical microbiology, food and beverage microbiology, and clinical microbiology.

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. We sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including GE Healthcare, Thermo Fisher Scientific Inc., and VWR. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, and Spain and sales facilities in France and Canada.

H.B. Fuller | Adhezion Biomedical, LLC is a medical device company focused on the development and commercialization of highly differentiated cyanoacrylate based surgical, wound management and infection prevention technologies. Founded in 2001, the company is based in Wyomissing, Pennsylvania. The vision of the Adhezion team is to redefine the way cyanoacrylate based surgical adhesives and sealants are used in medicine. Our mission is to provide technologies that achieve optimal patient outcomes. Adhezion currently is developing and commercializing cyanoacrylate‐based adhesives and sealants for use in both professional and consumer healthcare settings.

HDL Therapeutics is a clinical-stage company that researches, develops and commercializes therapeutics for the treatment of heart-related problems.

Healionics is addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 36 patents issued or pending.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS). PoNS™, short for Portable Neuromodulation Stimulator, is an innovative medical device. It is inclusive of a controller and mouthpiece, that delivers mild stimulation to the surface of the tongue. This stimulation triggers a flow of neural impulses to the brain structures that control balance and gait. PoNS is meant to be used in conjunction with supervised therapeutic activity, referred to as, PoNS Therapy™. Use of the device while engaging in movement and coordination tasks promotes neuromodulation, activating brain pathways to help improve balance and gait. PoNS is authorized in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. PoNS is authorized in Canada for three indications: (i) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) and is to be used in conjunction with physical therapy; and (ii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke, to be used in conjunction with physical therapy. PoNS is authorized in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait.

Helmer Scientific is a manufacturer of medical and laboratory equipment with a focus on healthcare solutions.

HEMEDEX INC. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood flow at the capillary level). This technology addresses the need for real-time, prognostic data in complex medical and surgical procedures. These complex procedures often involve compromised vasculature, delayed ischemia, or other serious pathophysiology, resulting in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. HEMEDEX's patented technology can provide an early warning of impending tissue ischemia, help target appropriate therapies, and rapidly assess the effect of interventions on cerebral blood flow (CBF), thus providing clinicians with a powerful tool to enhance patient care. HEMEDEX is ISO 13485:2012 certified.

Imagine your drug’s effect lasting for months, after one single dose, and with fewer side effects—Hera Health Solutions is turning this vision into reality. Pharma companies can rapidly turn their promising APIs into long-acting, precise, and profitable therapeutics. How? Through our proprietary, cutting-edge nanotechnology-based drug delivery platform. The best part? The platform is: ♻️ Biodegradable: Resorbs into the body. 💊 Versatile: Delivers your API through implants, pellets, patches, and more. ⏳ Long-acting: Lasting up to 48 months! We are focused on significant healthcare and industry challenges. Our mission is to revolutionize drug delivery and transform patient care. 💭 Send the direct message “Long-acting” to Hera’s LinkedIn inbox to explore your API’s potential. Or visit: https://www.herahealthsolutions.com/contact

HistoSonics is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquify and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels. The company's new platform delivers personalized, tissue specific treatments with precision and control, and without the undesirable side effects of many of today's interventional and surgical modalities. HistoSonics is led by a team of experienced domain experts and industry leaders with offices in Ann Arbor, Michigan and Minneapolis, MN.

To design a tool for surgical explant of endografts. Consider; 80% of AAA patients receive EVAR, the minimally invasive option for repair. Getting a quality result quickly and efficiently is most assuredly part of the goal for both the patient and physician. At some point, 5+% of EVAR grafts are explanted due to failure or infection. Our goal: develop a simple device for open surgical explant of an endovascular stent graft. At Hjärta Care we believe minimally invasive surgery should not just be the goal at implant. We believe the explant should be as atraumatic and painless as possible for both the patient and vascular surgeon. We discovered, through interviews and search of the clinical literature, that the syringe technique, orthopedic wire cutters, etc. were woefully inadequate in achieving a SAFE explant. In 2022 Hjärta Care received a patent for the XgraftR, a tool specifically designed for the removal of endovascular stent grafts during open surgical explant. This unique patented design allows for a simple and elegant explant, minimizing supra visceral cross clamp time and damage to the aortic intima.

Hospi is a healthcare technology company that innovates practical medical devices to enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.

Hyalex Orthopaedics is a venture backed Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX® materials technology. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics' products are in the development stage and have not been approved for use in humans by any regulatory agency.

Hydromer® is a leading global surface modification and coatings solutions provider. As a trusted partner to companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. Hydromer collaborates extensively with clients to deliver superior, customized polymer-based solutions. We create or modify coating formulations that adhere to a multitude of substrates and match the unique requirements and geometries of any device. We are a leader in developing coating formulas and processes that meet a market-driven need for greener, more sustainable solutions. We offer custom industrial and medical device coatings, contract coating services, customized coating equipment, contract manufacturing, and turnkey operations backed by outstanding teams of research and development, customer service, and tech support. Hydromer® has been a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 40 years. As a trusted partner to large and small companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. We are a GMP/ISO 13485 and ISO 9001 production facility located in Concord, North Carolina.

ICON works to accelerate the development of live-saving drugs and devices by providing a wide range of consulting, development, and commercialization services.

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing IV therapy systems, software, solutions, and consumables. Since IV therapy is our only business, meeting your IV needs with quality products and consistent supply is our only concern. We are 100% focused on bringing you intuitive, patient-centric IV products and services that provide meaningful clinical differentiation, consistent innovation, and superior value. We design our products to work within your existing workflows to minimize disruption and maximize the time you spend with patients. Together, we help forge the human and emotional connections that enhance clinical experience and are the essence of outstanding quality of care. For more than three decades, we have been dedicated to a singular purpose—improving the safety and efficiency of IV therapy. With the acquisition of Hospira Infusion Systems from Pfizer in 2017, we became the only company to focus exclusively on IV therapy across the continuum of care. Our focus allows us to bring you: > Dedicated and non-dedicated IV sets and needlefree connectors clinically proven to provide an effective barrier against bacterial transfer and colonization. > The industry's broadest IV smart pump offering covering large volume, pain management, and ambulatory needs. > IV medication safety software providing full IV-EHR interoperability with the highest customer satisfaction and compatibility with more EHR systems than any other company. > Significant US IV solutions manufacturing and supply capabilities.

iFIT Prosthetics LLC is a U.S. Veteran-owned business founded in 2010 by Dr. Timothy Dillingham, a board-certified rehabilitation physician and U.S. Army Veteran specialized in the care of persons with amputations. Our mission is to produce technologically advanced, adjustable, immediate fit, patient-centered, accessible prosthetic devices that enhance the lives of persons with lower limb amputations.

Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced synthetic therapies for the treatment of surgical wounds, burns, chronic ulcers, and soft-tissue repair. Imbed has a portfolio of products commercially available, and in development, based on its patented Microlyte® technology. Imbed Biosciences is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System. For more information, please visit www.imbedbio.com, facebook.com/imbedbio, and follow @ImbedBio on twitter.

ImmunSYS is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-stage metastatic prostate cancer and other metastatic solid tumor cancers. ImmunSYS is at the forefront of an entirely new approach to treating cancer. Our platform therapy has been shown to be effective in some metastatic cancers and may have wide applications as a cancer treatment for several solid tumor cancers, with the potential for cure in some patients. The company’s revolutionary therapy, YourVaccx™ utilizes a novel combination of controlled cell lysis and a triple-component immunotherapeutic drug. This new immunotherapy focused therapy is designed to empower the immune system to recognize and selectively attack cancer cells throughout the body. The company is initially developing the new cancer therapy for the treatment of metastatic prostate cancer, with a pipeline of additional development programs for other solid tumor cancers. Our proprietary therapy was conceived by the focal prostate cancer therapy pioneer and inventor of the male lumpectomy, Gary Onik, M.D. He is not only the inventor, but also a patient. Dr. Onik developed aggressive metastatic prostate cancer in 2018 and received his own therapy. He had a complete response and remains disease-free to date. ImmunSYS is committed to bringing life-changing treatments to cancer patients by bringing the tumor to the immune system to fight cancer in a new way. We believe our new YourVaccx™ therapy has the potential to offer cancer patients substantial benefits over the existing standard of care, including the potential for cure in some patients.

Enhance Productivity and Quality with Reporting Automation and Ultrasound Reading Tools Imorgon provides innovative solutions for Radiology reporting automation and ultrasound reading. Our tools dramatically improve the efficiency and quality of creating structured reports. Ultrasound Reporting Software: Measurement Transfer: Our tools extract measurements from various imaging modalities, including ultrasound, CT, and DEXA, from DICOM SR and other structured files. These measurements are parsed and seamlessly inserted into a reporting package, enabling the creation of structured reports more efficiently and with higher precision. Electronic Worksheets: Imorgon offers customizable electronic worksheets that allow technologists to capture exam findings consistently and quickly. These findings can be automatically integrated into the report, eliminating the need for a Radiologist to dictate them. This approach is superior to traditional solutions that store worksheet images in PACS and require Radiologist re-entry. Together, DICOM SR and electronic worksheets form a comprehensive ultrasound reporting solution. Ultrasound Reading and PACS: Many PACS viewing stations provide an inflexible and suboptimal exam review experience. Imorgon addresses these limitations by offering advanced features. Our platform enables the display of ultrasound images and clips in interleaved, acquisition order with automatic clip playing. Additionally, our Sonographer QC Workstation empowers sonographers to correct patient and study information, split or merge studies, delete images, add or edit annotations, and make measurements. These capabilities enhance efficiency and accuracy in ultrasound reading. Integration: Imorgon seamlessly integrates with enterprise PACS, HIS/RIS, and reporting systems, ensuring a smooth workflow and compatibility with existing infrastructure.

Impact Analytical is a compliance services company that specializes in analytical testing for medical devices, including material composition analysis and contaminant investigation.

Impact Biomedical, Inc. is an emerging human healthcare company and is a wholly owned subsidiary of DSS, Inc.

Implant Surfaces offers surface solutions for spinal, orthopedic, cardiovascular, and neurovascular device and instrument applications. Our advanced nano-engineered coatings and surface treatments enable a wide range of product enhancements including biocompatibility, optimum tissue integration, biofilm resistance, wear and corrosion resistance, reduced friction, hydrophilicity, hydrophobicity, anti-glare surface, aesthetic and color-coding, and desired electrical properties. Our surface modification capabilities include physical vapor deposition (PVD), Atomic Layer Deposition (ALD), Chemical Vapor Deposition (CVD), as well as our proprietary Atomic Plasma Deposition (APD™), Nano Plasma Deposition (NPD™), and Molecular Plasma Deposition (MPD™) processes.

InfoBionic.Ai's MoMe® ARC system empowers physicians with control to transform the efficiency with which they manage cardiac arrhythmia detection and monitoring processes for their patients. Leveraging a comprehensive, Cloud-based remote patient monitoring platform – the first and only of its kind – we deliver on-demand, actionable monitoring data and analytics directly to the physicians themselves. The MoMe® Kardia 3-in-1 device streams continuous ECG, respiration, and motion data to the Cloud for analysis, and delivers automated reporting to an iPad and or a web-based portal where physicians can access and interact with the data they need, in the detail they want – anytime, anywhere.

There are still broad swaths of uncharted territories concerning the role lipid core plaques play in heart disease. Now, you can achieve unparalleled insights with the Infraredx Dualpro IVUS+NIRS catheter and its accompanying Makoto Intravascular Imaging System, FDA-cleared to identify patients and plaques at an increased risk of MACE. For more information about the Makoto Imaging System or Dualpro IVUS+NIRS Catheter visit www.infraredx.com. Infraredx, a Nipro Company is now proud to offer the OKAY II Y-Connector to the US market. The number one selling Y-Connector in Japan is now available. Visit www.infraredx.com/technology/nipro-okay-ii/ to learn how you can reduce blood loss with the OKAY II Y-Connector.

InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. InfraScan Inc.'s patented NIR technology for diagnosing brain hematomas enables neurosurgeons to effectively, conveniently, and accurately detect intracranial bleeding in patients with Head Trauma.

Inmedixfocuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. Inmedixcall’sit Immuno-autonomics. Theyseek to understand and block this process to allow current autoimmune disease therapies to work much better.

Surgical software

InNeuroCo's mission is to create and deliver high-quality complex catheter solutions. Dedicating time and resources to design and develop safe revolutionary technology, which industry leaders and doctors not only approve of . . . but also depend on. ​InNeuroCo brings together brilliant minds in science and engineering with access to the most advanced neurovascular technologies to build life-saving medical devices that go the distance. When it comes to your life, we don't outsource our materials outside of the U.S. We insource high caliber U.S.-made materials to ensure high quality and safety because your life depends on it.

As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries and regions. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. Santen Pharmaceutical Official Social Media Global Terms of Use​ https://www.santen.com/en/legal/

InnovATEBio is a newly funded National Science Foundation (NSF) center for biotechnology education (NSF DUE 1901984). InnovATEBIO goal is to support initiatives for educating highly skilled technicians for the nation's biotechnology workforce.

Innovative BioTherapies (IBT) is a small biotechnology company located in Ann Arbor, MI, focused on developing medical devices to solve unmet medical needs.

InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its novel TMVR Saturn Prosthesis, designed to be consistent with the anatomy of the mitral valve. Saturn is a low-profile prosthetic designed for both Trans-apical and Trans-septal delivery. Our company mission is to bring patients a novel therapeutic system suitable to replace incompetent Mitral Valves based on a safe, effective, and easy-to-use transcatheter technology. InnovHeart is committed to pursuing this goal with the highest level of quality.

The OcuCheck is a point-of-care device that uses a specialized electrical chemical sensor with proprietary coatings to measure specific biomarkers in the tear film Currently, the OcuCheck is the only device that can simultaneously measure MMP-9 and tear film osmolarity in one device. It is also one of the most accurate devices for quantitative measurement of MMP-9.

inQB8 is a med-tech incubator founded in 2018 to develop novel, device-based solutions for the biggest cardiovascular challenges and create successful start-ups that can bring those solutions to the patients that need them most.

InSoma Bio is a company that borrows nature's own designs to develop unique products for reconstructive plastic surgery. Their product enables surgeons to use a person's own tissues to enhance the stability of autologous fat grafts and solve problems in tissue engineering and regenerative medicine.

Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. Founded in 2000 (NASDAQ: PODD), Insulet operates with a customer-centric focus to supply high-quality products and expand the use of insulin pump therapy. Omnipod products are now available in 20+ countries around the globe. HIRING SCAM ALERT Recently, individuals impersonating Insulet Human Resources members have offered fraudulent interviews and job offers to unsuspecting candidates. To help protect you from these scam artists, please be aware that: • Insulet will never interview a candidate over RingCentral, similar messaging apps or social media (i.e. Google Hangouts, WhatsApp, Facebook Messenger, etc.), or via text message. • Insulet will never send a company check or ask an applicant to pay a fee or purchase at home work/training materials in connection with an application for employment. • Insulet will never provide excess money to an applicant and ask the applicant to write a check for repayment. If you have any doubt about a job offer or any other communication purporting to come from Insulet, please reach out to us directly at 978-600-7000. If you receive any type of communication on behalf of Insulet that seems inappropriate or suspicious, please report this activity to: www.iC3.gov or www.stopfraud.gov.

To make bold and positive change in the biomedical and technology markets. An innovation hub, we relentlessly pursue ideas and inventions that result in superior products, processes, and design. This relentless pursuit drives us every day to bring ideas to market that improve lives and give back to the communities in which we operate.

IMI is the industry leader in tamper evident technologies for IV syringes, oral dispensers and other delivery systems. We have been providing innovative products for admixture, compounding and nuclear pharmacies for over 40 years. IMI manufacturers a complete line of sterile adapters, caps and plugs in addition to a variety of aspiration and venting needles. Each are manufactured to exacting standards right here in the USA. IMI has obtained Certifications to meet the requirements for ISO 13485:2003: CMDCAS & Medical Devices Directive 93/42/EEC

InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs. InterVene's BlueLeaf(TM) Endovenous Valve Formation System represents the first ever non-implantable, endovenous approach to deep vein valve failure. This technology allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no minimally invasive therapy exists to treat deep vein valve failure, one of the most prevalent underlying causes of these symptoms. InterVene plans to change that. InterVene was originally a product of the Stanford Biodesign Fellowship and is a former Company In Residence at the Fogarty Institute for Innovation. InterVene's offices are now located in South San Francisco near SFO airport.

IntraOp Medical is a medical devices company that specializes in electron therapy devices for treating cancer, providing compact and mobile linear accelerators for effective and precise radiation therapy at the point of care.

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

Invenio Imaging is a medical device start-up based in Santa Clara, CA dedicated to advancing the care of cancer patients by combining intraoperative histologic imaging with artificial intelligence. Our technology, the NIO® Laser Imaging System has been used in over 2500 cancer treatment procedures at major cancer centers both in the US and in Europe. In 2021 Invenio received a Medical Design Excellence Award, was selected to be a Rosenman Innovator and received CE Mark to commercialize in Europe.

At INVO bioscience, we are democratizing fertility. Our mission is to help people realize the dream of parenthood by increasing worldwide access to an efficient, effective, and connected experience in reproductive treatment. We are the manufacturers of INVOcell. The first and only FDA cleared, CE marked medical device used in intravaginal culture (IVC). INVOcell holds the gametes within the woman’s body during fertilization and early embryo development. A safe, intimate way for women to be connected right from the very beginning. With INVOcell, Life Begins Within™. We are looking for partners to help us bring treatment where it’s needed. We offer full-service partnerships including resources, training, clinical and lab support. Contact us to learn how you can join the movement to make advanced fertility care within reach.

At Pacira Biosciences, Inc., we are driving innovation to provide ways to manage pain safely and effectively. iovera° is a patented, 510(k)-cleared medical device, which uses targeted cryoanalgesia for immediate and long-lasting pain relief. iovera° treats peripheral nerves to temporarily stop pain signals for up to 90 days and provides pain relief until the nerve regenerates and nerve signaling is restored through an innovative handheld design. The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. iovera° should not be used for people with: cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud's disease, open and/or infected wounds at or near treatment site. Patients treated with iovera° (a needle-based therapy) may have certain reactions, including but not limited to bruising, swelling, inflammation and/or redness, local pain and/or tenderness, altered feeling at application site. Proper iovera° use (see User Guide) can help reduce or prevent these reactions: in treatment area(s) – skin damage from being exposed to cold/heat, skin darkening/lightening, skin dimples; outside treatment area(s) – muscles may not work/move normally. Adverse event reporting: email drugsafety@pacira.com or call 1-855-793-9727. Product quality complaints: email drugsafety@pacira.com or call 1-800-442-0989. Please don't report such information through this or other social media pages owned by Pacira Biosciences, Inc. If you do report through this page, Pacira reserves the right to contact you for information.

IRIDEX is a worldwide leader in developing and manufacturing innovative and versatile light-based medical systems and delivery devices to treat glaucoma and retinal diseases. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. We are dedicated to a standard of excellence, offering superior technology for superior results. Our products are sold in the United States and Germany through a direct sales force and in over 100 countries through a network of approximately 70 independent distributors. Some of our products include the Cyclo G6 glaucoma laser, IQ 577 retinal laser, IQ 532 retinal laser, and TxCell scanning laser delivery device. Learn more at iridex.com

The iSono Health has developed the world’s first AI-driven platform with an automated, portable, and wearable ultrasound to empower women and their physicians with early breast cancer detection and monitoring. Our patented compact ultrasound scanner captures 3D images by automatically scanning the whole breast volume in 2 minutes. The device connects to a smartphone/tablet/laptop. The data is transferred to a secure cloud for image processing and storage. Our machine-learning algorithm uses acoustic biomarkers to identify abnormal masses. Our platform’s automated operation and software expand ultrasound use in point-of-care diagnostics and monitoring of breast health at radiology centers, walk-in, and mobile clinics. iSono Health offers women and healthcare providers : Safety: No Radiation Actionable Feedback with AI Fast: 2min Scan Easy to Use

iuvo BioScience is a contract research organization serving the pharmaceutical and medical device industries. Our services encompass pre-clinical research, clinical research and consulting services. With a focus on safety and biocompatibility, iuvo provides assistance through the full product development life cycle, from research to release, including ISO 10993:2018 testing as well as testing programs and advisory services to support regulatory submissions. We have an AAALAC-accredited vivarium and offer full service, GLP-compliant toxicology testing, as well as microbiology and analytical chemistry testing laboratories. We are certified to ISO 13485:2016 and accredited to ISO 17025:2017 quality system standards. We bring decades of experience supporting healthcare and medtech companies of all sizes from around the world, and we work closely with our customers to deliver exquisite science, reliably and on time. Come to us with a specific test, a full program you need managed, or even a research question you need help answering. We are your Partner Research Organization.

Ivenix is a medical technology company that specializes in the development of large-volume infusion pumps dedicated to eliminating infusion-related patient harm.

IZI Medical is a prominent medical device manufacturer and distributor, specializing in minimally invasive diagnostic and therapeutic solutions. Founded in 1991 by a neuroradiologist and a radiation oncologist, the company is headquartered in Baltimore, Maryland. In 2022, IZI became part of Halma plc, operating as a standalone entity within Halma’s Healthcare sector. The company is dedicated to enhancing patient care through physician-inspired innovations and aims to improve the quality of life for patients. IZI Medical offers a diverse portfolio of 44 medical devices across four key markets: image-guided surgery, interventional oncology, interventional neuro and spine, and radiation therapy. Their products include tools for instrument navigation, tumor localization, and treatment planning systems. With over 100 active patents, IZI Medical emphasizes innovation in minimally invasive procedures. The company serves more than 2,500 hospitals in the U.S. and distributes its products to physicians in 35 countries, focusing on improving clinical efficiency and patient outcomes.

Jan Medical is a medical device start-up company dedicated to providing physicians critical data for accelerating and expanding therapy while improving the diagnostic experience for patients with brain disorders. Its proprietary platform technology, BrainPulse, uses accelerometers on a non-invasive headset to detect skull motion resulting from pulsatile blood flow into the brain. The BrainPulse system is an FDA cleared device for cranial motion measurement currently under research for a variety of neurological conditions. Jan Medical has developed clinical experience and collected valuable clinical data with the BrainPulse device in a variety of indications such as concussion, stroke, aneurysm, AVM, and vasospasm detection. Visit us at www.janmedical.com to better understand our company, our technology and our people.

Jeiven Pharmaceutical Consulting, Inc. (JPC) brings over twenty years of experience to our goal of providing pharmaceutical, biotechnology, medical device and dietary supplement companies with an unparalleled level of service and dedication to ensure the success of their projects. Our clients, which range from the small start-up to the large pharmaceutcial firms, come back to us because they know we will provide them with the highest level of service in combination with the expertise of our skilled consultants. The hallmark of our success has been our outstanding customer satisfaction and client retention. We take pride in providing, above all else, Reliable Guidance to clients of all sizes. Our areas of expertise include: 1) Clinical Trial Materials Project Management 2) Quality Assurance and Compliance 3) Auditing (contractors, suppliers, due diligence audits, mock-PAI audits, general GMP, GLP, GCP audits) 4) Training (GMP, GLP, GCP, DEA) 5) Regulatory Submissions (IND, IDE, CMC, 510(k), PMA, NDA, ANDA, eCTD) 6) Authoring SOPs and Quality Manuals 7)Formulation Development 8) Scale-up, Optimization and Method Transfer 9) Equipment Qualification 10) Analytical Method Development 11) Combination Drug / Device Products 12) Due Diligence Services for Venture Capital Firms 13) Process / Facilities Validation 14) Staffing 15) Comparator Drug Sourcing 16) Organizing the Clinical Supplies Support Group (CSSG) 17) Medical Device and In-vitro Diagnostics

JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System is the first and only device currently approved in the EU for the treatment of severe, symptomatic aortic regurgitation in patients that are deemed high-risk for surgical aortic valve replacement. The Trilogy System is also CE-Mark approved for treatment of severe, symptomatic aortic stenosis. In the US, JenaValve has completed enrollment of the ALIGN-AR IDE Clinical Trial which will support a future PMA submission. If approved, the Trilogy System would become the first and only TAVR system in the US indicated for the treatment of symptomatic, severe AR. JenaValve is headquartered in Irvine, California with offices in Leeds, U.K. and Munich, Germany.

Jointechlabs is a regenerative medicine company that offers point-of-care medical devices enabling safe and cost-effective non-surgical treatments.

Jordi Labs was founded in 1980 to provide the highest quality analytical services, polymer based HPLC columns and packing media in the industry. As a family company, we take pride in the production of each of our products. Customers in nearly all industries are currently using our columns, packing media, and SPE products worldwide. It is our goal to help our customers overcome their analytical challenges by providing excellent products and personal assistance from our highly trained staff. Jordi Labs provides contract analytical services with a special emphasis on chemical identification and liquid chromatography products. Products We manufacture a complete line of polymer-based high-pressure liquid chromatographic (HPLC) columns and gels for all types of applications including size exclusion (SEC) and solid phase extraction (SPE) cartridges. Analytical Service The service laboratory at Jordi provides extensive and specialized analytical testing of polymers, additives and other small molecules. Typical projects include product failure analysis, HPLC method development, polymer filler and additive quantitation, and unknown identification. Other services include method development, prep HPLC, training, depositions and consulting. Our two-fold business of providing services, as well as products, is especially qualified to meet the demands of the polymer industry.

We are a trusted manufacturing and packaging outsourcing partner to medical device and diagnostic companies seeking to deliver superior quality, improve time-to-market and simplify the supply chain for single-use medical devices. With more than 30 years of experience in complex thermoplastic devices and packaging, J-Pac Medical has the unique technology that allows it to manufacture anatomically correct, class III implantable textile assemblies, lab-on-chip reagent blisters, and complex thermoformed packaging. Additionally, the company offers full-service supply chain management, packaging and sterilization.

JuneBrain is an early start-up company based in the Washington, DC area. Our mission is to develop a telehealth eye-scanning system that allows clinicians to monitor patients with eye and brain disease outside of the traditional clinical setting, leading to earlier detection of new disease and improved monitoring of treatment efficacy. Though our mission begins in the eye care community, our long-term goal is to extend the use of our device into the broader neurological disease population, thus creating a pathway towards more frequent, widely accessible monitoring of eye and brain health.

At kallisio, we're on a mission to revolutionize head & neck cancer care by safeguarding patients against the harmful effects of radiation therapy. Our 3D printed patient-specific immobilization devices provide unparalleled protection to Organs at Risk (OARs) while allowing radoncs to deliver the highest effective dose of radiation treatment. In collaboration with MDACC, we've pioneered a groundbreaking, scalable, billable, and custom-fit solution for precise patient immobilization and tongue deviation. Our innovation aims to mitigate long-term side effects, including mucositis, xerostomia, and dysphagia. Interested in joining our mission to protect patients from radiation-induced harm?

A professional company specialized in producing innovative Safety Medical Products to protect health care workers against sharps injury. KB Medical Group is committed to address these issues by providing the most effective safety-engineered therapy devices for optimum safety in the hospitals. In the past several years, KB Medical Group has focused on working on a wide variety of innovative, high-quality enteral feeding products and accessories uniquely designed for delivering nutrition and medication to pediatric and adult patients. This new standard ENFit™ connection has been introduced in-line with ISO80369-3 and has a unique enteral-specific design that helps reduce the risk of enteral tube feeding misconnections and improve the patient's safety. Along with nutrition therapy, we also carry other medical categories which include: • Infusion therapy • Syringe and needle • Hazardous drug safety • Specimen collection • Anesthesia and pain management • Transfusion therapy • Urinary care • Renal therapy • Diabetes care

K.C. Pharmaceuticals, Inc. is committed in meeting the requirements of the Current Good Manufacturing Practices (CGMP) laid out in the Code of Federal Regulations (CFR) issued by the US Food and Drug Administration (FDA). We are devoted in producing finished pharmaceuticals and medical devices that uphold high quality standards in today's consumer market. As part of our ongoing efforts in maintaining compliance, we have been keen in implementing many systems and procedures designed to improve product quality and ensure customer satisfaction. Since our manufacturing paradigm is "Building Quality Into Products," we have various internal quality control and quality assurance checkpoints through audits, inspections, reviews, and tests to guarantee that all quality requirements have been met.

Keck Graduate Institute is a graduate education institution focused on biotechnology, life sciences, healthcare, and research.

At Kestra, we stand for patients at-risk and the people who care for them. Together we work to protect, support, and empower them with wearable technologies, tools, and better answers as they navigate life's most challenging medical events. Cardiovascular disease is the number one cause of death globally. We're taking a fresh approach to cardiac monitoring and delivery of definitive therapy with wearable products and applications. We aim to make the entire recovery process easier for patients by bringing comfort and assurance to them—along with advanced clinical insights and tools to their medical care teams. Kestra is a privately held, Bain Capital portfolio company, headquartered in Kirkland, Washington USA. Visit us at www.kestramedical.com

Founded in 1998, Key Tech (www.keytechinc.com) is a high-tech product design and prototyping company located in Baltimore, Maryland. Our clients value our ability to create first-of-a-kind applications and solve challenging technical problems. A diverse mixture of electrical, mechanical, and computer engineers, as well as industrial designers and physicists, we specialize in transforming complex technologies into simple, intuitive solutions. Services Include: Product de-risking, Prototype and Full Scope Development, Industrial Design, Technology Development, Expertise on Demand, and solving the seemingly unsolvable.

KitoTech Medical is a Seattle-based medical device company that has developed microMend PRO, a unique wound closure device. microMend PRO is a new wound closure device that is as effective as sutures and as fast and easy to apply as a bandage. It delivers superior clinical results and improved patient experience while reducing procedure costs. microMend PRO can close wounds up to 50 cm in length and is effective in closing all types of lacerations including those with jagged edges. Our products are used by medical personnel in emergency medicine, dermatology, surgeons, and more. Request a quote for your clinic today!

Know Labs is transforming non-invasive medical diagnostics. The proprietary technology platform uses radiofrequency (RF) dielectric spectroscopy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application is a non-invasive continuous blood glucose monitoring device that will provide the user with real-time information on their blood glucose levels, assisting billions of people with diabetes and prediabetes to manage this medical condition. Know Labs is a public company whose shares trade under the stock symbol KNW (NYSE American).

Koios DS™ is a Smart Ultrasound™ solution for radiologists diagnosing cancer. Using AI algorithms trained on tens of thousands of images combined with data from pathology results, Koios DS™ is clinical decision support for a new era of diagnostic excellence. Smart Ultrasound™ redefines what radiology professionals can discern in the radiology suite. Our proprietary technology and patented methods provide an invaluable “second opinion” that is already being adopted by leading healthcare institutions to improve diagnostic accuracy, speed clinical decision making, and elevate the quality of care. Our software is FDA cleared for use in the USA. Koios DS. We put the AI in ultrasound.

Koning Corporation develops and manufactures advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. This revolutionary technology provides true 3D images for early breast cancer detection, providing a significantly more accurate and effective test than mammography and tomosynthesis. Koning's vision is to fundamentally change breast cancer is detected and diagnosed, with earlier detection, increased patient comfort and lower costs. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. We believe that the power, versatility and lower cost of Koning Breast CT will serve as a viable substitute for many traditional imaging applications. Our hope is to be able to improve survival rates and outcomes for millions of patients. Koning Corporation's core technologies are protected by over 80 patents globally, and has received regulatory approval in the US (FDA), Europe (CE-Mark), China (CFDA), Australia (TPG), and Canada (Health Canada). Koning has been the beneficiary of over $17 M in venture funding and over $20 M in government grants to bring this exciting technology to market. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body.

Proprietary applications in diagnostics and therapeutics. International technology development. Translational medicine impacting Immunology, Oncology and Genomics.

Kurin® is a privately held, certified minority owned business dedicated to engineering better healthcare through innovative, cost-effective, clinician-approved technologies. Building on the successful invention, clinical adoption, and corporate acquisition of Curos™ disinfecting port protectors, Kurin is focusing its depth of experience in medical device engineering, marketing, sales and service, to tackle the persistent and costly fallout of false positive blood cultures. With agile development capabilities and intense customer focus, we have seen the Kurin Lock® with Flash Technology quickly gain caregiver acceptance, sideline skin contaminants during blood culture collection, and become the blood culture collection standard of care in hospitals. Curos™ is a registered trademark of 3M Corporation.

Latham BioPharm Group (LBG), part of Sia Partners, is a leading life sciences consulting company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies to solve complex business, regulatory, and product development challenges. Our experienced consultants come from large pharmaceutical companies, small biotechs, academia, and global CROs/CDMOs, and many have even held senior positions with government agencies. Since our founding in 1996, we have grown steadily and have built a robust capability set that has enabled us to help life sciences companies of various sizes drive long-term value into their organizations. In 2022, we became part of Sia Partners when they launched a division dedicated to life sciences consulting—a mutually beneficial merger that will open new doors as we look towards the future. Our core services include: • Product Development • Non-dilutive Funding • Strategic Consulting We are guided by value, both in our business model and in our industry-leading consulting. Our approach is scalable, flexible, and client-centric. We regard you as a partner and become a trusted part of your team. We adapt to your processes and align with your strategic direction and company objectives to generate meaningful analysis and quantifiable results. Both global organizations and emerging start-ups rely on us to guide their products and portfolios down a clear path to success. Sia Partners Sia Partners is a next-generation management consulting firm and pioneer of Consulting 4.0. We offer a unique blend of AI and design capabilities, augmenting traditional consulting to deliver superior value to our clients. With expertise in more than 30 sectors and services, we optimize client projects worldwide. Through our Consulting for Good approach, we strive for next-level impact by developing innovative CSR solutions for our clients, making sustainability a lever for profitable transformation.

Leaf Healthcare creates wireless patient monitoring solutions for health care providers who are seeking more efficient and cost effective ways to improve patient safety and clinical outcomes. Our first innovation, The Leaf Patient Monitoring System, wirelessly monitors a patient's position and movement to automate and document the management of prescribed turn protocols for patients at risk for Hospital Acquired Pressure Ulcers (HAPUs). The system is comprised of a lightweight, wireless, wearable Patient Sensor, a plug and play secure wireless network of antennas, and proprietary software that manages data, displays patient status, and provides necessary care alerts at a nurse's station or on mobile devices. At Leaf Healthcare, we focus on developing solutions that decrease healthcare costs and improve patient outcomes. We are working to broaden existing product features and capabilities, and develop innovative new technologies that enable more efficient and effective patient care.

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.

LENSAR® is the leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision and accuracy, while optimizing overall visual outcomes. The proprietary Augmented Reality™, LENSAR’s reconstructed 3-D imaging, measurement, and guidance system, provides high-resolution ocular images in a single scan. This technology facilitates precise surgical incisions and treatment for ultimate accuracy and reliable outcomes, all in a single procedure room. The LENSAR Laser System is the only femtosecond cataract laser built specifically for refractive cataract surgery. Because it was designed from the ground up, every aspect of the laser has been purposefully designed to meet the needs of cataract surgeons. LENSAR, Inc. is committed to revolutionizing refractive eye surgery. Our success depends on talented and motivated individuals who share our passion for making a difference in patients’ lives. We are a young and vibrant company located in Orlando, FL. We pride ourselves on having a highly collaborative, innovative environment where initiatives and teamwork are valued and individual efforts are recognized. If you’re looking for a career that enables you to pursue both professional and personal goals, we invite you to consider a career at LENSAR, Inc. Click on our website link below for current employment opportunities. Interested in learning more? Contact us at marketing@lensar.com

Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.

Building cutting-edge biosensor technology. Leveraging the latest advances in biochemistry and nanotechnology to gain access to data we have never been able to access before.

LexaMed is a company dedicated to providing the pharmaceutical, medical device and biotechnology industries with quality, compliant, state-of-the-art services in the areas of consulting, auditing, and laboratory testing. LexaMed's team of industry professionals has over two centuries of pharmaceutical and medical device experience. The skill-sets of our consultants are complementary and allow us to address situations of any subject or scope with technically compliant, practical comprehensive solutions. Our consultants are experienced in Quality Systems, Validation – product, process and equipment, Aseptic operations, Sterilization – radiation, ethylene oxide, VHP, steam, liquid, Regulatory Compliance, Microbiology, Engineering and Analytical Methods. LexaMed laboratories are ISO certified and provide quality services in microbiology and chemistry. Lab services include many offerings such as D and z-value determinations, BIER unit exposures, package integrity and container closure challenges, stability and accelerated aging under ICH specified conditions. Dedicated laboratory space and personnel are available for the execution of custom R&D protocols. LexaMed is ISO 13485 Certified, holds a State of Ohio drug license and DEA registration, retains a FDA registration for both medical devices and pharmaceuticals, and maintains active memberships in AAMI, ACS, ASM, ISPE, PDA, and RAPS.

People who struggle with hearing loss are at the heart of what we do at Lexie Hearing. With them in mind, we offer a hearing care solution that is affordable and convenient because we do not believe that people should have to spend thousands of dollars on their hearing health. And that's why we're changing the industry. We leverage smart, cutting-edge software technology to bring customers affordable, convenient access to hearing care, as well as a great customer-focused experience with high-quality hearing aids. We believe in healthy hearing for everyone, everywhere.

Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders. Liberate's lead product, the VentFree™ respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support. VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation. Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life, and considerable savings for the health care provider.

Liberty Oxygen and Medical Equipment enables you to stay safe and independent in your home by offering a comprehensive array of home medical equipment & oxygen [including CPAP supplies, compression stockings, bath aids, canes, wheelchairs, walkers & more] in addition to prompt, personalized care. With 7 locations in the Twin Cities metro, there's always a store convenient for you. Burnsville 14001A Grand Ave S 952-898-5008 Coon Rapids 11650 Round Lake Blvd 763-231-2177 Maple Grove 16322 County Road 30 763-494-4966 Maplewood 1715-D Beam Avenue 651-789-7500 Saint Louis Park 4820 Park Glen Road 952-920-0460 Shakopee 1667 16th Ave E, Suite 102 952-445-5454 Woodbury 1815 Radio Drive 651-789-0050

Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. We're also a manufacturer of premium sodium hyaluronate. From formulation to commercialization, we have everything it takes to move your project to the next level, making progress possible for our partners, people and most importantly, patients. Working from state-of-the-art facilities, our people are subject matter experts, our capabilities customized, our processes and systems qualified and our infrastructure optimized to meet your most sophisticated requirements regardless of scale. Our expertise is in drug products that are challenging and difficult to formulate, sterile filter, and aseptically fill. We've been the global leader in pharmaceutical-grade sodium hyaluronate (NaHy) for nearly 40 years. Leveraging this experience alongside deep expertise and capabilities in highly viscous solutions, we create tailored solutions that solve your drug development challenges across the entire development and manufacturing lifecycle. Our capabilities: Sterile Injectable Development - Formulation Development - Sterilization Development - Process Development - Analytical Services & Stability - Engineering Services - Validation Services Sterile Injectable Manufacturing - Sterilization - Aseptic Filling - Packaging - Analytical Services & Stability

Life-saving therapies. Critical diagnostics. Breakthrough clinical trials. Life Couriers places hope in the hands of patients everywhere by being the world's most trusted logistics partner for crucial pharmaceutical and medical products. We are the worldwide market leader for radiopharmaceutical and stem cell logistics. We have taken this experience with the most time-critical shipments in the world to expand our services to biopharmaceuticals, cell and gene therapies, lab specimens, clinical trials, organ transplant, medical devices, and more. We understand a fundamental reality - that missing a delivery can mean losing a life. That is why we have intentionally curated our culture to be solely focused on patient outcomes. Our people care more and they are deeply committed to enhancing, enriching, and saving lives through the power of logistics. We are Life Couriers. Logistics for Life.

LifeLens was founded in 2014 by Dr. Robert Schwartz, Landy Toth, David Robins, and Dr. Robert Van Tassel. Its mission is to create simple, commercially viable technologies for high fidelity physiologic monitoring.

Mission Statement: "We focus on ground breaking, innovative medical devices for the emergency medical care market. Our mission is to save and preserve the quality of lives". Management Team: Our management team brings extensive years of experience in the medical device, cardiology, neurology, and emergency medicine specialties. We have experience in medical device product development, launch and management as well as in running entrepreneurial businesses.

The Lifewave solution will establish a new standard-of-care for the guided-care of heart failure patients. Our solution consists of a digital AI-powered platform, and differentiated by a medical radar lung sensor that is non-invasive, simple-to-use, low cost, and provides a direct and absolute measurement of lung fluid for guiding care.

Lilu, Inc. is a women's health company based in New York, founded in May 2016. The company specializes in tech-enabled products that support new mothers during postpartum care. Lilu focuses on making breastfeeding, pumping, and early motherhood more efficient and comfortable. Their team of four has developed patented pneumatic massage technology to help address lactation challenges. The flagship product, the Lilu Massage Bra, is the first automated breast massage pumping bra. It uses compression massage technology to enhance milk output during pumping sessions. Additionally, Lilu offers the MilkSense App, currently in beta, which helps mothers track breast milk production and optimize their feeding routines. Lilu emphasizes user-centered design and aims to empower mothers through innovative solutions that improve postnatal care.

TandemLife is a medical device company that develops a circulatory system to provide support for patients during cardiopulmonary bypass procedures.

For 45+ years, LKC Technologies has been making functional eye testing simple and practical for busy clinicians. The handheld, portable RETeval® ERG/VEP device aids in the diagnosis and management of ischemic conditions such as diabetic retinopathy, optic nerve conditions, and other retinal dystrophies by providing objective results without corneal contact.

LogicInk is developing a wellbeing sensor platform. A series of bio-chemical signals that can be worn daily, to support your wellbeing with increased knowledge about your health and daily peace of mind – from UV exposure and particles in the air we breathe, to the diverse microbiome that permeates our skin through the surfaces we touch.

LSI SOLUTIONS®, located in beautiful Victor, New York, is a dynamic and growing medical device company that has more than doubled in size over the last seven years. - LSI SOLUTIONS® is dedicated to advancing minimally invasive therapeutics through research, development, manufacturing, and marketing proprietary products. - Company Mission: Our customer is ultimately a patient. Our technology challenges human illness. Our mission is to lead the world in surgical innovation and product delivery.

With proven research capabilities across disciplines and applications, we develop technologies for mission-driven organizations, bringing high-impact solutions to life. From small-scale prototypes to market-ready products, our scientists and engineers leverage biotechnology, advanced materials, and engineered systems to create solutions that save time, save money, and save lives. We collaborate with the best companies, universities, and government labs in the world to explore the most promising new ideas and deliver transformative technologies to align with our customers' expectations. Our robust network of manufacturers, suppliers, licensees, and distributors extends our global impact. Biotechnology We solve complex healthcare challenges through applied R&D in wound mitigation, drug delivery, biosensors and wearables, point-of-care diagnostic platforms, and medical training tools. Core competencies: - Delivering the power of laboratory diagnostics to the field including POC ELISAs, dissolvable capture swabs, and automated spectrometry systems - Bio-interfacing technologies including nanofiber-based electrodes and quantitative ultrasound - Engineering biological responses to enhance wound care including adhesion barriers and nanofiber dressings for localized pain relief - Leveraging nanotechnology for advanced pharmaceutical design - Creating medical simulation tools for bleeding control and joint reduction Materials and Systems We specialize in cutting-edge research, development, and analysis for a wide range of applications including protective coatings, textiles, composites, electromagnetics, and corrosion monitoring and prevention. Core competencies: - Military-specific materials development - Advanced manufacturing techniques such as additive manufacturing and precision machining - Chemical and biological defense - Performance evaluation and testing - Lightweight materials and structures - Asset monitoring and non-destructive evaluation

Machine Solutions is a provider of advanced equipment and services for the medical device, biopharmaceutical and blood- and plasma-collection industries. We have been persistent in our pursuit to add industry- leading technology leading to the unification of MSI, SteegerUSA, BW-TEC AG, Vante, PlasticWeld Systems, Crescent Design, Beahm Designs, Vela Technologies, SEBRA and Intec Automation to provide a breadth of products to support customer needs and growth. Machine Solutions provides proprietary mechanical solutions to a variety of complex process, testing and device design challenges. Our equipment has become the industry standard for balloon catheter pleat and folding, drug coated stent crimping, heart valve crimping, medical wire braiding and coiling, catheter lamination, marker band swaging, balloon forming, laser bonding, tube cutting and our thermal processing products are considered the foundational tool for a wide range of plastic manufacturing processes. As a pioneer in radio frequency technology, the company has continued to develop advancing technology for catheter tipping, bonding, flaring, flanging, hole forming, biopharmaceutical sealing, sterile connecting and disconnecting along with many other applications. Our testing products support customers to meet ISO 10555 general requirements for testing intravascular sterile use catheters with test equipment including hydraulic leak & burst testing, stent radial force testing, catheter trackability and torquability, stent securement and other testing services

Madison Scientific, Inc. (MadSci™) is an early-stage medical device company innovating solutions to improve care for individuals with hydrocephalus. The company’s SmartShunt™ Hydrocephalus Management System is designed to be an integrated solution for enabling personalized and informed hydrocephalus management. It features state-of-the-art SmartValve™ technology.

Madorra is empowering women to live fuller, richer, healthier lives. Our first product is changing the paradigm for treating vaginal dryness by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. We're giving postmenopausal women and breast cancer survivors the power to choose the non-hormonal treatment option they want. Madorra has developed the first, non-invasive, non-hormonal medical device to treat vaginal atrophy. This is an easy-to-use, at-home device, providing both immediate and long-term benefits.

Magellan Diagnostics is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing.

Magnolia Medical Technologies is on a Mission to ZERO®. Today, we offer healthcare institutions a solution to some of their biggest hidden problems – contamination leading to misdiagnosis of bloodstream infections, including sepsis, which can lead to unnecessary and prolonged antibiotic therapy, and false-positive CLABSIs. Tomorrow, we aspire to create a world free of in-vitro diagnostic errors where rapid, accurate test results improve the lives of patients and providers alike. We know that setting new standards of care is a journey enabled by purposeful innovation, partnerships, and perseverance. As the first step of our journey, we have successfully developed and proven our evidence-based technology platform, Steripath, which we’ve coupled with unparalleled support to change clinical practices and prevent unnecessary patient harm as well as system-wide costs associated with the misdiagnosis of sepsis. Our mission is further enabled by reducing false-positive CLABSIs and leveraging our extensive intellectual property portfolio – consisting of over 100 issued method, apparatus, and design patents and 70+ patent applications pending – to address other important sources of diagnostic error that are harmful to patients and costly to hospitals.

MakroCare is expert Regulatory Consulting and Clinical Services partner for pharmaceutical, biotechnology and medical device industries. Our global/regional teams and fit-for-purpose costing models to your development strategy, regulatory management, clinical research, medical/scientific support and quality assurance areas. MakroCare has operations and presence in US, UK, EU, and Asia.

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

MasterControl is on a mission to bring life-changing products to more people sooner. Everything we do is designed to help you develop, manufacture, and commercialize products that help people live longer, healthier, and more enjoyable lives. We offer the world's leading solution for product quality, helping highly regulated companies ensure quality and compliance in their life sciences operations. Our quality management system is the most established and used QMS in the industry and is used by the FDA, CDC, and ORA. And our digital manufacturing solution offers errorless and frictionless production by taking you 100% paperless on your shop floor. The results speak for themselves. MasterControl customers enjoy 80% faster post-production review times, 21% fewer deviations, and 100% right-first-time. There's a reason more than 1,000 global customers have used MasterControl to bring more than 250,000 life-changing products to market. Learn more today at mastercontrol.com.

Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical's mission is to empower women to protect their pelvic health.

𝘐𝘮𝘱𝘳𝘰𝘷𝘪𝘯𝘨 𝘏𝘦𝘢𝘭𝘵𝘩 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴. MaximBio's comprehensive in-house capabilities provide you a world-class experience and confidence in our ability to keep costs down and deliver your products in time. At MaximBio, our team of dedicated professionals with over 25 years of expertise work to create a custom-fit, full service program in state-of-the-art facilities to meet all your needs and specifications: • FDA cGMP Registered for manufacture and distribution of medical devices • Compliant with 21 CFR Part 820 for medical devices • ISO 13485:2016 Certified for manufacturing and packaging of medical devices

Maxwell Biomedical is Pioneering a Non-Ablative AF Solutions for Lifelong Functional Sinus Rhythm and Heart Failure Management – Seamless Treatment, Proactive Care

Medeologix is a contract development and manufacturing partner for minimally invasive devices, we empower MedTech companies globally to transform visionary concepts into mass-produced realities. Our unparalleled engineering expertise and seamless design-for-manufacturing integration accelerate our clients' product time to market, ensuring the swift delivery of innovative, high-quality medical devices that set new industry standards and ultimately enhance patient well-being.

Restech offers minimally invasive tools to multiple specialties in order to accurately diagnose and manage reflux, and will continue to create solutions related to the complexity gastric related diseases. Restech’s tools are helping evolve the standard of care for patients with reflux, and fecal incontinence, providing physicians with the necessary data to transform the algorithm of care for tens of millions of patients.

Medfix® International, LLC specializes in cost effective surgical solutions in each of our subspecialties. Our subspecialties include spine retractor systems, disc preparation systems and procedure specific instruments. We work directly with healthcare facilities and distributors, putting high-quality instrumentation in the hands of surgeons in over 57 countries. Our extensive product portfolio offers a single source for spine surgery instruments. We are able to service our clients with stock availability, short lead times, as well as competitive pricing. Medfix® manufacturing capabilities are able to meet demand at any level. Our focus is cost reduction without compromising quality.

Emergo provides quality and regulatory compliance consulting to medical device and IVD companies. We assist with medical device registration/approval, regulatory strategy, ISO 13485 and QMS compliance, local in-country representation and post market surveillance in 20+ markets worldwide. Offices in North America, South America, Europe, Asia, Australia and the Middle East.

Over 100 million Americans have either a pre-chronic illness, or a disease and the majority don’t even know it. Early detection, intervention and timely personal monitoring matters; but, improving wellbeing requires consumer interactions to be easy, convenient and fit naturally into their daily “life flow.” Medic.Life is a unique biotech startup focused on blending miniaturized assay systems, medical IoT, AI and mobile into a waste analyzer platform – a smart toilet – resolving pain points for everyday users and providers. Within 2 years, our technology will be found in clinics, senior care, primary care, pharmacies, retail outlets, and homes, while generating mountains of personal health data. As such, Medic is really a data company with a sophisticated user interface that captures, analyzes and trends vital health indicators every time our toilets are used and notifies users when anomalies are detected. It’s like having a Medic at your disposal. Medic.Life has a strong IP position with 60 patents granted and more than 90 pending so far. We are working with over 20 partners for our onboard science center (microfluidics, lab on chip, proprietary sensors) and seek to double that number in the 2020-21 timeframe. If you have miniaturized technology to analyze urine, feces, vitals, body composition and circulation, then please contact us.

Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities where an unmet need exists for improved patient safety and efficacy. Medicus is opportunisticly exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.

MED Institute accelerate product development. MED Institute is dedicated to bringing new medical device products to market that are safe and effective for patients. From concept to commercialization, our team has the knowledge and experience to guide your products through the complex steps required for market approval.

Who We Are - Kimball Electronics is a leading contract manufacturer of durable goods electronics serving a variety of industries on a global scale. Kimball Electronics continues to make the customer the focus of everything we do. Our touch is felt throughout daily life via the markets we serve: Automotive, Industrial, and Medical. Recognized with a reputation for excellence, Kimball Electronics is committed to a high-performance culture that values personal and organizational commitment to quality, reliability, value, speed, and ethical behavior. Our employees know they are part of a corporate culture that builds success for customers while enabling employees to share in the Company’s success through personal, professional, and financial growth. What We Do - Kimball Electronics is a preeminent Electronics Manufacturing Services (EMS) provider serving customers around the world. Our contract electronics manufacturing services teams provide manufacturing, engineering and supply chain services, design and testing services, as well as regulatory support processes which utilize common production and support capabilities for a variety of industries globally.

MedSpark is a medical technology company that specializes in developing innovative medical devices.

Melio is developing a clinically actionable fast and comprehensive test for all common infections

Melodi Health offers novel technologies that improve patient outcomes for women undergoing breast surgery. Melodi Health manufactures the Melodi Matrix, designed to support the soft tissue space around a prosthetic device while delivering antibiotics to the surrounding tissue. The Melodi Matrix is currently an investigational device being studied in a prospective, multi-center, randomized, controlled clinical trial in breast reconstruction.

Mercator MedSystems, Inc., is a medical technology company focused on the treatment of peripheral artery disease utilizing its catheter-guided, microfluid injection systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. The Company’s technology also enables the commercialization of novel therapeutics for other vascular diseases, hypertension, oncology, and regenerative medicine.

MMI ia an incubated entity in Mergenet Solutions, Inc.

Mérieux NutriSciences Italia, appartenente all'Institut Mérieux, è impegnata a livello globale nella salvaguardia della salute dei consumatori e della sostenibilità, offrendo un'ampia gamma di test laboratoriali e servizi consulenziali nei settori alimentare, farmaceutico, packaging, cosmetico, ambientale. Leader di riferimento nel mercato italiano grazie ad una consolidata esperienza nei servizi analitici di chimica, microbiologia e biologia, Mérieux NutriSciences Italia adotta un approccio a 360° per fornire soluzioni pratiche e innovative ai suoi clienti mediante le attività di analisi, consulenza, audit, training, etichettatura e supporto normativo, ricerca, studi sensoriali e molto altro ancora. Giovane e dinamica, nonostante gli oltre 40 anni di storia, Mérieux NutriSciences Italia opera nel rispetto di elevati standard etici e di qualità e accoglie con favore l'opportunità di coinvolgere giovani talenti, che contribuiscono in modo significativo all'innovazione e alla crescita sostenibile dell'azienda. Visita la nostra pagina > www.merieuxnutrisciences.com/it/lavora-con-noi

As a global healthcare company, we understand customer needs and innovate and deliver medical solutions that transform patient care. Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

Developer of bio-engineered surgical implants designed to facilitate new tissue growth and also aid in connective tissue repair. The company's implants specialize in viable alternatives to conventional ACL reconstruction for patients who have sustained any kind of leg injury, enabling surgeons to perform surgery to restore normal anatomy and function of the knee.

Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.

Microrite is a San Jose, CA based Consulting and Training Company helping Pharmaceuticals, Biotechnology , Medical Devices and Drug-Device Combination Products in the areas of Quality Assurance, Quality Control, Microbiology, Process Development, Process Validation, Facility and Utility Validation.

With our proprietary processes and tools, Microspec has earned a global reputation for extruding the smallest, most complex medical tubing in the industry, with the tightest tolerances.

Micro Systems Engineering, Inc. (MSEI), with its main office in Lake Oswego, Oregon, is is a pioneer in developing innovative implantable medical device technologies and devices that save and enhance the quality of life for millions of patients across the globe. With more than 40 years of experience in design and manufacturing active implantable medical devices, our continuing success is based on our company's core values – innovation, quality, reliability, integrity, teamwork, and undisputed expertise – thus enabling us to inspire confidence and trust in physicians and patients worldwide. MSEI has two main divisions, Operations and System Design & Development. With over 400 technical staff including physicists, electrical, software, biomedical and materials engineers, MSEI employs an elite team of the brightest minds in the medical technology industry. The Operations division is a specialist in medical microelectronics manufacturing including development, design, testing, supply chain and system integration for medical technology, in particular for active implants in the area of CRM (cardiac rhythm management) and other medical applications. The Operations division is dedicated to the innovative design and quality construction of electronic modules used in implantable medical devices. System Design & Development is the innovation center for next generation class III active implants. This includes full system design, clinical research, hardware and software, as well as the design and test of application-specific integrated circuits (ASICs). The resulting products deliver life-saving therapies to patients accurately and reliably across the globe.

Miist Therapeutics is a pharmaceutical company focused on developing novel treatments to free people from addiction, starting with smoking. Our initial focus is to eliminate the inordinate amount of death and disease that cigarettes cause by putting an effective quitting aid in every smokers pocket. The majority of US smokers are already trying to quit year after year, they are simply unable to because of today's ineffective treatment options. We are changing that here at Miist and building a future without unwanted addiction.

Minerva specializes in quality investigations, product development, technology transfer and productivity improvements services for the cell and gene therapy, biotech and medical device industries, using advanced data, knowledge and risk management. Our team of interdisciplinary professionals supply us and our clients with cutting-edge knowledge while keeping our rates very competitive. Our team includes Quality Investigators, Engineers, Data Analysts, Information Scientists, and Biotechnology professionals. We also have a network of advisors in Quality Investigations, Life Sciences, Data Sciences, and Engineering. We tailor our services according to our client's location and budget needs: • Full-time Remote Work with On-Location Manager • Part-time Remote work with partial On-Location • Virtual Person-to-Person Advisory Services • Full-time On-Location • Other arrangements as needed Minerva uses process characterization and data structuring to help companies grow through continuous improvement and effective change management. Our data-driven and risk-based reports on product development and sustaining are fast, reliable, and compliant, and designed to facilitate your analysis and decision-making. We are best known for our agile implementation of databases and information management systems for tracking and visibility of medical device development, drug development and approval, methods development, sample testing, and operations sustaining. Let Minerva help your company achieve its development, operations and quality objectives through our services in Knowledge Management, Data Management, Risk Management, and Language Management.

Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development and manufacturing partner to leading device companies around the world. Today, through life-cycle efficiency, opportunity realization, and increased utility, the organization is creating value in key technology segments, including RF energy, fluid and gas management, optical systems, and stimulation and active wearables. From design and manufacturing services to whole product solutions, Minnetronix brings expansive industry insight and intentional technical acumen, delivering better medical devices to market, faster. Minnetronix is based in St. Paul, Minnesota. ​

Mizuho OSI is the leader in the markets for specialty surgery and patient positioning. The company’s portfolio includes specialty surgical tables for procedure-specific approaches that improve patient outcomes in spine and orthopedic surgeries along with disposable and reusable surgical patient care products.

At Modular Medical, we are dedicated to helping people with diabetes gain access to high quality care by making it affordable and easy to use. Diabetics want their lives back. We aim to help.

MDS is a contract research organization that provides molecular diagnostics and toxicology services to pharmaceutical and research institutions.

Morari's objective is to restore confidence in male sexual health by eliminating the embarrassment and frustration of premature ejaculation (PE). PE is the most prevalent male sexual dysfunction, estimated to affect 30% of men worldwide. With a higher incidence than erectile dysfunction or an enlarged prostate, men rarely talk about it or seek treatment. The Morari product concept would allow the male who desires a delay in ejaculation to use an external device that when activated by either partner, would use neuromodulation techniques to interfere with nerve signals to delay an ejaculation. When deactivated, the elements would not interfere with nerve signals.

Morphoceuticals is pioneering the bioelectric reprogramming of biology. They are focused on organogenesis and organ regeneration without transplantation. The company has successfully achieved limb regeneration in adult frogs using a novel drug combination.

MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client's industry experience, integrating its seven business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, due diligence and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA's integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, London, England, Winterthur, Switzerland, Eschborn, Germany and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.

Founded in 1990, MVA Scientific Consultants is a leading full-service analytical microscopy laboratory offering customized testing solutions across industries such as environmental forensics, industrial hygiene, pharmaceuticals, and nanomaterials. Our expertise in microscopy supports regulatory compliance, quality assurance, litigation, and R&D projects. We are ISO/IEC 17025 accredited, cGMP compliant, DEA licensed, and FDA registered, ensuring high-quality reporting and strict client confidentiality. Visit our website to learn more about how MVA Scientific Consultants can assist you with your next project.

myBiometry is a platform to remotely monitor and manage patients with chronic conditions using software and biomarker data generated from proprietary sensors. Our initial focus is asthma.

Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.

Myomo is a healthcare technology company that specializes in assistive technology for rehabilitation and mobility solutions.

Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options.

Nanofuse is a regenerative therapeutic that has the properties of replacing or "regenerating" human bone cells to form normal bone. NanoFUSE Biologics products contain the only bioactive glass that is FDA-Cleared to be combined with demineralized bone matrix (DBM). The regenerative efficacy comes from the osteoinductivity of the DBM component plus the osteopromotivity of the bioactive glass. Bioactive glass has been clinically proven for over 30 years but only until now has NanoFUSE Biologics used bioactive glass to create a revolutionary and patented regenerative therapeutic.

NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. The company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. This unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. The company's patch based product diagnosis, PainShield®, carries an FDA clearance. NanoVibronix catheter based products include the CathbotTM . NanoVibronix Inc. is located in Elmsford, NY. Its subsidiary, NanoVibronix Ltd. is located in Nesher, Israel.

NANOVIS is a rapidly growing nanotechnology surface company. Our scientists use a broad portfolio of advanced nanotechnologies designed to improve spine, orthopedic, and dental surgical outcomes. nanoVIS Ti ™ Surface Technology received FDA nanotechnology designation and is cleared on commercially pure titanium and titanium alloy implants.

We make sure great products get made. Too many great product ideas never get made. Natech ensures our clients' innovative ideas are manufactured so they can get started on their next great idea. As an injection molder and contract manufacturer, Natech specializes in an engineering-focused approach to manufacturing. Our core team are experts in design for manufacturing, assembly and scaling new products. Natech is an ISO 9001, ISO 13485 and FDA-registered molder. Headquartered in Long Island, NY, Natech operates three facilities, including a class 8 cleanroom for medical molding and assembly. Natech Plastics serves the medical, diagnostics, electronics, consumer goods and packaging markets. Contact a Natech engineer to get started on your new product.

Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world. Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status.

Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical instruments to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. The system aims to improve surgical outcomes with cutting-edge technologies that – reduce recurrence risk and conserve lung function – shorten hospital length of stay and enhance surgical workflow.

Nectero Medical is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients' lives.

Neocis, the first dental robotics company, is committed to enhancing dental surgeons’ capabilities and advancing patient care. Or Yomi is bringing the power of surgical robotics to dentistry.

Nervonik has developed a novel miniaturized neuromodulation device with sensing feedback to provide closed loop optimized therapy.

Electrodiagnostics

At Neuralace Medical, we are driven to accelerate the world's transition to sustainable, non-invasive chronic pain relief. What do we believe that very few others do? We fundamentally believe that overcoming chronic pain is inevitable. With our bold vision, we are challenging the conventional thinking the healthcare industry is currently laden with to implement innovations and technological advances to improve the overall quality of life of individuals by maximizing pain relief and minimizing side-effects, redefining the very concept of pain therapy which can leave patients with more side-effects than benefits. NeuraLace is not just a device developer, but also a technology company with a focus on medical innovations that can significantly restore the quality of life patients suffering from chronic pain. Our inherent interest in innovation and deep technical knowledge, along with the partnerships we are currently developing, will allow us to realize our vision and create something truly special. We are a startup medical technology company here to make a dent in the world of pain therapeutics!

NeuraMedica is medical device startup focused on the development of a novel, bioabsorbable surgical clip for durotomy closure in spinal surgery. This technology was intially developed out of Oregon Health and Science University (OHSU). The company is located in Oregon City, Oregon in the Portland Metropolitan area.

NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinson's disease, essential tremor, epilepsy, and depression.

NeuroDx is a medical technology company that specializes in using non-invasive thermal dilution to detect fluid flow in CSF shunts.

Our NEUROGENX Team is proud to abundantly equip and enable providers to deliver a higher standard of care to patients suffering various balance issues, neuropathy and other chronic nerve conditions. At the heart of our partnership is a philosophy in which we invest fully in our providers as partners and hold ourselves accountable and pledge our commitment. A commitment to ensure our partners both clinical and business success. We have built our NEUROGENX Solutions Program on this: (1) Support & Service (2) Performance & Results (3) Model Training & Continuous Coaching to Ensure Clinical & Business Success within the first months, throughout the first year and years to come. We recognize conscientious and enterprising providers have different needs as well as different visions about practice growth. For these reasons, we have multiple steps and pathways for procuring and implementing NEUROGENX Clinical and Business Solution Assets to create a custom fit to suit every enterprising style and budget. We're committed to work with you to customize a combination of technologies, training and support systems to attain your perfect fit!

NeuroStar is a medical devices company that offers therapeutic solutions in the field of neuroscience and mental health.

NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology. NeuroSigma's Monarch eTNS® System is a bioelectronic medical device that uses external trigeminal nerve stimulation to treat neurological and neuropsychiatric disorders. In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD. The new Monarch Pediatric Care Co-Pay Program is making eTNS therapy available to a substantially greater number of children diagnosed with ADHD.

Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera's minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.

Developed the Neutrogena MaskiD™that forms a translucent, flexible layer that conforms to every contour of the face. The hydrogel mask, created from cellulose sourced from locust beans and red seaweed, is custom-3D-printed with a unique combination of five powerhouse ingredients from the Neutrogena®library of clinically-tested skincare solutions

Neutron Therapeutics LLC is a pioneer in Boron Neutron Capture Therapy (BNCT) using our nuBeam platform, the world's only neutron beam for BNCT that conforms to IAEA international standard for clinical use.

Neuvotion is developing breakthrough solutions for facilitating and restoring movement. Our approach combines targeted neurostimulation and AI (artificial intelligence) to deliver unparalleled therapeutic value for patients with a movement disorder or impairment from stroke or injury. Neuvotion products allow doctors and therapists to leverage state-of-the-art technology, while monitoring patient progress in-person or remotely.

Reimagining. Redesigning. What are the possibilities when it comes to sustainability for the future and innovation for today? That's what we ask ourselves at NewGen Surgical. Founded in 2012 in the San Francisco Bay Area, and recipient of the California Product Stewardship Green Arrow Award for circular economy innovation, NewGen Surgical develops healthcare products that minimize environmental impact without clinical compromise, protecting the foundation of all health - our environment. NewGen Surgical offers the world's first upcycled, plant-based medical devices for the O.R. that minimize plastic, fossil fuel dependency, CO2e and chemicals of concern. Over 1,000,000 products have been delivered to date, equating to 42 tons of plastic and 48 metric tons of carbon eliminated from the healthcare supply chain.

Nexalin Technology is a non-invasive and drug-free therapy for those living with anxiety, depression and/or insomnia. Nexalin's Patented Waveform (1 U.S. Patent #6904322B2) The Nexalin device produces a patented waveform that provides Transcranial Electrical Stimulation (TES). In clinical trials, this unique waveform resulted in the greatest increase in beta-endorphins. The Nexalin device has undergone extensive safety analysis with the results clearly indicating that the device is safe for its intended use. Additionally, the FDA classification of the device for clinical trials places it into a non-significant risk (low risk device) category. Natural frequency will promote balance in the brain by normalizing neurochemistry.This effectiveness of this unique therapy is long lasting and FDA approved. Laboratory and clinical evidence suggest that Nexalin's patented electrical stimulation affects the hypothalamus and related brain structures to adapt and change the levels of neurochemicals including neuropeptides, neurotransmitters, and neuromodulators. The clinical data suggests that the Nexalin electrical stimulation will move endocrine outputs toward normalization, specifically from the hypothalamic nuclei and associated brain structures. A key indicator of this is a significant clinical change in levels of enkephalins and beta-endorphins in the cerebral spinal fluid of Nexalin-treated subjects, as well as other neurochemicals like Serotonin and Dopamine.

NFANT Labs is an emerging digital health company focused on improving the outcomes and lives of Neonatal infants. The nfant® Feeding Solution is the first FDA cleared IoT medical device focused on the NICU. We are determined to guide infants to faster and safer feeding.

Nob Hill Therapeutics mission is to commercialize the first-of-its-kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.

Noble manufactures and commercializes training devices that mimic the exact feel, force and function of drug delivery devices such as autoinjectors, prefilled syringes, on body, nasal and pulmonary devices in order to increase patient adherence and confidence, and decrease usage errors. Noble is an Aptar Pharma company, which is part of AptarGroup, Inc. (NYSE:ATR).

Their vision is to develop clinically validated ‘therapeutic wearables’ that allow for medical devices to become a true alternative to pharmaceuticals in the management of chronic neurological disorders.

Nonin Medical invented finger pulse oximetry and is a global leader in developing highly accurate noninvasive medical monitoring solutions that improve the quality of people's lives. Technology driven, we provide pulse and cerebral oximeters, capnographs, sensors, OEM/eHealth, and veterinary solutions that meet customers'​ needs today and tomorrow. Nonin Medical is headquartered in Plymouth, Minnesota, USA, and has an additional customer service center in Amsterdam, the Netherlands. We sell our products to clinicians and consumers in more than 125 countries and have more than 200 OEM partners worldwide. BUY AMERICAN QUALITY. For more information, call (800) 356-8874 (toll free US and Canada) or +1 763.553.9968. Email: info@nonin.com or infointl@nonin.com. Or visit nonin.com. Vision To improve the quality of people’s lives throughout the world by expanding the capabilities of noninvasive measurements. Mission To provide a diverse portfolio of simple, noninvasive measurements that lowers the cost of care and empowers individuals and caregivers to make better decisions. These solutions will be high quality, high performance, and easy to use. Values ■ Quality – We thrill our customers by providing the finest experience. We anticipate their needs. ■ Agility – We are fast, agile and focused. We creatively drive change. ■ People – We care about our people, foster learning and provide opportunities for growth. ■ Community – We care about supporting our communities and the lives of others. ■ Integrity – We are honest, ethical and dedicated to doing the right thing.

Noninvasix will be the first company to monitor the severity of sepsis and septic shock non-invasively, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real time. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand our technology's use and clinical impact in other indications and settings. Noninvasix is backed by 15 years of optoacoustic research and more than $6.5 million in research grants.

Nordson MEDICAL (Nasdaq: NDSN) is a global expert in the design, development, and manufacturing of complex medical devices and component technologies. We serve interventional, surgical, and specialized markets as the engine of innovations that save or enhance patients’ lives. We work with companies at any point in the product lifecycle to bring their innovative ideas to life. As a single-source partner, we enable our customers to save costs and speed time to market. Our 3 areas of focus provide customers with a complete solution: • Design & Development • Components & Technologies • Finished Device Solutions We offer innovative tools, technologies, and solutions that can help your team bring critical technologies and complex devices to market faster and more cost effectively. • Our online store (https://bit.ly/3PapqHV) offers several configurations of components and technologies • Our innovative prototyping tools and project accelerators help you design and develop clinically effective, complex devices and technologies — in less time and at less cost • Our experienced team comprises more than 250 technical staff, including 100+ with advanced engineering degrees Company & Culture: Quality is paramount in everything we do because our components and finished devices are used to save or enhance patients’ lives every day. We have developed a culture of continuous improvement and a single global quality system to ensure reliable, consistent product performance. Our commitment to excellence is at the heart of our interactions with customers, suppliers, and coworkers. Our quality mantra is “Quality Works Here.” View our Online Store to see the large selection of components that we currently offer: https://bit.ly/3PapqHV

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech Systems primarily serves the medical, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire/cable/interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has seven manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Northern Biomedical Research is a non-clinical research organization focused on targeted delivery of therapeutics using advanced techniques. Our team is experienced in providing industry-leading research for targeted-delivery of drugs, biologics, gene/cell therapies, and medical devices. With a strong regulatory history and scientific background in neuroscience, cardiovascular research, ophthalmology, and orthopedics, our team works closely with Sponsors to design a non-clinical program to exedite the regulatory process. For more information, stop by Booth 250. Â

At Nosco, we specialize in creating high-quality printed packaging solutions for the pharmaceutical, home healthcare + OTC, natural health and consumer products markets. With a focus on reliability, quality and responsiveness, we deliver cartons, labels, literature and flexible packaging tailored to each customer's unique needs. Our Brand Promise at Work Through our work together, we provide printed packaging that helps our customers save lives, promote health and encourage happiness. We do this every day with reliability, quality and responsiveness.

Nova Biomedical is a company dedicated to using advanced technology to develop better blood testing analyzers for medical use. These products are called in vitro diagnostic devices (IVD). We use some of the same advanced technology to provide the biotechnology industry with innovative instruments for cell culture monitoring. Nova is the largest privately owned IVD company in the U.S. and the third largest in the world, with over 1,200 employees globally. Our eight percent compounded annual growth over nearly a decade is more than double the IVD market growth, making Nova one the fastest growing IVD companies in the world. Corporate Commitment to Quality Nova's size and rapid growth are the result of customers throughout the world responding to the exceptional quality and value of Nova's technology, products, and customer service. Our strong corporate commitment to these three areas has made Nova a world leader in clinical, veterinary, and biotechnology chemistry testing analyzers. A Leader in Medical Science Technology Maintaining leadership in any technology industry requires a long-term perspective and commitment to research and development. Nova Biomedical has consistently invested more than 10 percent of sales into research and development — more than double the industry average. Our investment in research and development provides a continuous product pipeline of new and better technology products for our customers. Working at Nova Biomedical We practice our core values of mutual respect, honesty, and integrity throughout Nova. With a strong sense of family in the workplace, we are proud that one third of all our employees have been with us for over 10 years.

In 2023 NeuraSignal, Inc. acquired the business of NovaSignal, the original developer of NovaGuide. NeuraSignal is a medical technology company with a mission to save lives by unlocking the power of cerebral blood flow data. The company's FDA-cleared NovaGuide Intelligent Ultrasound combines non-invasive ultrasound, robotics, and artificial intelligence to assess cerebral hemodynamics in real time. Using cloud computing and data analytics, NeuraSignal supports physicians in their clinical decision making in several neurological conditions including stroke, traumatic brain injury, and dementia. To learn more, visit www.NeuraSignal.com.

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis' scCO2 technologies exceed the highest standards for product safety and performance. These processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials that are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials, such as allograft tissue, without damaging the product's structural or chemical integrity. NovaSterilis serves a variety of markets, including complex medical devices, drug delivery, tissue engineering, biotherapeutics/API, and additive manufacturing. With NovaSterilis, you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

Novex Innovations is a true CDMO (Contract Development/Manufacturing Organization) supporting our clients efforts in the commercialization of their products. Our areas of operation include: Biological Formulations Clinical Formulation Tissue Processing Bioengineered Tissue Active Pharmaceuticals Diagnostic Materials Medical Devices Development to Pre-Clinical to Commercial Regulatory Support Storage & Distribution & Order processing services. Scale-up optimization Product characterization Manufacturing through all phases of clinical trials Commercial modeling, manufacturing, and distribution Proof of concept Our clients range from single person operations to multinational companies. We provide process development, manufacturing, storage, and product distribution, all under cGMP procedures and policies. We operate cleanroom space at Class 1,000 and smaller scale spaces at Class 100, all for clinical and commercial manufacturing. Our Quality System is regularly monitored to the current ISO 13485 standards by BSI. Novex is also registered with the FDA. Our customers are both national and international and have a good understanding of other regulatory agencies as well. Customers have the option of storing their products at and having Novex ship on their behalf.

Founded in 2003, LinkedIn connects the world's professionals to make them more productive and successful. With more than 1 billion members worldwide, including executives from every Fortune 500 company, LinkedIn is the world's largest professional network. The company has a diversified business model with revenue coming from Talent Solutions, Marketing Solutions, Sales Solutions and Premium Subscriptions products. Headquartered in Silicon Valley, LinkedIn has offices across the globe..

Novuson, a spinout from the University of Washington's highly regarded Applied Physics Laboratory's Center for Industrial and Medical Ultrasound, is developing its Direct Therapeutic Ultrasound (DTU) technology platform for coagulation and hemostatic control in surgical and trauma procedures.

NOWDiagnostics (NOWDx) develops and manufactures over-the-counter (OTC) and point-of-care (POC) diagnostic tests. Its patented approach enables virtually any immunological assay to be accurately performed onsite in one step using a small amount of capillary blood, yielding results in minutes. With over 75 patents issued and pending, NOWDx's First To Know® and ADEXUSDx® product lines are available in markets worldwide. Founded in 2013, with headquarters and manufacturing in Springdale, Arkansas, NOWDx envisions a world where people have greater access to in-home testing with results in minutes. The company’s investors include Kompass Kapital Management, DigitalDx Ventures and the Labcorp Venture Fund. NOWDx is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.

Noxilizer, Inc. provides ultra-low temperature (10°C to 30°C) nitrogen dioxide sterilization technology that offers many benefits over traditional sterilization methods. Noxilizer sells sterilization equipment to pharmaceutical, biotech and medical device manufacturers and also offers contract sterilization services at its Baltimore, MD facilities. Noxilizer’s expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process. To learn more about Noxilizer’s contract sterilization services or sterilization equipment please email info@noxilizer.com or visit www.noxilizer.com

Founded in 1944, NSF is committed to protecting and improving human health and the environment on a global scale. NSF is an independent organization that facilitates standards development, product certification, testing, auditing, education and risk management for public health and the environment. Manufacturers, regulators and consumers alike look to NSF for the development of public health standards and certification that help protect the world's food, water, health and consumer products. Widely recognized for its scientific and technical expertise in the health and environmental sciences, NSF is a Pan American Health Organization/World Health Organization Collaborating Center on Food Safety, Water Quality and Indoor Environment. NSF operates more than 320,000 square feet of state-of-the-art laboratory space and serves 40,000 clients in more than 180 countries worldwide. Its 3,000 team members include microbiologists, toxicologists, chemists, engineers, and environmental and public health professionals. Visit us at www.nsf.org.

Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's mission is to create a hand-held, disposable, all-in-one, self-test for infectious disease testing, which delivers battery-powered, sample-to-answer results within one hour, without the need to mail in a sample. The company is headquartered in Austin, Texas.

Nuo Therapeutics, Inc. is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure injuries.

NuTech Spine was incorporated in 1994 by Founder and President, Ken Horton. Since then, NuTech has been on the cutting edge of Orthopedic, Spinal, and Sports Medicine. NuTech Spine offers quality products & services to its patients and physicians with knowledgeable staff and product literature.

Nuvaira was established in 2008 to address unmet clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD. The company offers innovative COPD therapies to help preserve patient lung health with a catheter-based system used to treat overactive airways.

We are Nuwellis, (Nasdaq: NUWE) formerly CHF Solutions. Our solutions go beyond chronic heart failure, so we've rebranded to reflect our therapeutic focus areas: heart failure, critical care, and pediatric fluid imbalance. We are a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. Our Aquadex SmartFlow® System gently removes fluid from adult and pediatric patients weighing 20 kg or more. Nuwellis consists of a purpose-driven team that puts patients and their providers at the center of everything we do. This is the new well. And for those whose lives and life's work are transformed by our fluid management technologies, the new well is everything. Nuwellis is headquartered in Eden Prairie, Minn., with a wholly-owned subsidiary in Ireland. The Company has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions (Nasdaq: CHFS).

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success is inspiring patients and providers.

Objective Biotechnology's mission is to develop high-impact technologies that enable comprehensive measurement and manipulation of biological systems at multiple scales, unlocking new research capabilities.

OBVIUS Robotics, Inc. is a medical device company based in South Florida, founded in 2020. The company focuses on developing innovative technology to enhance vascular access procedures, particularly central line placements. The inspiration for OBVIUS Robotics came from a critical care physician's experience with the challenges of central line placement in patients with complex anatomy. The flagship product, the CERTA Access System, is a handheld image-guided needle placement device designed to improve the accuracy and safety of central venous catheterization (CVC) procedures. This user-friendly device allows clinicians of all experience levels to visualize target vessels and perform needle placements quickly and effectively. The CERTA Access System has achieved significant clinical success, with a 100% access success rate in initial cases and has received FDA Breakthrough Device Designation, indicating its potential to enhance patient care. OBVIUS Robotics is dedicated to making vascular access more reliable and efficient for healthcare providers.

Octagos Health is a dynamic and rapidly growing healthcare technology company dedicated to improving patient outcomes through AI-driven solutions. Octagos provides a cloud-based platform that aggregates remote and in-person device interrogations for all cardiac rhythm management (CRM) manufacturers, wearables (Holter, MCT, etc.) and remote physiologic monitoring (RPM).

touchOPHTHALMOLOGY are a leading provider of learning resources, congress highlights and CME accredited activities for ophthalmologists.

Ocutrx Technologies, Inc. is a high-tech company that specializes in augmented reality (AR), extended reality (XR), and 3D visualization technologies. They develop innovative solutions for various sectors, including medical, military, consumer, and enterprise applications. Ocutrx aims to enhance how users interact with visual data, focusing on improving situational awareness and accessibility for visually impaired individuals. The company offers several products, including the OcuLenz AR/XR headset, which assists patients with advanced macular degeneration and is also suitable for gaming and telemedicine. Their ORLenz system enhances surgical visualization, allowing surgeons to interact more effectively with patient data. Ocutrx also provides customizable AR/XR platforms for developers and enterprises, promoting productivity and immersive experiences. Ocutrx serves a diverse range of customers, including healthcare professionals, military personnel, and developers creating AR/XR applications. The company holds over 25 patents related to AR/XR innovations, particularly in healthcare, showcasing their commitment to advancing technology in this field.

OD-OS aims to set new standards of care for retina treatment. By extending our innovative Retina Navigation platform, our goal is to become the global leader in novel therapeutic solutions for the growing number of people suffering from retina diseases. Join the Navilas mailing list: https://tinyurl.com/od-os-mailing-list Follow us on Twitter: https://twitter.com/OD_OS_Navilas Privacy Policy Social Media Pages: https://www.od-os.com/legal-notice-container/privacy-policy/social-media

Okami Medical, Inc. is a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention.

Oleander Medical Technologies is developing a revolutionary new treatment for advanced-stage cancers using Targeted Osmotic Lysis (TOL) process, which is patented. The company is also pending additional process and device patents.

A Chicago-based medical device development firm partnering with entrepreneurs, startups and large organizations worldwide to bring their innovations to life.

At Opticyte, we are committed to transforming the standard of care for the leading causes of organ failure, including sepsis. The problem is massive, is expensive to treat, and leads to one death every 2.8 seconds globally. Current technologies fail to provide clinicians with the definitive data they need to diagnose, monitor, and treat patients in real-time, when they have the best chance of preventing organ failure. Unlike existing oximeters, our VitalO₂ is accurate for people of all skin tones. Our VitalO₂ monitor is the first and only single solution to provide definitive, continuous, and actionable insights for these critical unmet needs. The FDA awarded Opticyte Breakthrough Device Designation on the strength of our clinical data and the promise of our technology to save lives. Opticyte's executive and advisory team includes pioneers in new optical spectroscopy and multivariate analysis technology, leaders in medical device commercialization, and medical clinicians. The company's early funding successes, research validation, and product development milestones provide credibility and reinforce our position as a disruptive medical device innovator.

Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 45 years, we have proudly helped our clients earn more than 85 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, integrated clinical data solutions, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.

OraSure Technologies developd, manufactured and distributed of point-of-care diagnostic tests, molecular collection devices. These include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick® platform; sample self-collection and stabilization products for molecular applications; and oral fluid laboratory tests for detecting various drugs of abuse. Orasure's wholly-owned subsidiaries include DNA Genotek, CoreBiome, and Novosanis.COVID-19: BARDA funded the development of a rapid coronavirus test that can be self-administered at home.

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed's team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Orchestra BioMed biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine.

Organogenesis™ is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.

OriGen Biomedical is a leading producer of cryopreservation and cell culture products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical® products are designed with the patient and user in mind and we strive to maintain excellent customer service to ensure that patient care is the priority. OriGen is a growing, privately-held medical device manufacturer founded in 1997 and headquartered in Austin, Texas. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention of improving patient health. OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. Our European distribution center serves to reduce the time to patients by providing stock products for quicker turnaround times out of the Netherlands.

Orthobond is an antimicrobial technology company that has developed proprietary antimicrobial nanosurfaces, with broad applications in the medical device industry and more such as commercial, industrial, automotive, and beyond. We’re the first company to utilize nanoscale surface modifications that can be permanently bound to any surface, killing bacteria, viruses, and fungi by mechanically rupturing pathogens without using antibiotics.

Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. 𝗢𝘂𝗿 𝗩𝗶𝘀𝗶𝗼𝗻: To be the unrivaled partner in MedTech, delivering exceptional experiences and life-changing solutions. 𝗢𝘂𝗿 𝗠𝗶𝘀𝘀𝗶𝗼𝗻: We provide medical technologies that heal musculoskeletal pathologies. We enable our teams through opportunities for growth, ownership of responsibilities, and empowerment to execute. We do this for patients and the healthcare professionals who treat them. We collaborate with world-class surgeons and other partners to bring to market highly innovative, cost-effective, and user-friendly medical technologies through excellent customer service. We do this to improve people’s quality of life and, in doing so, create exceptional value for our customers, employees, and stockholders. 𝗢𝘂𝗿 𝗩𝗮𝗹𝘂𝗲𝘀: • Take Ownership • Innovate Boldly • Win Together Join our mission to revolutionize musculoskeletal care and be a part of innovation that changes lives. Start your journey now at https://orthofix.com/about/careers/.

Orthogonal is a product development and consulting firm that creates software for medical hardware such as smartphone apps talking to devices that operate directly on the human body to treat sickness and injury. Our solutions take on some of the toughest healthcare problems facing our loved ones, healthcare system, and society. Working at Orthogonal, you will immediately be exposed to projects designed to: •Revolutionize the rapid detection of COVID-19 and other infectious diseases. •Improve the minute-by-minute lives of millions of people suffering from the lifetime affliction of diabetes by managing the delivery of insulin. •Transform the early diagnosis of Alzheimer's disease. •Give patients an at-home means to stimulate specific nerves to treat chronic conditions that drag down their quality of everyday life. •Power the next generation of omics-based cancer-detection systems. Specifically, Orthogonal develops Software as a Medical Device (SaMD), digital therapeutics (DTx), and other types of connected medical devices. We accelerate the product innovation pipeline at medical device, diagnostics, and pharmaceutical manufacturers to modernize patient care and gain competitive advantage. Orthogonal's industry-leading experience with SaMD enables us to rapidly develop, launch, and continuously improve connected, compliant products – and we offer this innovative approach to clients, so they can build their own SaMD product development workflows. Over the last decade, we've worked with partners ranging from startups to Fortune 500 firms to develop and bring their connected devices to market in a highly regulated space.

OrthoNovis is a medical device company that offers physicians and healthcare facilities the ability to purchase high quality products direct from the manufacturer. The OrthoNovis "direct to consumer" business model allows us to deliver innovative products at a price below other comparable products in the market. That is our GoDIRECT® Advantage!

OrthoPediatrics is an Indiana-based bio-science company that designs and develops orthopedic implants and instruments for pediatric conditions.

Nonsurgical solutions for back problems

Opening Eyes Beautifully!! Osheru is dedicated to leading minimally invasive technology for excess skin removal. Ziplyft, our innovative device, streamlines eyelid surgery for patients and surgeons, while expanding the market for this procedure.

Osseus is a pioneering medical device firm focused on developing advanced technology products for the minimally invasive spine surgery theatre. Our teams of forward-thinking surgeons, bright-minded engineers and visionary product managers design systems aimed at enhancing patient outcomes and changing healthcare for the better. Our Values Excite: We inspire excitement by developing next generation systems. Envision: Our creative team envisions solutions to bring innovative ideas to life. Evolve: We continually evolve our portfolio of products to stay ahead of the curve. Our Difference As an organically funded, privately held medical device pioneer, Osseus is not bound by corporate bureaucracy or shareholder demands. We have the freedom to explore new possibilities, experiment with new technologies, and form close partnerships with surgeons to develop groundbreaking answers to surgical questions. Using advanced materials and leading-edge technologies like additive manufacturing, we are creating modern, inventive devices that help solve anatomic challenges and push patient outcome boundaries. Our History After working in the medical device industry for decades, our founders decided it was time to do things differently. What started as a collection of next-generation ideas, has become an innovative medical device firm with the freedom to explore novel concepts, partner with entrepreneurial surgeons, and develop leading-edge spinal systems. At Osseus, creative minds are always at work. #SpineIndustry #MedicalDevices #Healthcare #SpineImplants #3DPrinting #AdditiveManufacturing

Ossio is an orthopedic medical device company founded in Israel in 2014 with the vision to completely transform the orthopedic experience for physicians, patients, and payors. Ossio's mission is to replace metal implants as the standard of care in the $10B+ orthopedic fixation market (screws, pins, plates) with an intelligent bone regeneration technology. OSSIOfiber™ represents a breakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore mobility with nothing permanent left behind. Our products have the mechanical strength needed for easy insertion and secure fixation while enabling the body to regrow bone, completely incorporating and replacing the implant without the adverse inflammation and weakness often seen in “bio-resorbables”.

Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections.

Minimally invasive surgery for otitus media and typanocentesis.

Otomagnetics is a medical device manufacturer that designs and commercializes magnetic injection system for the delivery of drugs to the inner ear.

A device from OtoNexus Medical Technologies uses air-coupled ultrasound technology to accurately assess middle ear infections, and in particular to differentiate when and when not to prescribe antibiotics.

Overture Life is a clinical-stage biotechnology company whose mission is to automate assisted reproductive processes to improve IVF pregnancy outcomes through process automation and non-invasive embryo selection. Its revolutionary technologies help standardize fertility treatments, by simplifying techniques and optimizing resources to make reproductive technologies more affordable, reliable, and accessible. Founded by recognized global leaders in embryo genetic testing and assisted reproduction, Overture is backed by Khosla Ventures, Felicis Ventures, Octopus Ventures and GV, and maintains offices in the U.S. and Spain.

Oxus is an engineering, manufacturing, and service company specializing in medical devices and gas separation technology. We design and manufacture our products in Auburn Hills, Michigan. As an ISO 13485 certified and FDA registered OEM supplier, we understand the technical challenges of product realization. We have supported our customers in bringing to market an assortment of challenging products; from industrial design and engineering, through process design and manufacturing.

Pace® Science and Technology Company makes the world a safer, healthier place. We partner with clients to provide the service, science, and laboratory data needed to make critical decisions that benefit us all. Through a nationwide laboratory network, Pace® advances the science of businesses, industries, consulting firms, government agencies, and others. ANALYTICAL SERVICES Pace® Analytical Services is a division of Pace® Science and Technology, providing local testing and analytical services backed by a large, national laboratory and service center network. Through in-lab, mobile, and emergency onsite containment and regulatory services, we ensure our air, water, soil, and more are safe for our communities and lives. LIFE SCIENCES Pace® Life Sciences is a division of Pace® Science and Technology committed to advancing the science of the pharmaceutical and biopharmaceutical industry by providing full-service CDMO/CRO capabilities and professional services for in-house labs through a nationwide network of service centers, manufacturing sites, and FDA-registered laboratories. COMMITMENT We believe the work our customers do is important to improving our communities and lives and are committed to supporting them through strong partnerships, delivering upon expectations, and providing exceptional customer service.

CONNECTING THE HUMAN BRAIN What if we could restore or enhance function using the power of AI and advanced technology? Our direct data interface enables this connection. MISSION We are building a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. Our first clinical application will help severely motor-impaired people communicate, enabling social connection and restoring independence. ABOUT Paradromics was founded in 2015 by a team of engineers and neuroscientists, received early support from both NIH and DARPA, and is currently backed by venture capital.

The Lubrizol Corporation, a Berkshire Hathaway company, is a specialty chemical company whose science delivers sustainable solutions to advance mobility, improve wellbeing and enhance modern life. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has more than 8,000 employees. For more information, visit www.Lubrizol.com.

PATH is a global team of innovators working to accelerate health equity so all people and communities can thrive.

PathMaker Neurosystems is a near-commercial stage neuromodulation company founded to commercialize recent advances in the development of non-invasive devices for the treatment of patients with serious neurological conditions. The company's technology is based on the premise that electrical fields can be used to stimulate the nervous system in a non-invasive manner, offering the potential to treat a wide range of neurological disorders.

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

Penderia Technologies develops wireless technologies for orthopedic applications, with a focus on implantable sensors for monitoring injury and healing progress.

Helping medical device Sponsors improve healthcare since 1967, NAMSA is the world's leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients' products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, NAMSA is the industry's premier, trusted partner for successful development and commercialization outcomes. Learn more: https://namsa.com/about/client-testimonials/

Perimeter Medical Imaging AI is a pioneering medical technology company driven to transform cancer surgery with advanced imaging tools. We can't imagine how frustrating it is for surgeons to do everything they can and still have to make the "dreaded call" to the patient. That's why we developed our OCT technology that provides 10x the resolution of X-ray and ultrasound at 2mm imaging depth for real-time insight, so surgeons can act in the moment with greater certainty. A Toronto-based company established in 2013, with U.S. headquarters in Dallas, Texas, Perimeter seeks to harness the power of big data, artificial intelligence, and machine learning technology to further our mission of improving the standard of care, providing better long-term outcomes for patients, and reducing healthcare costs.

Perosphere Technologies is focused on bringing forth new, Point-of-Care (PoC) solutions that make diagnosis, treatment, and prevention a matter of actionable data. We bring the clarity and confidence needed to transform an incomplete clinical picture and drive the way decisions are made in coagulation.

Peytant Solutions, Inc. (PSI) is a medical device company, incorporating Regenerative Human Biomaterial   with  absorbable and alloy implant technologies. Our percutaneous, biologic AmnioStent...

Phantom Neuro is creating the first minimally invasive peripheral neural interface, the Phantom X. Our technology allows complex electronic systems, like prosthetic limbs, to operate like natural extensions of the human body. We are a group of forward thinking individuals on a mission to help people with function-limiting injuries.

PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world PharmaLex adds to Cencora's expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle. Learn more at http://www.pharmalex.com

The mission of PharmaLogika is to provide quality services and the highest level of expertise to start-up as well as established industry leaders from discovery, through clinical trials, to commercialization of ideas. Our goals include the deployment and management of consulting teams utilizing our online products, while maintaining the lowest possible overhead cost structures. Our target audience is primarily but certainly not exclusively small to medium size businesses within the Pharmaceutical, Biotech, and Medical Device industries.

Solving unmet needs in vascular access care

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body. Its piezoelectric technology offers improved safety and efficacy, and is simple, cost-effective, and rapid to produce at scale. Founded by experts in the field of drug delivery and commercial translation, Piezo's diverse team aims to help translate the next generation of nucleic acid medicines. For more information, please visit www.piezotx.com or email partnerships@piezotx.com.

PinkDx is an early-stage company whose vision is to positively impact the health of women throughout their life journey. We focus on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and provide answers that have an immediate, positive impact on their lives. Our first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer. Led by a team of diagnostics industry veterans, PinkDx is privately held, with funding from prominent biotechnology investors, including Catalio Capital Management, The Production Board, Mountain Group Partners, Byers Capital and Mayo Clinic.

Podimetrics is the creator of the SmartMat™ and integrated clinical and patient support services that can help save the limbs and lives of patients living with complex diabetes. We provide high-risk patients our SmartMat™ through partnerships with payers and at-risk providers, including the Veterans Health Administration. After placing their feet on the mat for just 20 seconds a day, patients’ data are automatically sent to our care management team, which helps address any concerning findings. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and allows clinicians to achieve unparalleled outcomes — keeping vulnerable patients healthy at home and saving limbs, lives, and money. Founded in 2011 by a physician and engineers from MIT and Harvard, Podimetrics is headquartered in Somerville, M.A., and backed by Norwich Ventures, Scientific Health Development, Polaris Partners, and Rock Health. For more information, go to www.podimetrics.com or follow us on Twitter @podimetrics.

PolarityTE, Inc., headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. PolarityTE's first regenerative tissue product is SkinTE®. PolarityTE has an open investigational new drug application (IND) for SkinTE® with the U.S. Food and Drug Administration (FDA) and is now pursuing the first of two pivotal studies on SkinTE® needed to support a biologics license application (BLA) for a chronic cutaneous ulcer indication. SkinTE® is available for investigational use only. Learn more at www.PolarityTE.com.

Polysciences introduces Kyfora Bio, our bioprocessing brand, supporting development of cell and gene therapy (CGT) breakthroughs from bench to clinic. Backed by 60+ years of specialty chemical development, manufacturing, and application expertise, Kyfora provides research grade through cGMP transfection reagents and excipients for viral vectors, mRNA vaccines, and other drug delivery applications. Our cost-effective and scalable cGMP processes empower advanced therapies to improve patient lives.

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, visit prapela.com

Precision Medical Products currently provides medical devices / supplies (DME) to patients and surgical facilities nationwide. PMP places the highest value on customer service and satisfaction. Our representatives offer face to face and in home supply of medical equipment to the patients we serve. Our excellent patient service levels have allowed us to achieve Joint Commission Accreditation and award-winning acknowledgments. 2015 FASTEST GROWING Company in Sacramento. (Sac Business Journal) 2014 FASTEST GROWING Company in Sacramento. (Sac Business Journal)

Precision Medical Technologies, Inc. is a contract manufacturer of orthopedic implants and instruments with a focus on spine, extremities, trauma and sports medicine. We are ISO 1 3485:2003 Certified. The business is divided into two separate operating Divisions; Implant Manufacturing and Instrument Manufacturing with both segments being staffed with their own Quality Engineering, Production Engineering, and Operating Management. The Instrument Division operates out of the Warsaw and Rome City facilities, while the Implant Division is only located at the Warsaw facility. The Implant Division's strategy is to minimize variation in the manufacturing process to drive high quality performance. The primary objective is to reduce or eliminate job changes, manufacture on dedicated equipment, and complete the implant production in one operation. Statistical monitoring of the process provides our Engineers with the data to continually improve quality and productivity. The Instrument Division's business is truly a job shop environment with normal order quantities of 1 0, 20, or 50 units with multiple components. This product mix requires constant changes or set-ups on CNC equipment; the low volumes require 1 00% check of critical dimensions at the machine. The concentration of effort in this business is in the areas of consistent machine set-ups and high quality efficient production on the back shifts.

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management. Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results. As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Are you ready to make a real difference and help us transform this exciting industry? Follow our company page for more information about us and the work we do, and check out our current openings for your next career move!

Presbia is a medical device company focused on the development of the presbyopia-correcting Presbia Flexivue Microlens™ – an innovative solution for the common age-related loss of the ability to read or focus on near objects. The 3mm diameter lens is implanted in a corneal pocket created by a femtosecond laser.

We are a clinical-stage, privately held medical technology company developing a transformational neuromodulation platform to treat diseases of undesired neural activity.

Pharmacology Research Institute is a healthcare organization that focuses on meeting patient needs through quality care and improved access to investigational treatments.

PROCEPT BioRobotics is a medical robotics company that specializes in minimally invasive robotic surgery technology.

Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix™ is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system. Aortix™ is currently in the research and development phase and is not available for sale in any country. (Caution: investigational device. Limited by federal law to investigational use.)

We realize product visions that enhance people's lives. Product Creation Studio is an integrated product development consultancy. We fuse our passion and expertise in strategic design and precision engineering to create, innovate, and solve complex challenges for our clients across the consumer, medical, and industrial fields. From burgeoning start-ups to top-tiered companies, we make products happen.

Profusa's mission is to make our body's chemistry easily accessible to improve health and wellness. We are dedicated to becoming a leader in the development of real-time biosensors that provide unprecedented insights into our overall health status. We are leading the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Our technology enables the development of bioengineered sensors that become one with the body to detect and continuously transmit actionable, medical-grade data for personal and medical use. Profusa's first clinical offering, the Lumee Oxygen Platform™, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. It may be used in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery. Any questions? Please visit profusa.com or email us at info@profusa.com

Promaxo is a medical technology company that develops and commercializes customer-centric MRI systems and MRI based technologies that enhance patients' experiences and outcomes. The Promaxo MRI system is designed for image-guided interventions including live MRI guided biopsies, treatment planning, robotic surgeries, and radiation.

Since 1989 ProMed has been recognized as a leading Contract Manufacturer of complex, intricately designed molded silicone and plastic components and assemblies for highly regulated industries. ProMed's expertise lies in applications for short-term and long-term implantable devices, drug-releasing combination devices, and specialized manufacturing for aerospace, defense, and automotive applications. We collaboratively work with our customers from prototype through production, providing over 30 years of experience related to design for manufacturability, material selection, tooling/fixturing, process development, manufacturing, and other value-added services that result in cost-effective solutions with superior quality. With four facilities spanning more than 134,000 sq/ft of office, laboratory, and Class 7 Manufacturing space, ProMed's in-house services include tooling design and manufacturing, quick turn prototyping, injection and transfer molding of components, micro molding of tightly tolerance components, insert over molding, advanced material blending of specialty additives, automated assembly, testing support for drug delivery and combination devices, as well as customized packaging services.

Prompt Praxis Laboratories, LLC, founded in 2011, is a women-owned fully-integrated laboratory powered with the current information technology to facilitate rapid drug testing or development. The emphasis on automation of critical laboratory processes allows PPL to minimize human error within the testing and analysis process. Prompt Praxis Laboratories provides a full range of rapid testing and support services focusing on pharmaceutical products and compounded sterile or nonsterile preparations. Our support activities span three major industries: > Pharmaceutical > Compounding Pharmacy > Medical Devices The scope and breath of the services we offer are extensive, and we anticipate phasing in specialty capabilities based upon the growth of our client base and diversification of development activities. Services in support of other dosage forms may be included in various expansion phases of the laboratory. Prompt Praxis Laboratories, LLC, has developed and validated numerous Ready-to-Analyze® test methods. These methods have been validated to a typical concentration range of 1 to 50 µg/mL with short run times facilitating rapid turnaround. These methods are envisioned to be applicable without further validation to test samples after a quick specificity experiment that demonstrates their utility on the specific samples to be tested. We hope to encourage compliance with the new 503B section of the Food, Drug & Cosmetic Act by cost-effectively providing options to physicians, pharmacies, and outsourcing facilities in an effort to ensure chemically safe and effective compounded preparations.

Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. We power motivating, care-connected patient journeys and unify value for all stakeholders – providers, payers, pharma, and other healthcare and life sciences organizations. The Propeller Platform includes FDA-cleared and CE-marked medical devices, consumer apps, support and coaching, and secure access to clinical data for provider monitoring. Our precision approach is designed to motivate behavior change and track patient adherence with the goals of enabling medication optimization and helping predict costly exacerbations. In more than 150 peer-reviewed abstracts and publications, our digital-first chronic respiratory care platform has demonstrated improved quality of life and clinical outcomes while lowering healthcare costs. As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.

PRO-spectus helps pharmaceutical companies, medical device manufacturers, and diagnostic firms overcome barriers that stand between products and patients. We turn complexity into possibility by expanding access to specialized products across the continuum of care. Our team of market access and patient support experts combines deep strategic experience with innovative technology to help clients meet the challenges of a constantly evolving healthcare landscape. With comprehensive solutions in Patient Support Services, Market Access, Reimbursement Support, and Policy Strategy, we are passionate about developing and implementing strategies that open access to products for the patients who need them.

ProTrials Research, Inc., is a full-service clinical research organization (CRO) and woman-owned business headquartered in Los Gatos, CA, with clinical operations personnel located throughout North America and across the world. ProTrials works with sponsors in the pharmaceutical, biotechnology and medical device industries to deliver high-quality clinical development services in a wide range of therapeutic areas. Founded in 1996, ProTrials has been successfully supporting clinical research for over 27 years.

Pryor Products is the leading manufacturer of IV stands and rolling bases for medical equipment. Our products are used for mounting IV pumps of all shapes and sizes, vital signs monitors, computers, ventilators and many other types of medical instrumentation. Today our products are hard at work throughout the world, in every conceivable healthcare area. Pryor Products has been built on strong customer relationships since 1972. Our design team works closely with our OEM partners design and marketing teams to get you the exact product that you need. Our in-house design services eliminate costly project delays and ensure that your go-to-market timelines and strategies are met. Our manufacturing facilities are based in Oceanside, CA. Here we provide design, manufacturing, CNC machining, assembly and customized shipping options. Each product is custom made to customer specifications and are thoroughly tested for adherence to exacting tolerances. Contact us today to discuss how Pryor Products can help you enhance the value of your products with our IV stands, rolling carts and custom clamps.

We are the makers of the CardioChek and A1CNow point-of-care test systems. Our aim is to help healthcare providers close gaps in care with fast, accurate testing for cardiovascular disease and diabetes risk factors. CardioChek Plus provides full lipid panel and glucose results in as little as 90 seconds. A1CNow provides A1C results in 5 minutes. Both systems are portable and easy to use, making them ideal for nearly any healthcare setting. The company’s name represents the three pillars upon which it has built its success: People, Technology, and Service.

Pulmodyne, Inc. is an ISO certified manufacturer of medical devices for the acute care, emergency/prehospital, and homecare markets. Located in Indianapolis, Indiana, Pulmodyne was founded in 1985. They develop and produce a wide range of proprietary products for direct distribution worldwide. The mission at Pulmodyne is to build a world class organization of the highest standards to meet the needs of customers.

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The people at Pulse Biosciences are some of the top experts in pulsed electric field technologies and have a broad range of engineering expertise across multiple medical device domains and will utilize nsPFA™ technology to treat a variety of applications for which an optimal solution remains unfulfilled. We have a deep and broad IP portfolio with over 130 issued patents globally owned and licensed. With this growing patent portfolio surrounding our innovative technology, Pulse Biosciences seeks to aggressively realize the potential of Nanosecond Pulsed Field Ablation technology by building a rich pipeline of transformative commercial applications.

We're a small but rapidly growing neurotechnology company based in Durham, North Carolina. Our vision is to enable and support outstanding basic and translational neuroscience research through innovative and affordable products. We launched XCSITE 100, our tDCS/tACS research solution, in 2016. Today, XCSITE 100 is used in leading brain stimulation labs across the United States. We are actively developing new technology and working with our stakeholders to provide new research solutions to enable cutting edge neuroscience.

Qnovia has created an inhaled drug delivery platform to deliver a broad range of pharmaceuticals.

The QTI team has been on an incredible journey, starting with a shared mission to create disruptive innovation to expand access to medical imaging while ensuring superior patient experience and improving health outcomes. We anchor our efforts in medical imaging because when the body can be scanned often and without harm, health conditions can be detected before symptoms appear. Chief among the new advancements in medical imaging is 3D body imaging. Today QTI focuses on our breast imaging technology, which is native 3D, high resolution, and generates reproducible image quality regardless of operator or breast size or tissue type. Current breast imaging paradigm leads to unnecessary concern and cost. ▪️Unlike mammography, QTI technology is effective in screening women with dense breasts, or 40% of women in US. ▪️35% of women aged 40-70 do not get screened. Of the 65% of women who get screened, 15% suffer unnecessary callbacks for ultrasounds, MRI, or biopsies. 80% of biopsies are benign. ▪️QTI’s technology can be a much-needed alternative for high risk women under 40, as cancers in younger women are usually aggressive and survival outcomes are poor. Our QT Imaging Breast Acoustic CT™ Scanner is the only true 3D imaging device, FDA cleared for use as a transmission and reflection low frequency soundwaves imaging system for a patient’s breast. There is no ionizing radiation or compression like in mammography or contrast dyes injections like in MRIs. The technology uniquely quantifies breast density. Surface-to-volume ratios and volumetric doubling time growth rate can be calculated to determine significance of lesions and improve specificity. This breast scanning system gives women the choice they deserve to ensure their breast health over time; for healthcare providers, a technology that is accessible, affordable, and accurately visualizes internal structures of the breast; and, for investors, a market segment extension and a purposeful investment opportunity.

The next generation of wound care products won't only cover your wounds, they'll actively kill bacteria and help your body heal itself. We research & develop long-lasting antimicrobial wound care products with no bacterial resistance. Recently granted FDA cleared and patent approval.

Quris-AI is an artificial intelligence innovator that is disrupting drug development. Its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. Quris-AI is led by a track-record team of top scientists and strategic investors. Its first AI-based drug is now prepping for clinical testing.

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Aspiration System*, which includes a novel aspiration pump and catheters to allow rapid and consistent removal of blood clots from the brain. The RapidPulse logo and the word mark RapidPulseTM are trademarks of RapidPulse, Inc., and are the subject of applications pending in the United States and internationally. *The RapidPulseTM Aspiration System is not cleared for sale in the United States.

Collaborative robots have reshaped automation by enabling a wide spectrum of new applications in different industries – but a significant dexterity gap still remains even with these robots. Manipulation of delicate, fragile, or brittle items is still out of reach for robots. Inspired by our human fingertips which provide unmatched dexterity, we have set out to reduce this gap by adding tactile sensing similar to the sensing in our fingertips to enable robotic manipulation of more delicate items. Introducing the Tactile Fingertip. Ras labs has combined material science innovation with data science and precision engineering to provide the first state of the art, Tactile Fingertip for robotic gripper fingers. Our sensor is based on our patented Electroactive Polymer which can be fabricated in many configurations. Both squishy and a level of firmness. Think our revolutionary technology could help your business? Send us a message. We'd love to chat!

ReacX Pharmaceuticals, Inc., headquartered in South San Francisco, CA, is a commercial-stage biopharmaceutical company developing therapeutics based on its proprietary ProNeura™ drug delivery technology. The company’s flagship product, Probuphine®, is the first FDA-approved long-acting formulation of buprenorphine designed for the maintenance treatment of opioid dependence. It provides continuous, six-month drug delivery following a single implant procedure, ensuring consistent therapeutic levels. Beyond opioid addiction treatment, ProNeura™ technology is being explored as a platform to develop treatments for other chronic conditions such as diabetes, psychosis, multiple sclerosis, and even weight loss where stable, long-term drug release can enhance patient care and outcomes.

Rebeccatech focuses on delivering innovative medical solutions to the hands of professional care givers. Funded by industry veterans, the team specializes in micro-devices, plasma technology, radio-frequency, and device integration.

Regel’s technology utilizes a deactivated Cas system (dCas) which targets the epigenome without editing or damaging the DNA. This approach harnesses the natural mechanisms of gene regulation, allowing for efficient and permanent restoration of normal gene expression.

High-Throughput Screening Platforms

RegenLab is recognized as a global leader in medical biotechnologies, specializing in cellular therapies, manufactured in the USA. RegenLab is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patient's own blood. Regen® A-PRP® is FDA cleared and developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over one million treatments worldwide using RegenLab products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.

Regen Suppliers sells regenerative products and services and medical devices. The biologic produces include umbilical allografts, and exosomes. The devices and equipment include ultrasound machines, shockwave, micro needling, PDO Threads, cryogenic freezers, centrifuges and more.

We are developing a novel device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease. By minimizing the risk of infection, we enable more patients with kidney failure to receive quality care in the comforts of their own homes.

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Remmie Health is a digital health technology venture that delivers next-generation, AI-enabled, ear-nose-throat care for easier, accessible diagnosis, timely intervention, and exceptional patient care. Remmie is a patient-centric, primary care telemedicine/at-home examination device + API + AI system that enables patients/consumers to receive virtual/hybrid care from healthcare professionals, covering 22+ most commonly occurring respiratory conditions, causing over 120 million annual visits as the leading reason for ambulatory care, impacting every family 2-9 times a year. The winner of the Muse Innovation Fellowship, UCLA Knapp Venture Competition, and Rice Business Plan Competition, Remmie Health is a UnitedHealthcare Accelerator (powered by Techstars) and Plug and Play portfolio company. The company is based in Seattle, WA.

RemSleep creates products for sleep apnea and other sleep disorders. Now selling ResPlus CPAP machines. The soon to be FDA cleared, Deltawave device provides maximum airflow with minimum noise. it is the most comfortable interface on the market.

RenOVAte Biosciences Inc (RBI) is a Delaware Incorporated, Maryland based animal biotechnology company founded in December 2016. RBI is in the business of performing sophisticated and precision genome editing and genetic engineering in livestock species, to address critical priorities of animal and human health.

Reprieve Cardiovascular, Inc. is developing innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients. In 2022, Reprieve initiated the FASTR Trial (pilot study) to compare decongestive therapy administered by the Reprieve Decongestion Management System to Optimal Diuretic Therapy in the treatment of patients diagnosed with acute decompensated heart failure. Reprieve is a privately held medical device company, headquartered in Milford, Massachusetts, USA.

ReShape Lifesciences Inc. is America's premier weight-loss and metabolic health-solutions company, offering an integrated approach to managing and treating obesity. The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The recently launched 𝗋𝖾𝗌𝗁𝖺𝗉𝖾𝗰𝗮𝗿𝗲™ virtual health coaching program is a reimbursed, virtual tele-health, weight-management program that supports lifestyles changes for al weight-loss patients, to help them keep the weight off over time. Together, we will build a healthy life, one choice at a time.

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

Respirogen's technology will provide oxygen independent from damaged lungs. Acute respiratory distress syndrome (ARDS) is an acute severe lung disease commonly encountered in intensive care units (ICU). It can be caused by several triggers, including pneumonia or trauma. It is characterized by widespread injury of the alveolar–capillary membrane, resulting in protein rich noncardiogenic pulmonary edema (fluid accumulation in the lungs) and acute respiratory failure (ARF). ARDS results in severe hypoxaemia, which is refractory to oxygen treatment and requires assisted ventilation.

RespirTech, a Philips company, works with healthcare teams, patients and caregivers to provide effective airway clearance therapy with the Philips InCourage system and Philips Respironics CoughAssist T70. Our dedicated customer care team contributes to improved management of chronic respiratory conditions like cystic fibrosis, COPD, bronchiectasis and certain neuromuscular and neuromotor diseases. RespirTech's innovative products and exceptional service supports patients on their journey to better breathing. Respiratory Technologies, Inc., dba RespirTech, was founded in 2004 and acquired by Philips in 2017.

restor3d enables surgeons to improve the reconstruction and repair of the human body through 3D printed implants with enhanced anatomical fit and superior integrative properties. Leveraging expertise and experience in 3D printing of key biomedical materials spanning a wide range of properties, restor3d seeks to improve medical device solutions.

Restorative Therapies is a medical devices company that provides revolutionary Functional Electrical Stimulation devices and therapies to help patients achieve their full potential.

ReSuture's mission is to ensure safer surgery and medical device development through purpose-driven innovation. We recreate the conditions of the operating room in realistic and portable systems - creating physical models that replicate human anatomy with diseased conditions. Our medical device customers use our technology to demonstrate their products to surgeons and hospitals, ensure customer retention through ongoing training, and conduct R&D on new devices. ReSuture's patented manufacturing method allows us to create next-generation pathology-specific surgical models for vascular/endovascular, interventional radiology, structural heart, and interventional cardiology device manufacturers. Our products help ensure safer and more effective market adoption of surgical devices, and empower physicians to deliver the highest caliber of care. ReSuture is supported by the National Science Foundation to create a surgical data analytics platform that will give surgeons insight into their performance, and help medical device manufacturers better understand how providers are utilizing their devices. Movement and pressure data collected from ReSuture's models will provide the first objective, data-driven solution for training on novel medical devices.

REVA Medical, LLC. is a leader in bioresorbable polymer technologies for vascular applications. REVA's lead product, Fantom Encore, is a drug-eluting bioresorbable scaffold for the treatment of coronary artery disease. Fantom Encore is made from Tyrocore, REVA’s proprietary tyrosine derived polymer. Unlike metallic stents, Fantom Encore is designed support the artery through the healing process, and then disappear (or “resorb”) from the body in order to restore natural function to the artery. Learn more at www.revamedical.com.

RevMedx is a start-up medical device company dedicated to bringing lifesaving products to the field of trauma medicine. Working under grants from the US Army, we are developing a line of wound dressings that will create a new standard for the treatment of traumatic hemorrhage—the leading cause of combat mortality. Currently our line of hemorrhage control products include: XSTAT, XGAUZE, AIRWRAP, SHARKBITE kit and TX2/TX3 Tourniquet Belts.

Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now with FlowSense. FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app. Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$7.5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2024. To date, the company has brought in >$19M in dilutive and non-dilutive financing. Follow on products for other chronic conditions are currently in development.

Rapid Reliable Results COVID testing has shined a light on a major bottleneck in the laboratory workflow for accessioning samples, decapping of the samples, and movement of the samples into high throughput assay workflows. Rhinostics offers a simple and elegant solution that can remove time and significant labor, allowing laboratories to move larger number of samples through their laboratories at a lower cost, lower error rates, and with time savings. Rhinostics is revolutionizing sample collection with comfortable, automatable, rapid solutions that concentrate samples that save time, costs, and improve assay sensitivity. The polypropylene anterior nares (nostril) collection device is comfortable and easy for self-collection or in the clinic. It is connected to a threaded cap that can be automatically decapped using the Hamilton Lab Elite instrument. The samples can be shipped dry (RT-PCR does not require live virus so viral transport media (VTM) is not required. The entire 96 well plate of vials can be simultaneously scanned through a 2D barcode on the bottom of the collection vial and the automated decapper robot can be connected to other liquid handling systems and linked into the high throughput assay workflow.

Riparian Pharmaceuticals is an early stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics In nature, the riparian zone is a unique rich ecosystem created through the interaction of a river with its banks. In the human body, moving blood, or hemodynamics, similarly interacts with the walls of blood vessels generating unique biological activity. This very interaction, between hemodynamics and the vascular wall, is a critical and unexplored determinant of vascular health. Riparian is deploying hemodynamics as a tool to discover first in class therapeutics acting on new pathways at an earlier stage of disease than is possible today.

RIVANNA® is elevating global standards of care through the development and commercialization of world-first imaging-based medical technologies, including BoneVision™ Multi-Probe Multi-Angle Image Acquisition, BoneEnhance® Multi-Frequency Image Reconstruction, and SpineNav3D™ AI-Enabled Spine Recognition. RIVANNA's complete clinician-assistance solutions improve decision-making, workflows, health outcomes, and patient satisfaction. Headquartered in Charlottesville, VA, RIVANNA is privately held and operates an FDA-registered and ISO 13485:2016 certified manufacturing facility. For more information, visit rivannamedical.com.

At Rockley, we believe that our unique biosensing platform could be a game-changer for personal health management, transform healthcare, and improve people's lives around the globe. By helping enable real-time insights, Rockley is well-positioned to revolutionize the way we manage our health and well-being for decades to come. From wearable biosensing wristbands, chipsets, and algorithms to cloud-based analytics and AI, our end-to-end biomarker sensing platform includes a range of hardware and software solutions that enable the non-invasive, continuous, and real-time monitoring of multiple biomarkers. Leveraging our world-class expertise in silicon photonics, we have miniaturized the capabilities of lab spectrometer into a compact form that can be integrated into wearable consumer devices and medical monitoring systems. This revolutionary breakthrough should enable three critical capabilities: • Detecting and measuring multiple biomarkers non-invasively with a single device • Monitoring biomarkers on a routine, round-the-clock, near real-time basis • Creating new opportunities to enhance multiple clinical workflows In addition to monitoring individual biomarkers, understanding how these biomarkers interact with each other and with other factors is equally critical. Our analytics and AI have the potential to identify patterns for individual biomarkers and deliver a holistic assessment of a person's overall health and well-being. Continuous health monitoring is the next evolution for medical device manufacturers and the healthcare industry. Rockley's ability to deliver real-time insights could have a transformative impact on personal health and well-being — from day-to-day health management to the early detection of diseases. Armed with these insights, consumers could make better-informed decisions about their health and lifestyle, and healthcare providers could make better-informed decisions for their patients.

About Route 92 Medical, Inc. Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design. Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to treat challenging diseases such as stroke. Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the world's leading clinicians with the goal of improving procedural and patient outcomes. The Monopoint operating platform received U.S. FDA 510(k) clearance in 2020. The company is currently enrolling the SUMMIT MAX randomized controlled trial under an FDA-approved Investigational Device Exemption.

RTI Surgical (RTI) is a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. We focus on specialized clinical segments, including breast and plastic surgery, sports medicine and orthopedics, and neuro and spine surgery. Our Mission is to enhance patients' lives by creating the best clinical outcomes through innovative, high-quality medical solutions.

Rx-360 is a pharmaceutical industry consortium that aims to improve the quality and security of supply chains for proprietary and generic pharmaceutical companies and suppliers.

RxFunction®, Inc. is a medical device company with a mission to design and market medical technologies that improve balance, increase mobility, and enhance confidence for patients. Walkasins® Lower Limb Sensory Prosthesis is clinically proven to improve gait and balance, and reduce the risk of falls. Walkasins replaces part of the lost nerve function for the feet. It is intended for individuals who experience numbness in their feet and struggle with mobility problems due to peripheral neuropathy. Walkasins is only available by prescription. To learn more, please visit us at www.rxfunction.com. RxFunction created Walkasins by building upon patented technology developed by co-founder and scientist Lars Oddsson, PhD. Development of Walkasins was supported by Small Business Innovation Research grants from the National Institutes of Health and is manufactured in Minnesota. RxFunction is the exclusive provider and manufacturer of Walkasins. Caution: Individual results and activity levels while using Walkasins may vary depending on many factors. There are risks associated with the use of this product and there are certain individuals who should not use the product. Only a qualified clinician can tell you if this product is appropriate for you and your individual circumstances. Please consult with your healthcare team for complete information regarding benefits, risks, and possible outcomes.

RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery. The company’s mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every unique eye.

RyMed Technologies, LLC specializes in the development and marketing of innovative safety products for intravenous catheter management. RyMed's products are designed to reduce the two most critical vascular access catheter complications of Catheter-related Bloodstream Infections (CR-BSI) and Intraluminal Thrombotic Catheter Occlusions. RyMed manufactures and distributes the InVision-Plus® needleless connector with Neutral Advantage™ Technology and the InVision-Plus CS--the only needleless connector treated with Chlorhexidine and Silver. RyMed's Neutral Advantage Technology meets a 10-Point Standard; ten features designed to work together to maximize intraluminal catheter protection and prevent catheter-related bloodstream infections (CR-BSIs). RyMed also represents PICC Guard, the only FDA cleared Tamper-Evident and Tamper Resistant technology. PICC Guard can address your opioid epidemic concerns while providing patient centered care.

SafeGuard Surgical provides biodegradable surgical devices that will ensure safer surgery for superior patient outcomes while reducing costs, preventing additional surgical interventions and reducing patient length of stay, but most importantly preventing mortality and morbidity which is much too common risk from surgery. Our mission is a scalable and sustainable innovative global outreach to improve surgical outcomes in advanced surgical procedures adapting US ideas in underdeveloped and advancing outcomes in contemporary nations.

SalutarisMD is a medical device company that specializes in engineering a novel ophthalmic treatment for Wet age-related Macular Degeneration with a minimally invasive procedure.

At the heart of every great company, you will find an idea that spawned a product, a product that fostered a culture, and a culture that created a brand. A brand that stands uniquely alone in a crowded marketplace. SAM Medical is no exception. What began as a spark of innovation, when founder Dr. Sam Scheinberg saw a groundbreaking medical innovation in a simple gum wrapper, is now a globally recognized brand of emergency medical solutions. Military, law enforcement, fire & rescue, hospital staff–if someone is in the hurt business, odds are they know and trust SAM Medical. To serve these diverse customers and fuel our founder's passion for innovation, SAM has built a world-class organization. Based just outside of Portland, Oregon–a bioscience and technology hub–our Tualatin facilities provide access to best-in-class talent and resources. Our corporate offices, research and development lab, manufacturing facilities and warehouses are aligned and integrated to increase the pace of innovation and get our solutions to our customers quickly. In just 35 years we've managed to place our name alongside the most respected, award-winning, medical giants while maintaining the spirit of innovation celebrated in vertically integrated, agile start-up organizations.

Sana is a digital heath company driven by 25 years of research into relief for symptoms of chronic pain and insomnia. Sana is developing the first non-invasive, comfortable bio-therapeutic device capable of inducing a deep restorative state of relaxation to alleviate pain and tension. The device provides relief in just 10 minutes through the use of audio-visual neuromodulation, and is currently undergoing FDA certification and clinical trials.

Sanovas, Inc. is a life science asset holding company that is developing and accelerating companies that create medical technologies which are advancing the next generation of minimally invasive surgical tools and technologies.

As an emerging leader in the development and commercialization of energy transfer technology, SANUWAVE® presents products that help expedite wound healing on a cellular level. SANUWAVE's easy-to-use ENERGY FIRST® product portfolio works to help heal some of the most difficult, stalled, or hard-to-heal wounds by activating the body's normal regenerative process using an assortment of energy waves, from shockwaves to ultrasound. SANUWAVE values patient comfort and the importance of wound healing, recognizing its' value to not only improve patient quality of life but to help avoid further complications that could lead to amputation or even lives lost. SANUWAVE's minimally to completely non-invasive technologies can help wounds heal with little to no pain or discomfort. Most treatments can be done in under ten minutes, however, results may vary depending on wound size and patient response to treatment. The UltraMIST System delivers low-frequency ultrasound to the treatment site using a noncontact fluid (e.g., saline). MIST Systems produce a low energy ultrasound-generated mist used to promote wound healing through wound cleansing and maintenance debridement by the removal of fibrin, yellow slough, tissue exudates, and bacteria. The MOA includes control of inflammation, augmentation of local tissue perfusion, wound bacteria and bacterial biofilm reduction, increased angiogenesis, and more. The dermaPACE System is an advanced wound care device that utilizes pulsed acoustic cellular expression (PACE®) technology, a proprietary form of focused, extracorporeal shockwaves. It is the first shockwave system to be FDA-cleared for the treatment of diabetic foot ulcers (DFU). For general inquiries, please email: info@sanuwave.com

Saranas has developed a technology that allows for the early detection and monitoring of bleeding complications associated with vascular access procedures. The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel. By sensing a change in the vessel's electrical resistance, the Early Bird is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex cardiac interventions, where the femoral artery or vein is used to gain vascular access to the heart. The technology was invented at the Texas Heart Institute.

In vitro diagnostic company, specializing in the production of antibodies, controls, blockers including HBR. - Clean Rooms - Filling - Finishing - Packaging - Sub-Assembly - Inventory Space - Kit Manufacturing - Lyophilization - Antibody Production - Medical Device Manufacturing

At Scientia Vascular, we believe that without access, therapy can not exist. Through cutting-edge innovation, we're answering our calling to radically disrupt the way diseases of the brain are treated. Our teams have been at the forefront of neurovascular systems, pushing beyond established boundaries to deliver the products physicians and patients need most.

SecondWave Systems is a pioneer in the emerging field of bio-ultrasonic medicine. The company is developing a first-of-its-kind noninvasive, wearable ultrasound stimulation platform that will give patients and their physicians a new option for treating debilitating or life-threatening disease.

Securisyn Medical is dedicated to creating and cultivating an approach to airway management that will enhance airway safety, prevent unplanned extubation and its associated complications, provide peace of mind for patients, their families, and practitioners and decrease healthcare costs through ethical, profitable, and sustainable business practices.

Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM"​) system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. Offering proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world. TransDermal Infusion delivers HA, Botox, Fillers, Hair Restoration, PRP & more without needles, downtime.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure's Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure's cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Sequence Inc. provides turn-key consulting solutions and services for the biopharmaceutical manufacturing industry with a focus on Commissioning, Qualification and Validation (CQV) and Digital Solutions for facilities, utilities, equipment, computerized systems and labs. Through a fully functional, mock pharmaceutical manufacturing training facility, consultants are trained in a hands-on environment that is unique in the industry that includes both equipment and software. Founded in 2002, Sequence provides consulting solutions to clients across the U.S. and parts of Europe. The company is headquartered in the heart of RTP in Morrisville, NC with a second hub in Framingham, MA.

Seraph Biosciences, Inc. is a biomedical device company headquartered in Detroit, Michigan. The company was founded in 2014 with the primary purpose of commercializing its groundbreaking, diagnostic technology known as Seraspec®. Seraph's team consists of seasoned academic physicians, biomedical engineers, artificial intelligence experts, and device commercialization professionals tasked with combatting the major public health crises of our time. By leveraging the principles of Raman Spectroscopy, Seraspec® represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral and fungal pathogens. Seraspec's® patented technology and method of detection effectively eliminates the need for time-consuming and costly laboratory-based methods of specimen collection, processing and pathogen identification. Safety, efficiency, accuracy and profitability are simultaneously enhanced through a portable, point-of-need technology for real-time pathogen detection and identification. A higher power just got involved in the fight against infection.

SFC Fluidics, Inc. has a mission to advance healthcare and improve quality of life through our enabling microfluidic technologies. The company's vision is to become a recognized global leader in the drug delivery, with a focus on insulin, and health monitoring markets where our unique product lines improve lifestyle and affordability. SFC Fluidics® is a VIC Technology Venture Development™ portfolio company.

Shape Memory Medical is dedicated to developing innovative embolization solutions for peripheral vascular, cardiovascular, and neurovascular markets. We are the first medical device company to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology (smart polymer) to a vascular market. We look towards what lies ahead, as we develop an aortic portfolio to address clinical needs and shape the future of sealing and healing.

ShiraTronics is a forward-thinking medtech startup committed to revolutionizing the field of migraine medicine with our minimally invasive neuromodulation system. Our mission? To transform the lives of those facing Chronic Migraine by reducing headache days and restoring quality of life.

Sibel Health, through engineering excellence, will deliver Better Health Data for All by developing soft, flexible sensors that are powered by advanced analytics, operated by best-in-class software, and integrated with the cloud optimized for artificial intelligence and machine learning.